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ABSTRACT

The development of materials for tissue regeneration, cell manufacturing, and drug
delivery is possible by the manipulation of polymer properties and the use of three different
techniques including layer-by-layer, electrospinning, and molding technique.

By applying the layer-by-layer technique over biomaterials, it is possible to develop
polymeric multilayers that promote a more favorable environment for cellular functionality,
increasing the possibility of improving their acceptance in the area of implantation. IRVASE
demonstrated being a powerful technique that allows for a reliable characterization of the
physical-chemical and thermal properties of the fabricated surfaces. This opens the possibility to
monitor the design of surfaces with specific characteristics, with the use of different polymeric
combinations or the number of formed multilayers over the surface. In addition, other results
presented here have demonstrated that the multilayers could be a platform to induce signals to
cells and improve their cellular activities, promoting the manufacturing of cells of high quality.

On the other hand, this dissertation has demonstrated that nanofibrous materials that
mimic the physical or morphological characteristics and a large percentage of the chemical
composition of the extracellular matrix of tissue in the human body could also be designed by
applying

the

electrospinning

technique.

It

was

possible

to

develop

collagen

and

collagen/hydroxyapatite nanofibrous membranes for soft and bone tissue regeneration,
preserving the chemical structure and biological function. Through the manipulation of the
electrospinning equipment, voltage, and injection flow, it is possible to obtain control over the
diameter, morphology, and orientation of the nanofibers.

Finally, polymers can also be used to design a microneedle patch useful for drug delivery
by applying the molding technique. This work demonstrated that a microneedle patch of chitosan

was successfully created for the delivery of meloxicam. Chitosan/meloxicam patches presented
an organized distribution and homogeneous dimension of microneedles. Results revealed that
the chemical composition of chitosan and meloxicam were successfully preserved, and a
penetration study showed a sustained insertion of microneedles in cadaver skin of a cow’s ear.
This dissertation demonstrated that polymers have the capacity to be used to fabricate
materials for tissue regeneration, cell manufacturing, and drug delivery application.
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All Rights Reserved
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INTRODUCTION
Biomaterials have been defined as a material used as a medical device that interacts with
other biological systems with the intention of evaluating, treating, increasing, or substituting a
tissue, organ, or function in the human or animal organism. Within their more relevant
characteristics, they are biochemically compatible, not toxic, not irritable, hypoallergenic, and not
carcinogenic [1]. In addition, biomaterials have abundantly been fabricated out of materials such
as metals (medical implants, knee implant, hip implant), polymers (mammary implants, contact
lenses or ocular lenses), and composite materials (dental implants) [2].

Polymers have demonstrated being useful for the fabrication of biomaterials with excellent
properties capable of replicating specific characteristics, functions, or mechanisms in the human
body. Polymers such as chitosan [3], hyaluronic acid [4], heparin [5], among others, have
demonstrated to offer antimicrobial [6], and anticoagulant [7] properties. In addition, polymeric
systems have facilitated the promotion of processes such as cell adhesion, proliferation,
differentiation, and tissue regeneration [8][9]. In addition, they have been abundantly used to
prepare devices for drug delivery applications [10]. Many of these biomaterials have been
elaborated in several presentations such as hydrogels [4][11], sponges [12], nanofibers [13][14],
or in multilayers [15][16] by using distinct techniques such as layer-by-layer [17], lyophilization
[18][19], spin coating [20][21], drop-casting [22], electrospray [23], and electrospinning [24].
This dissertation is focused on developing biopolymeric materials for tissue regeneration,
cell manufacturing, and drug delivery by using three different techniques, including the layer-bylayer, electrospinning, and molding technique.

Layer-by-layer (LbL) is a technique that utilizes electrostatic forces of polymers to
generate multilayers over surfaces [25]. Through their research, Catherine Picart [26][15] and M.
J. Kipper [17][3] have demonstrated the positive effect encouraged over cellular adhesion and
1

biocompatibility by the fabrication of polymer multilayers over the biomaterial’s surface, applying
the layer-by-layer technique. Their significant progress has been with the use of peptides [27],
growth factors [16], or chemical agents such as crosslinking [28] added over the layers.
Biochemical signals have offered the capacity of stimulation and cell development, offering
benefits over the regeneration of different tissues in the human body. In the field of cell
manufacturing, polymeric multilayers or functionalized multilayers with biochemical signals should
be further explored, with the purpose of knowing if these surfaces offer the capacity of promoting
a robust and scalable biomanufacturing of cells for therapeutic purposes. Hence, the LbL
technique was used to explore these assemblies for cell manufacturing of human mesenchymal
stem cells (h-MSCs) using biochemical signals as cytokines or cocultures with cells of the immune
system. In addition, a full characterization of physical-chemical, mechanical, and thermal
properties for a synthetic and natural system of multilayers was carried out.

On the other hand, the electrospinning technique is a versatile technique to intimately
simulate the morphological characteristics of the extracellular matrix (ECM) in scale, orientation,
and geometry [29][30][31]. Electrospinning is a technique in which a polymeric solution is
exposed to a high voltage by pumping the solution through a needle attached to a high voltage
power supply, generating a nanometric fiber when the solvent is evaporated through the action of
an induced electromagnetic field [32]. Today, multiple researchers have reported the development
of collagen nanofibers and their in-vitro studies as promising results to possibly name collagen
nanofibers as an ideal scaffold [33][34]. This is because collagen is one of the main components
of the ECM of all connective tissues [35]. Type I collagen is found abundantly in the skin, bone,
tendon, ligaments, and cornea [36]. However, a problem has been evidenced when using highly
toxic solvents such as triﬂuoroacetic acid, [37] triﬂuoroethanol [38], and 1,1,1,3,3,3,-hexaﬂuoro2-propanol (HFIP) [39][40] in the fabrication of collagen nanofibers. Even though these solvents
help in the production of “collagen nanofibers,” recent results show that nanofibers obtained did
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not preserve the chemical structure of collagen [41]. These fluorinated solvents disrupt the
collagen’s secondary structure, converting the electrospun collagen into gelatin [24]. Therefore,
the electrospinning technique will be used to study the fabrication of collagen nanofibers and
collagen/hydroxyapatite with benign solvents that help preserve the chemical structure of collagen
and allow for their use as potential platforms for bone tissue regeneration.

The molding technique has been used in the pharmaceutic industry to present different
ways to deliver drugs. This technique has been useful to make tablets, capsules, and
sophisticated systems such as a microneedle patch. A microneedle patch is a platform composed
of needles uniformly organized and designed to painlessly penetrate the skin at a controlled
depth, avoiding stimulation of nerve endings [42]. Many researchers in the veterinary field have
been working on the well-being of livestock animals [43]. Today, they have identified that the
degradation time of the drug is a problem. Drugs such as flunixin meglumine, which is a pain
management medication for livestock animals, has a degradation half-life of only 6.2 hours. Other
drugs have longer half-lives, such as meloxicam, which has a relatively long half-life of 28 hours.
Currently, researchers are working on finding new alternatives to improve and control the
degradation time and administration of different drugs. Consequently, the last goal of this
dissertation was focused on fabricating a chitosan-based biodegradable polymeric microneedle
patch by the molding technique for the delivery of meloxicam as a pain management drug
approach for cattle.
Each chapter of this dissertation represents published investigations as the first author,
which were published during the doctoral studies in peer-review journals and editorials. The
literature review presented in this chapter is orientated on the three topics that make up this
dissertation: Human mesenchymal stem cell manufacturing (Section 1.2) supporting chapters 2
and 3, electrospun collagen scaffolds for tissue regeneration (Section 1.3) supporting chapters 4
and 5, and microneedle chitosan patches for drug delivery (Section 1.4) supporting chapter 6.
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CHAPTER 1.

1.1.

Literature Review

Effects of Physical, Chemical, and Biological Stimulus on h-MSC Expansion and
their Functional Characteristics

1.1.1. Abstract
Human adult mesenchymal stem or stromal cells (h-MSC) therapy has gained
considerable attention due to the potential to treat or cure diseases given their
immunosuppressive properties and tissue regeneration capabilities. Researchers have explored
diverse strategies to promote high h-MSC production without losing functional characteristics or
properties. Physical stimulus including stiffness, geometry, and topography, chemical stimulus,
like varying the surface chemistry, and biochemical stimuli such as cytokines, hormones, small
molecules, and herbal extracts have been studied but have yet to be translated to industrial
manufacturing practice. In this review, we describe the role of those stimuli on h-MSC
manufacturing, and how these stimuli positively promote h-MSC properties, impacting the cell
manufacturing field for cell-based therapies. In addition, we discuss other process considerations
such as bioreactor design, good manufacturing practice, and the importance of the cell donor and
ethics factors for manufacturing potent h-MSC.
1.1.2. Introduction

The demand for human adult mesenchymal stem or stromal cells (h-MSC) has increased
in the past 20 years [1]. The tissue regenerative capacity and immunosuppressive potential [2]
along with the self-renewing and clonogenic characteristics make them uniquely suited for a
myriad of clinical applications and cell-based therapies [3][4][5]. h-MSC have the ability to
differentiate into 3 main lineages: adipocytes, osteoblasts, and chondroblasts [6]. h-MSC
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therapies have been proposed as treatment for Alzheimer’s disease using 174 million cells per
patient (M-Cells/P), amyotrophic lateral sclerosis (126 M-cells/p), orthopedic diseases (bone and
cartilage)(101 M-cells/p), cancer (132 M-cells/p), cardiovascular disease (120 M-cells/p), Crohn’s
disease (1508 M-cells/p), diabetes (375 M-cells/p), erectile dysfunction (15 M-cells/p), graft versus
host disease (578 M-cells/p), hematological disease (192 M-cells/p), kidney disease (261 Mcells/p), liver disease (420 M-cells/p), lung disease (451 M-cells/p), lupus (70 M-cells/p), multiple
sclerosis (190 M-cells/p), Parkinson’s disease (168 M-cells/p), psoriasis (420 M-cells/p), and
spinal cord injury (109 M-cells/p) [1].

In the year 2000, the consumption of h-MSC for clinical and academic/preclinical work was
about 1x1011 total cells. Recent reports have shown higher consumption values up to 7x10 12 total
cells, which indicate an exponential increase in the coming years [1]. Jon A. Rowley and
colleagues have indicated that by 2040 the h-MSC consumption will be focused on five
applications: 1) Therapeutic products with a demand of at least 300 trillion cells; 2) Tissue
engineering with 33,600 transplants and 185,000 limb amputations per year in the USA (278 trillion
cells only for bone tissue engineering); 3) Products derived from h-MSC like raw materials for
clinical trials, extracellular vesicles, protein/cytokine production (300 trillion cells); 4) Systems and
synthetic biology where h-MSC will be used in gene silencing, potency, targeting, molecular
engineering, and biodistribution; 5) And Emerging industries, like cosmeceuticals and engineered
biomaterials [1].

Therefore, the demand for h-MSC could become a big problem if the cell manufacturing
field cannot accommodate the production line to supply future needs. Given the high number of
patients and the millions of cells per patient required, it is necessary to explore ways in which
processes can improve to meet the demand. Expansion methods and technologies employed in
the cell manufacturing process, like planar and 3D bioreactors, have been essential to produce
higher amounts of h-MSC. However, such methods still fall short to meet the high demand for
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cells with the expected potency. Thus, there is room to explore new strategies that enhance and
support the manufacture chain process to obtain not only large quantities but also high potency in
the final cell-based product.

Figure 1-1. This review article focuses on the role of different stimuli on h-MSC behavior that
could lead to more efficient manufacturing processes. Reprinted from Annals of Biomedical
Engineering, 48, Castilla‐Casadiego D. A., Reyes-Ramos A. M., Domenech M., Almodovar J.,
Effects of physical, chemical, and biological stimulus on h-MSC expansion and their functional
characteristics,1-17, Copyright 2020, with permission from Springer.

This literature review, as illustrated in Figure 1-1, describes the role of different stimuli on
h-MSC behavior for more efficient manufacturing processes by increasing productivity and
retaining desired properties of h-MSC will positively impact cell-based therapies. The effect of
surface chemistry and physical stimulus in cultures including the type of culture substrates,
substrate stiffness, and other aspects of geometry and topography of materials on h-MSC
expansion and potency are discussed within the cell manufacturing perspective. Also, the
influence of culture parameters and biochemical stimuli such as cytokines, hormones, small
molecules, and herbal extracts are discussed as potential strategies to promote cell growth, the
reduction in consumption of culture components derived from animal sources, and the refinement
of potent immunosuppressive properties expressed in manufactured h-MSC. Finally, ethics
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factors, sustainable banks for the future, issues, and challenges of good manufacturing practices
are briefly discussed.
1.1.3. Response to Physical, Chemical, and Biological Stimuli

1.1.3.1.

Culture Substrates

h-MSC respond to physical and chemical signals presented by the local microenvironment,
such as surface chemistry, substrate stiffness, topography, and 3D materials including nanofibers
or hydrogels [3][4][7][8]. Culture substrates composed of either synthetic or natural polymers
together with biophysical cues are a promising strategy for supporting and enhancing the cell
manufacturing process. In recent years, natural and synthetic biomaterials have been created,
which are capable of mimicking the native extracellular matrix (ECM) through cell organization,
mechanical forces, and bioactive molecule delivery [9][10]. Interactions with different physical
cues require a broad understanding of how h-MSC could be affected by the phenomena
mentioned above. For example, mechanical properties of substrates, such as stiffness and
elasticity, modulate the behavior of h-MSC during culture and those effects persisted after several
rounds of cell expansion [11]. This "mechanical memory" state will likely impact cell safety and
potency in tissues [12][13]. In the next sections, the recent advances and limitations of culture
substrates for cell manufacturing applications are summarized.

1.1.3.2.

Tissue Culture -Treated Plastic (TCP)

Cell isolation and expansion processes are performed on traditional tissue culture-treated
plastic (TCP). TCP has been the preferred choice for cell culture due to its excellent cell adhesive
properties, optical transparency, and biocompatibility. Although for most cells high-fold cell
expansion is facilitated, TCP substrates have a stiffness and are incapable of supporting matrixmediated signaling. Several studies have shown that when h-MSC are cultured for extended times
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on TCP they lose their proliferative capacity and multi-lineage differentiation potential
[14][15][16][17][18]. Moreover, after several passages, h-MSC enter into a “senescence” state,
which leads to permanent cell cycle arrest. Work by Yang and colleagues shows that h-MSC can
develop mechanical memory if expanded on TCP, meaning that cells can store past signals of a
culture microenvironment. This behavior was monitored through the activation (nucleus location)
or deactivation (cytoplasmic location) of the transcriptional coactivator YAP/TAZ and RUNX2
genes on TCP and soft hydrogels, which affected cell potency after in vivo transplantation [17][19].
In addition to transcriptional activity, changes in cell behavior can also be perceived by the loss of
the elongated morphology and the appearance of abundant large and flat cell clusters in a culture,
both indicators of cell differentiation. For example, Dolley and collaborators studied the expansion
of human bone marrow MSCs (h-BMMSC) cultured using a serum-free defined medium on
Corning Synthemax surface, TCP, and ECM coatings and compared it to standard culture
conditions supplemented with serum [20]. Their findings showed that cells seeded in Corning
Synthemax surface and ECM coatings presented similar cumulative cell number for all sixty days
of testing [20]. Both surfaces with serum-free medium reported a production of approximately
1x1014 cells in sixty days. However, TCP with serum only yielded 1x10 9 cells in the same time
period. Additionally, cells maintained the normal elongated and spindle-like morphology on the
different substrates except on TCP. Such changes in cell behavior associated with the use of TCP
as the main culture surface limits its continued use in the propagation of h-MSC and has been the
main motivation for the engineering of culture substrates. Potential alternative substrates for hMSC cultures are summarized in the next sections and are grouped based on the physical
properties examined.

11

1.1.3.3.

Stiffness

Mechanical properties impact h-MSC proliferation, maintenance of phenotype, and
differentiation [21][22]. The stiffness of the culture substrate is one of the significant properties
impacting the differentiation potential and phenotype of h-MSC. Stiffness is a measure of stretch
ability and rigidity of the materials [23] and it is typically obtained from the slope of the linear region
of the stress-strain curve, “Young’s modulus”, where stress and strain are representing strength
and ductility, respectively [24]. Cells can exert traction forces generated from cytoskeleton’s
tension on the substrate due to its stiffness [12] leading to the activation of mechano-transductive
signaling that modulates cellular activities [25][26]. Thus, the substrate stiffness influences the
cell’s adhesion strength and surface spreading [27].

The differentiation of h-MSC into different cell lineages is one of the main cellular functions
impacted by substrates stiffness. For example, stiff surfaces induce osteogenesis, whereas softer
substrates support adipogenesis and decreases the proliferation rate [28]. Therefore, it is vital to
consider the mechanical properties of the substrates to avoid undesired changes in cell
differentiation during the expansion process [29]. Li’s team evaluated different ranges of stiffness
to examine the impact on fibrotic cell behavior, which has a direct relationship with the preservation
of stem cells characteristics [17]. They found that surfaces of low stiffness (2-5 KPa), which fell in
the range of those reported for soft tissues, inhibited fibrogenesis as compared to TCP (2 GPA).
Moreover, substrates of high stiffness (50-100 kPa) induced cell fibrogenesis [17][30] suggesting
the potential of soft substrates to preserve the stem cells characteristics. Kureel and colleagues
also examined the impact of stiffness in stemness and growth by measuring cell doubling times
and differentiation potency in polyacrylamide-based substrates of variable stiffness. The
cumulative doubling time of umbilical-cord and bone-marrow derived h-MSC seeded onto a
polyacrylamide gel of Young’s modulus of 5 kPa showed an increase of nine times higher
population doubling in comparison to h-MSC seeded on TCP. Also, the adipogenic differentiation
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potential was limited in TCP [31], further supporting the mechano-sensorial capability of h-MSC.
Thus, soft substrates represent a good alternative to maintain the differentiation capability and
enhanced growth rates; however, the stiffness of the culture substrate needs to be tailored early
during the cell expansion process to meet the desired therapeutic application.

1.1.3.4.

Fibrous Scaffolds

Scaffolds represent an ideal structure as a substrate for cell growth, mimicking their
environment. Several scaffolds have been created with a fibrous or flat organization, where the
mechanical properties in combination with changes in surface morphology/chemistry provide a set
of biophysical cues to guide cell behavior through cell-material interactions [32]. Fibrous
substrates are typically fabricated by phase separation, melt spinning, self-assembly, twisting,
braiding, knitting and electrospinning methods [33]. Electrospinning is a promising technique
where ultrafine fibers are obtained by electrically charging a polymer solution droplet [34]. This
technique enables the generation of fibrous substrates and controls over the physical parameters
including fiber diameter, density, and anisotropy, to generate substrates that mimic the natural
fibrous structure and architecture of the native extracellular matrix [35][36]. Fibrous substrates
have been shown to modulate important cellular processes such as cell growth and migration, but
little is known about how fibrous substrate could help in the expansion and manufacturing process
of h-MSC, since many of the studies have been made with non-human cells. Li and colleagues
reported using PLGA electrospun fibers to observe if h-BMMSC had good interactions with the
engineered microenvironment. They reported that cells seeded onto electrospun fibers maintain
their phenotype, have good adhesion and proliferation, and had a five fold increment in the total
cell number by day ten [34]. Similar results were reported by Baker and co-workers using synthetic
fibrous material and hydrogels with different stiffness levels composed of methacrylated dextran.
Cell proliferation of h-MSC on the stiff hydrogel substrates resulted in a 15% higher return than hMSC seeded on soft hydrogels, while the soft fibers showed a 10% increase over h-MSC on stiff
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fibers networks [35]. Thus, the alterations observed in the behavior of h-MSC as a consequence
of the fibrous or flat state of the substrate indicate that the structure of the material is also an
important property to consider in the design of culture substrates for cell manufacture applications.

1.1.3.5.

Topography

Physical cues of the cellular microenvironment are considered important factors in cell
function. These cues directly affect the cells mechano-sensitivity due to the cell-substrate
interactions. The substrate topography, including geometry, is based on surface modifications with
different shapes to generate mechanical stress in the cells, therefore affecting cell behavior [37].
Research performed by Lee J and colleagues showed that geometric cues (different shape and
size) on hydrazine-modified polyacrylamide (PA) hydrogels are more favorable to the activation
of stemness markers. They evaluated the role of substrate stiffness, such as 0.5 KPa (soft) and
30 KPa (stiff), combined with different geometries, i.e., circle, oval and star, on the maintenance
of the h-MSC phenotype. They concluded that soft substrates and micro-patterns can regulate the
spreading and cytoskeletal tension, enhancing the expression of h-MSC multipotency markers
[38]. On the other hand, Seunghan Oh and colleagues were interested in controlling the expansion
of undifferentiated h-MSC, as well as regulating their differentiation using variation in surface
geometry. They found that TiO2 nanotubes with a specific diameter of 30 nm promotes adhesion
without differentiation and strongly enhances cellular activities compared to smooth TiO 2 surfaces;
however, larger diameters between 70-100 nm induce selective differentiation to osteoblast.
Therefore, there is a way to enhance cell adhesion during cell expansion, controlling h-MSC fate
[39]. In addition to geometries, topographical characteristics are perceived by h-MSC and shown
to influence behavior by altering gene expression patterns that directly impact cell growth,
adhesion, and differentiation [38]. McMurray and co-workers examined the impact of
nanotopographies as an easy-to-use and easy-to-manufacture surface to maintain multipotent
characteristics on bone marrow and adipose-derived h-MSC. They found that polycaprolactone
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(PCL)-based nanotopographies with 120 nm pits in a square arrangement with a center-center
spacing of 300 nm were supportive of cell expansion for up to 8 weeks without losing stem-cell
phenotype h-MSC [40]. These findings suggest that both geometry and topography can be
incorporated into culture surfaces to stimulate a desired phenotype of h-MSC. Additional studies,
including a broader pool of h-MSC sources and mechanistic evaluation, are needed to determine
its potential applicability to achieve reproducible alterations in the therapeutic potency of h-MSC.

1.1.3.6.

Surface Chemistry

Surface chemistry modification has been studied as a potential option to retain h-MSC
expansion without affecting functional characteristics. These modifications include the
immobilization of polymers and small molecules on the surface through covalent bonding,
electrostatic interaction, and hydrophobic bond methods. These alterations have demonstrated
moderate cell adhesion and prevent undesired changes in the phenotype and potency of h-MSC
[41][30]. However, studies have reported issues about surface chemistry and the effect on h-MSC
behavior. For instance, the instability of surface modifications is a significant problem. Cell
adhesion is directly related to surface hydrophobicity due to the interaction with serum proteins
[42]. Curran and co-workers performed a comprehensive study of the impact of functional groups
on h-BMMSC behavior. Main functional groups found in biological systems, including methyl (CH3), hydroxyl (-OH), carboxyl (-COOH), amino (-NH2) and silane (-SH), were evaluated. Results
showed that these modifications could enhance or commit the cell to a specific lineage. For
example, the –NH2 and –SH-modified surfaces promoted and maintained osteogenesis while the
–OH and –COOH-modified surfaces promoted and maintained chondrogenesis. Thus, functional
groups can be used to complement traditional cell differentiation methods using culture media
preparations to either reduce or replace the need for cytokines and growth factors [42][43]. Even
though the functional chemistries showed good results for promoting cell differentiation, they are
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not appropriate for h-MSC expansion from a manufacturing standpoint because of the inability to
maintain an undifferentiated state in the bulk population.

An alternative approach is to use polyelectrolyte multilayers to functionalized culture
surfaces using natural polymers. Our research group has demonstrated that it is possible to create
bioactive surfaces via the layer-by-layer assembly method to improve h-MSC activities and
responses [44][45]. Multilayers of heparin and collagen (HEP/COL) were used to prepare the
bioactive surface onto TCP to enhance h-MSC response to soluble interferon gamma (IFNgamma). Multilayers were formed varying the final layer between COL and HEP and
supplemented with IFN-gamma (50 ng/ml) in the culture medium. Even though IFN-gamma is a
cytokine associated with innate and adaptive immunity, combating viral infections, bacteria, and
protozoa [37], it has an antiproliferative effect reported for many kinds of cells [46][44][34]. The
results showed that this polymeric system reduces the antiproliferative effect of IFN-gamma. HEPending ﬁlms supplemented with IFN‐gamma presented a better proliferative effect compared with
COL-ending ﬁlms and TCP (surface without HEP/COL multilayers). Furthermore, HEP-ending
ﬁlms supported the high expression of cytokines, including interleukin-6 (IL-6), vascular
endothelial growth factor-A (VEGF-A), basic fibroblast growth factor (FGF-2), and colony
stimulating factor 1 (M-CSF) as compared with the other conditions examined. Hence, this system
may be beneficial in cell manufacturing practices because it was able to present a platform
(HEP/COL multilayers + Cytokine/IFN-gamma) which enhanced immunomodulatory properties
and therapeutic potential of h-MSC while eliminating the antiproliferative effect offered by IFNgamma [44]. The role of cytokines as a biochemical stimulus on h-MSC manufacturing is further
discussed in the next section.
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1.1.3.7.

Biochemical Stimulus on Human Stem Cell Manufacturing

Role of Cytokines

Cytokines have demonstrated their potential to stimulate changes in the behavior of human
stem cells, including the promotion of migration [10], proliferation or cell survival [47],
differentiation [48], osteogenesis [49], enhancing and inhibiting chondrogenesis [50],
neovascularization [51], mineralization [52], tissue repair [53], suppressing cellular senescence
[54], immunosuppressive capacity [55], tumorigenesis and angiogenesis [56], along with other
effects such as impairing maintenance and altering hematopoietic support [57]. Consequently,
several studies have demonstrated that cytokines are advantageous for stem cell manufacturing
or h-MSC expansion.

Reduction in Consumption of Culture Components Derived from Animal Sources

Researchers who have used cytokines like IFN-gamma [10], FGF-2 [57][58], VEGF-A [59],
tumor necrosis factor alpha (TNF)-α [60], and granulocyte-macrophage colony stimulating factor
(GM-CSF) [61] have identified that their use is crucial for modulating several cellular activities of
h-MSC, and their effect can be regulated by their concentration [59]. A direct advantage of
supplementing cytokines on cultures of human stem cells is the reduction in consumption of
culture components derived from animal sources such as fetal calf serum [62][63]. One of the
main issues of good manufacturing practices (GMP) in the cell manufacturing field is associated
with the selection of the culture medium. The culture medium of choice is generally of a xeno-free
source, as animal-derived products could potentially transmit unpredicted viruses or other
pathogens [64]. Hence, new media formulations on h-MSC expansion have been focused on
utilizing non-animal derived products to avoid secondary effects or complications that can
compromise cell production [65][66]. Lucas G. Chase and colleagues achieved h-MSC expansion
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using a serum-free medium supplemented with transforming growth factor beta1 (TGF-β1), FGF2, and recombinant human platelet-derived growth factor-BB (PDGF-BB) [19]. Results showed
that PDGF-BB, FGF-2 individually supplemented, as well as combinations of two factors PDGFBB/FGF-2, PDGF-BB/TGF-β1, and FGF-2/TGF-β1 enhanced cellular expansion compared with a
growth factor-deficient serum-free medium (SFM) or 10% fetal bovine serum-containing medium
(SCM). Although these combinations produced promising results, the combination of these three
supplements together provided an enhancing effect on h-MSC proliferation showing phenotypic
retention [62]. Prior studies have also demonstrated that TGF-β1, FGF-2, and PDGF-BB are
sufficient to support h-MSC growth in serum-free medium [67][68]. Muller examined the
proliferative effect of platelet lysate as a supplement, compared with media alone or supplemented
with 5% serum-free media containing fresh frozen plasma (FFP) or 10% fetal calf serum (FCS)
(standard condition) [69]. Several concentrations (1-100 Million-platelets/mL) of platelet lysate
were evaluated in combination with 2.5% FFP. Results showed that media supplemented with
10% FCS duplicated the proliferative effect compared with media containing 5% FFP. However,
platelet lysate supplemented in 2.5% FFP showed a significant advantage in cell proliferation. A
concentration of 10 Million-platelets/mL added to 2.5% FFP demonstrated the same proliferative
effect as that of h-MSC in 5% FFP. Concentrations of 50 and 100 Million-platelets/mL presented
a similar effect compared with h-MSC in 10% FCS. Therefore, it is possible to say that platelet
lysate promotes a positive effect on h-MSC proliferation, and additionally minimizes the use of
fetal calf serum to maintain the cellular culture. These studies demonstrate how a combination of
different cytokines could be useful to significantly reduce or eliminate the use of animal-derived
products, while maintaining or enhancing h-MSC properties. The main limitation of current xenofree media is its costs. Optimization of recombinant cytokine production, as well as the evaluation
of multiple cytokine combinations could lead to xeno-free formulations of reduced costs. Also, it is
imperative to evaluate substitutes for cytokines such as peptides or other small molecules with
reduce manufacturing costs.
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Self-renewal of h-MSC and Retention of Multilineage Differentiation Ability

Another advantage of using cytokines for human stem cell manufacturing is associated
with retention of the multilineage differentiation ability during the process of proliferation [70]. Yukio
Kato and his team worked on identifying a growth factor that was involved in the self-renewal of
h-MSC and the preservation of multilineage differentiation potential [70]. Their findings
demonstrated that FGF-2, which is a potent mitogen for h-MSC, markedly improved the growth
rate of bone-marrow-derived h-MSC in monolayer cultures and the multilineage differentiation
ability of h-MSC was maintained throughout numerous mitotic divisions [70]. Similarly,
Sotiropoulou reported that FGF-2 induces an increase in the proliferation response of h-MSC.
However, this cytokine generates an upregulation of human leukocyte antigen (HLA-class I) and
promotes low human leukocyte antigen – DR isotype (HLA-DR) expression, which is involved in
the regulation of the immune system in humans [71]. Although their results showed upregulation
of HLA, allogeneic immune responses were weak, compared with the responses provoked by
allogeneic peripheral blood mononuclear cells (PBMCs), which consist of monocytes and
lymphocytes (T cells, B cells, NK cells). On the other hand, the in vivo immunosuppressive ability
of h-MSC was enhanced when FGF-2 was added at concentrations above 5 ng/mL supporting the
use of FGF-2 to stimulate the growth of h-MSC for immunosuppressive applications. The
mechanism of action was further investigated by Young Do Kwon and collaborators that examined
the effect of the mitogen-activated protein kinase (MAPK) signaling pathway in the FGF-2
supplemented cultures. MAPKs are known as the main signal transducers for growth factors,
cytokines, and stress. They also control cell proliferation and apoptosis [72]. Results showed that
Jun N-terminal kinase signaling is involved in the FGF-2 induced proliferation and preservation of
the multilineage differentiation ability of h-MSC [72]. Other cytokines of the same family, such as
fibroblast growth factor receptor 1 (FGFR-1), have been demonstrated to induce proliferation, as
well as control the maintenance of stem cell viability [73]. The proliferation effect has been shown
19

by inhibiting the cyclin-dependent kinase inhibitors P21waf1 and P27kip [73]. Although FGF-2 is
known as a potent mediator of proliferation by itself, the effect of FGF-2 and other members of the
FGF family should be examined in combination with either cytokine of the same family or other
types of cytokines to explore improvements on h-MSC proliferation.

Other cytokines such as IL-1 beta have also demonstrated an ability to stimulate h-MSC
proliferation. Alexey E. Bigildeev and his group investigated the effect of IL-1 beta on h-MSC [74].
Specifically, they studied proliferative potential, immunomodulatory properties, and the ability to
support early hematopoietic precursor cells of h-MSC cultured in standard conditions or treated
with 4 pg/ml human recombinant IL-1 beta. Results showed that IL-1 beta promoted cell expansion
and enhanced the potential to maintain a phenotype [74]. Interleukin-17 (IL-17), which is a cytokine
secreted by TH-17 cells [75], was used by Ki and collaborators to evaluate the effect of
supplemented IL-17 at a concentration of 50 ng/ml on h-MSC for up to 8 days [75]. Their results
suggested that IL-17 promotes the growth of these cells as compared to cells without IL-17
supplementation. Their findings showed that after 2 days of culture, significant differences were
observed. In addition, they revealed that the production of reactive oxygen species (ROS) is vital
to favor h-MSC proliferation in the presence of IL-17. Accordingly, cytokines have demonstrated
to be not only useful to minimize issues in GMP such as reducing the use of animal-derived
products but also useful to stimulate h-MSC proliferation.

Improving Immunosuppressive Properties

Manufacturing processes are characterized by quality control of the specifications of their
products. The quality criterion for the immunosuppressive properties of h-MSC is the cytokine
profile and immunomodulatory function. h-MSC have the potential to treat immune-related
diseases due to their immunosuppressive properties [76]. The interaction of cytokines with h-MSC
has positively impacted the cell manufacturing field of h-MSC by improving their intrinsic
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immunosuppressive properties. Many researchers have demonstrated that the supplementation
of IFN-gamma on h-MSC cultures enhances the immunosuppressive properties of h-MSC in
different ways. For example, Keon Hee Yoo and collaborators revealed that IFN-gamma induces
indoleamine-2,3-dioxygenase (IDO) expression, which is a crucial modulator in the
immunosuppressive pathway in h-MSC, through the IFN-gamma-Janus kinase signal transducer
and activator of transcription pathway [76]. Therefore, their results provided a convenient and
practical way of obtaining functionally qualified h-MSC, which can adequately control the immune
response. In addition, their findings recommend that cell therapy based on h-MSC primed with
IFN‐gamma can be used for the clinical treatment of allogeneic conflicts. Similarly, studies by
Todd C. McDevitt also has revealed that IFN-gamma plays a crucial role in stimulating h-MSC
immunomodulatory activity [77]. Their results showed the IFN-gamma induced expression of IDO,
resulting in an augmented and continued suppression of T-cell activation and proliferation [77].
This resulted when his team evaluated the microparticle delivery of IFN-gamma within h-MSC
spheroids an evaluated their immunomodulatory activity. Consequently, McDevitt and his group
concluded that this microparticle-mediated presentation of bioactive IFN-gamma offers a potent
methodology to guarantee and maintain immunomodulation of h-MSC. Comparably, James A.
Ankrum reported that IFN-gamma enhances IDO expression of cryopreserved h-MSC pretreated
at a concentration of 100 ng/ml [78].

Other groups also have suggested that h-MSC stimulated with IFN-gamma consistently
enhance their immunosuppressive properties [79][80][81][82]. Steven R. Bauer reported that
immunosuppressive properties could be predicted by the morphological features of IFN-gamma
stimulated h-MSC [79]. Additionally, Gordana Vunjak-Novakovic reported the inﬂuence of IFNgamma on the proteome and metabolome of therapeutic h-MSC [83]. Results highlighted that IFNgamma at a concentration of 500U/m encouraged the expression of antipathogenic proteins as
well as induced h-MSC to limit inﬂammation and ﬁbrosis while helping h-MSC survival [83]. Also,
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results presented for Jacques Galipeau and his team demonstrated by performing a secretome
analysis study of h-MSC that IFN-gamma is upregulated by h-MSC or downregulated in responder
PBMCs and associated with T cell suppression [84].

On the other hand, researchers such as S. Jyothi Prasanna and her team have reported
that not only IFN-gamma but also TNF-α stimulates the immune properties of human bone marrow
(h-BMMSC) and Wharton jelly mesenchymal stem cells (h-WJMSCs) [85]. Their discoveries
reported that h-BMMSC improved suppression of mitogen motivated lymphoproliferation only
while h-WJMSCs treated with IFN-gamma were exceptional suppressors of mixed-lymphocyte
reactions. Moreover, h-WJMSCs presented a mayor yield than h-BMMSC under the presence of
both pro-inflammatory cytokines treatments [85]. Hence, it is possible to affirm that the interaction
of both cytokines allows the control of the immunosuppressive properties of h-MSC. Likewise,
Patrick T. Coates described that the enhancement of immunosuppressive properties of h-MSC
could be generated under the influence of the proinflammatory cytokine interleukin-17A [86].
In essence, the role of cytokines in human stem cell manufacturing is mainly related to the
reduction in consumption of abundant culture supplements, enhancement of their proliferative
potential, retention of their multilineage differentiation ability, and the enhancement of
immunosuppressive properties of h-MSC. Cytokines can be used to modulate several cellular
activities of h-MSC, and their effect can be regulated by their concentration. In addition, cytokines
contribute to minimizing the use of culture components derived from animal sources which leads
to better GMP, offering a safer production. FGF-2 and IFN-gamma have amply been explored to
modulate proliferation and immunosuppressive properties of h-MSC, respectively. Hence, it would
be interesting to examine the response of these two cytokines working together as a supplement
on h-MSC cultures. Another useful alternative would be to evaluate a cocktail composed of
diverse cytokines to promote the production of robust h-MSC. The impact of cytokines on h-MSC
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culture has mostly been evaluated in a bench scale. It is important that preliminary trails are
performed on larger scales to assess the impact of scalability.
Other Biochemical Agents
Other soluble factors such as hormones [65][87][88], small molecules [89], and herbal
extracts [90] also have been linked to the proliferative potential of h-MSC. 17β-Estradiol (E2) is a
steroid hormone characterized for its role in the modulation of numerous cell functions [88]. Ho
Jae Han et al studied the role of E2 on proliferation and the linked signaling pathways using hMSC. They incubated h-MSC at a concentration of 10 -9 M E2. Their findings showed that E2
increased the cell population by approximately 40% in the S phase compared with the control.
Moreover, they conjectured that E2 induces proliferative activity via estrogen receptors (ERs)
expression in h-MSC. Another hormone, insulin-like growth factor 1 (IGF-1), also has presented
abilities to promote cell proliferation of h-MSC [87]. An interesting finding was reported by Russell
et al who explored the proliferative effect of IGF-1 using a concentration of 100 ng/ml. The results
showed that IGF-1 polypeptide improved the proliferation of small cells (5–9 μm), but not cells
with a size greater than 13 μm [87]. On the other hand, small molecules like GSK3β inhibitor 6bromoindirubin-3'-oxime (BIO) also has been employed to induce h-MSC proliferation in-vitro [91].
In this work, Benoit and collaborators evaluated concentrations of 0, 2, 5, and 10 µM of BIO. Their
results showed that BIO concentrations in the range of 2-5 µM were the most promising for
inducing a proliferative response of h-MSC. Anything above 5 µM resulted in cell death and below
2 µM did not have any significant effect [91]. Herbal extracts such as Dhanwantharam Kashaya
(DK), which is an artificial herbal preparation commonly used in Ayurvedic medicine [91][92], have
been studied on the proliferation of h-MSC [93][94]. Warrier and colleagues examined the
capacity of DK on the proliferation, viability, and senescence of human Wharton jelly MSCs (hWJMSCs) in-vitro [92]. In this study, they treated medium in the absence and presence of DK at
a series of concentrations 5, 7.5, 10, 20, 40, and 50 µg/mL. The results showed that DK
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signiﬁcantly improved the proliferation of cells, describing a dose-dependent behavior. The
maximum effect obtained was at 10 µg/mL [92].

Glucocorticoids, which are a class of steroid hormones involved in the metabolism of
proteins, carbohydrates, and fats and have anti-inflammatory activity, have contributed positively
to the immunomodulatory potency of h-MSC [89]. Jeffrey M. Karp and his team reported that it is
possible to enhance the performance of h-MSC via the intracellular delivery of steroids [89]. Their
findings demonstrated that glucocorticoid steroids increase h-MSC expression and activity of IDO.
They described that h-MSC treated with glucocorticoids, budesonide, or dexamethasone have a
supportive effect on improved IDO expression following IFN-gamma stimulation as well as the
ability to restore IDO expression in over-passaged h-MSC. Another alternative that has been used
to enhance the immunomodulatory capacity of h-MSC is linked to hypoxic pretreatment by
improving the secretion of cytokines and soluble factors associated with immunosuppression
response [95]. J. Wang examined the effects of hypoxia on the immunomodulatory properties of
human

gingiva–derived

MSCs

(h-GMSCs).

They

found

that

hypoxia

improves

the

immunomodulatory properties of h-GMSCs by stimulating the production of anti-inflammatory
cytokines [83]. Numerous other studies reported that hypoxia upregulated the expression of IDO
in human adipose tissue-derived h-MSC [96].

Many researchers worried about the potential risk of infections as well as immunological
reactions that fetal calf serum (FCS) as a supplement may generate. For instance, Karen Bieback
and her team investigated the effects of pooled human AB serum (AB-HS) and thrombin-activated
platelet-rich plasma (t-PRP) versus FCS as the standard control medium [66]. This study was
performed using three separate conditions: 10% FCS, 10% AB-HS, and 10% t-PRP. Results
demonstrated that 10% AB-HS and 10% t-PRP offer a significantly robust proliferative effect on
h-MSC than FCS does. h-MSC cultured using AB-HS and t-PRP exhibited a 3 times higher
expansion compared to cultures with FCS after the first six passages [66].
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In summary, physical, chemical, and biochemical stimuli are crucial during the production
of h-MSC. One of the most important contributions of biochemical stimulus has been the focus on
reducing essential culture components derived from animal sources, which is crucial to eliminate
the potential risk of infections that these sources may offer. On the other hand, even though a
range of biochemical stimuli have been studied, mainly in an individual manner, showing
exceptional results on cell expansion, it is imperative to study further and evaluate the effect of
preparing cocktails using combinations of these stimuli. A combination of cytokines or other
soluble factors, such as hormones, small molecules, and herbal extracts could be used to create
a supportive and robust supplement for fast h-MSC production.

1.1.4. Scaling h-MSC Manufacturing: Strategies to Stimulate Proliferation

The increasing clinical demand for h-MSC requires robust, large-scale production
strategies [1]. To extensively manufacture stem cells, two different cell culture systems have been
identified: planar or monolayer culture system and the 3D system for h-MSC expansion. Planar
systems include T-flasks and multi-layered flasks. 3D systems comprise various bioreactors (wave
stirred tank, rotating wall vessel, packed-bed, roller bottle) and microcarrier-based culture systems
[97][98]. The type of bioreactors has played a significant role on the scaling of h-MSC
manufacturing where their difference in size, geometric design, operational parameters, and the
material of fabrication impact cell production. Likewise, cell culture conditions in bioreactors also
exert a crucial effect on scaling h-MSC manufacturing. In this section, the impact of scaling in hMSC manufacturing in response to cell culture conditions, and operational parameters of
bioreactors will be described.
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1.1.4.1.

Influence of Cell Culture Conditions in Bioreactors

Multiple systems strategies and technologies geared towards maximizing cell culture
expansion have been explored. Strategies include the evaluation of culture parameters such as
different types of culture medium, serum, pH, glucose concentration, agitation rate, and dissolved
oxygen (dO2) concentration [99][100][101][102][103]. The impact of bioreactor design and flow
conditions or shear stress as a biomechanical parameter in regulating h-MSC proliferation has
also been explored [67][104][105]. For example, different types of microcarriers with the main goal
of obtaining which one might be more useful to improve proliferation have been investigated [106].
Similarly, other teams have studied the effect of microcarrier concentration [99][102][107]. Tristan
Lawson and colleagues used a 50 L single-use stirred tank bioreactor to examine the influence of
various culture parameters on the proliferation respond [103]. First, they identified the optimal pH
and dO2 culture set-points. Four distinct pH levels (7.2, 7.4, 7.6, and 7.8) and three dO 2
concentrations (20%, 50%, and 80%) of air saturation were evaluated in cell cultures for 10 days.
Results of a single cell donor showed that a pH between 7.4 and 7.6 provided optimal proliferation.
A total of 5 x108 cells were obtained using pH between 7.4 and 7.6 versus 4 x10 8 cells at pH 7.2
and 2 x108 cells at pH 7.8 for 10 days of culture in 3L bioreactor cultures. Although dO 2
concentrations showed similar growth rates, 80% dO2 was selected to examine the other
parameters. Two culture mediums in combination with two types of serums were examined as
follows: minimum essential medium-α-based medium (αMEM) or Dulbecco’s modified eagle’s
medium (DMEM) with 5% human platelet lysate (h-PL) and αMEM and DMEM supplemented with
10% FBS. Their findings indicate that using αMEM/h-PL a higher cell growth was achieved
compared to the other conditions [103].

Similarly, Christopher J. Hewitt reported that h-PL containing medium increased the hMSC growth rate 20% more compared with the FBS supplemented, and this enhanced
proliferation rate was consistent across all donors examined [101]. In other studies, αMEM has
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been supported as the preferred media for h-MSC. Allen Kuan-Liang Chen reported that αMEM
supported faster h-MSC growth than DMEM, additionally a low glucose concentration (1-1.5 g/mL)
was a more favorable condition in which to obtain improved h-MSC growth yield [99]. Glucose
concentrations between 1-1.5 g/mL presented similar cell concentrations of 4.6x104 cells/cm2.
Higher glucose concentrations of 2 and 2.5 g/L yielded lower cell concentrations of 2x10 4cells/cm2
and 2.5x104 cells/cm2, respectively. Lawson and colleagues used these optimum conditions and
monitored h-MSC expansion in a 50 L bioreactor. Results showed that using αMEM/h-PL or
DMEM/FBS working at optimum conditions made it possible to achieve between 1-1.25 x1010 cells
in 11 days, representing a significantly greater difference in growth compared to the un-optimized
conditions, which produced 4 x10 9 cells in 11 days. In other words, the optimized conditions
increased h-MSC production 2.5 times [103]. Likewise, Donghui Jing and collaborators evaluated
growth kinetics of h-MSC in a 3L single-use, stirred-tank bioreactor by using different
concentrations of lactic acid, dO2, and pH [102]. Results showed that minor concentrations of lactic
acid at 1.1 g/L were favorable to promote cell growth. They obtained cell values of 60x10 4 cells for
0 g/L of lactic acid, 70x104 cells for 1.1 g/L, and 30x10 4 cells for 1.6 g/L. They noticed that larger
concentrations of lactic acid inhibit h-MSC growth. Similarly, pH between 7 - 7.5 was
advantageous to promote cell proliferation as compared to low pH (< 6.8) as previously reported
by Lawson and colleagues [103]. A dO2 concentration between 5 -10% was found superior to 10%
for cell growth [102].
1.1.4.2.

Influence of Operational Parameters in Bioreactors

In addition to cell culture conditions, shear stress generated by a fluid flow can also impact
cell proliferation response in a bioreactor [105]. Teng Ma and collaborators grew h-MSC in a
perfusion bioreactor system to examine the effect of fluid flow. Two flow rates (0.1 and 1.5 mL/min)
were examined on h-MSC growth. Results showed that significant (P<0.05) enhancement in the
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total amount of cells produced were obtained using a low flow rate [105] suggesting that low shear
stress is best for h-MSC cultures.

On the other hand, the capacity of cell expansion has been tested by using different cell
culture technologies. Kamilla Swiecha and her team studied the stimulus capacity of different
bioreactor designs on h-MSC production from 3 different donors [104]. They evaluated a multilayer vessel (ML), a stirred tank bioreactor with microcarriers (STR), a hollow fiber bioreactor (HF),
and a packed-bed bioreactor (PB). Results demonstrated that bioreactor designs can offer a
positive or negative stimulus for cell expansion. Notably, poor cell expansion was obtained in HF
(1x104 cells/cm2 for 5 days), while STR (4.5x104 cells/cm2 for 7 days), ML (4.25x104 cells/cm2 for 6
days) and PB (3.4x104 cells/cm2 for 7 days) achieved an analogous level of production with high
density expansion [104].

Microcarriers have been demonstrated to be a useful support matrix to promote cell growth
in bioreactors [99][60][102][106]. For this reason, many researchers have focused on studying the
effect on h-MSC production. Andrew Ball and colleagues evaluated diverse microcarrier types to
measure their ability to support h-MSC growth including cytodex 1, cytodex 3, fact III, collagen,
plastic, plastic plus, proecntin F, and hillex in suspension in a single-use bioreactor [106]. Their
findings showed that only cytodex 1, cytodex 3, collagen, and hillex produced a robust growth
[106]. Similarly, Françoise De Longueville and his team studied h-MSC growth profiles in BioBLU
0.3c Single-Use Vessel used in suspension with cytodex 1 and cytodex 3 microcarriers [60]. Their
results revealed that cytodex 1 promoted cell expansion demonstrating a yield of approximately
42x104 cells/mL compared with 15x10 4 cells/mL using cytodex 3 for 10 culture days [60]. Other
authors also have studied the effect of microcarrier concentration on h-MSC expansion
[99][102][107], reporting that h-MSC expansion is dependent on the amount of microcarriers in
the bioreactor. Studies by Allen Kuan-Liang Chen demonstrated that h-MSC cultured in spinner
flasks at three different concentrations of cytodex 3 can generate distinct cell numbers [99]. They
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examined microcarrier concentrations of 4, 8, and 12 mg/mL, and their results revealed that 8
mg/mL is the optimum concentration to achieve higher h-MSC propagation [99]. Other studies
have shown that the growth of h-MSC in spinner ﬂasks with proecntin F microcarrier in suspension
is more effective using a concentration of 10 g/L compared with 5, 7.5, and 15 g/L [107].

In summary, the scaling up of h-MSC manufacturing can be controlled by changing the
conditional parameters of the technology used (planar or 3D culture system), varying culture
conditions, and using additives. Moreover, it is important highlighting that for each type of
bioreactor there is a different range of optimal working conditions. Thus, operating conditions
should be explored in future research to standardize cell culture conditions and operational
parameters for each type of bioreactor.

1.1.5. Making Sustainable Banks for the Future

Banking is required to help meet the global demand of the large number of cells required
to cover the health industry. In 2011, Cooper and Viswanathan demonstrated that umbilical cord
MSCs (UCMSCs) could maintain pluripotency, safety, and efficacy after a prolonged storage
period. They tested 5 different samples each with different time points of 1, 6,12, 24 and 36 months
and their results showed negligible differences between all the time points in cell count, viability
(>97%) and immunophenotype (>98) analysis [108]. Their research demonstrated that highquality manufacturing conditions are essential for the future of stem cell banks development. Also,
they indicate that UCMSCs collection procedure is more straightforward than other types of hMSC extraction procedures (e.g. bone marrow extraction which is an invasive and painful
procedure) [109], without ethical concerns and does not harm mothers nor newborns [110]. To
ensure quality and safety, the banking procedure is highly dependent on an optimum
cryopreservation process to guarantee the long-term storage of cells. The significant factors
affecting the cryopreservation process are: 1) optimal cryopreservation media, whether it is
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needed to use a low concentration of dimethyl sulfoxide (DMSO) or non-DMSO [90] in the
cryopreservation protocol and, 2) freezing temperature rate [125] where controlled-rate freezers
[111] were developed, but there is a non-uniform temperature distribution. Following all those
studies, Lechanteur’s group reported a clinical-grade large-scale expansion and bank of h-MSC
during 8 years with 59 validated donors, 464 h-MSC aliquots or bags, and 6 clinical trials of hMSC infusion. Making sustainable cell banks is time-consuming and challenging, with major
challenges in developing a bank with GMP, relevant potency assay, and removing the use of
DMSO [112].

1.1.6. Importance of the Cell Donor
h-MSC studies generate considerable cell-to-cell variations because of the heterogeneity
of cells between donors, tissue of origin and cell populations [113][114][115]. Since donor health
and age influence the optimal function of the h-MSC, donor-to donor variability represents an
essential factor even when working with the same tissue source. Studies have shown that there
are age-related effects on functional cells [116] while others have shown no effects, even when
they focused on osteoprogenitor cells from h-MSC. In 2003, Stenderup reported that age is only
associated with a decrease in h-MSC proliferation level without affecting functionality [41].
Baxter’s and Mareshi’s groups reported that h-MSC isolation and in-vitro expansion from pediatric
and adult donors generates negligible differences in cellular functionality except for proliferation
rate, where cells from the youngest donor developed a higher growth rate, suggesting
enhancement on standard cell expansion protocols for clinical use [117][118]. Although there is a
clear effect of donor variability on h-MSC quality, very few studies have investigated the effects
of physical and chemical cues with regards to donor variability. Researchers must validate their
results with cells from different donors and sources.
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h-MSC-based therapies are classified depending on the donor: allogeneic (cells from a
healthy donor) or autologous (patient’s own cells) [119]. Allogeneic therapies currently represent
the highest number of h-MSC products with marketing authorization, 9 products from 13 approved
[120]. The main manufacturing differences are the number of therapeutic doses in each batch and
the number of patients treated, positioning allogeneic therapies as the preferred manufacturing
process in the future [121]. This shows the importance of generating better h-MSC expansion
processes due to the required high demand. Current and projected demand does not meet the
number of cell donors available.

1.1.7. Issues and Challenges on Good Manufacturing Practice of h-MSC

GMP for h-MSC production involves all the processes starting from the donor selection
and continuing until the specific clinical application. Because of the extended process there are
many potential sources of error. Hence, a relevant issue on GMP is related to the operational part
of cell manufacturing that minimizes the steps prone to human error (i.e., contamination issues),
which can affect the production and general assessment of cell potency and safety. For these
reasons, process automation is implemented in cell manufacturing as a strategy to control process
variables to minimize variability associated to manual handling. An example of automation in cell
culture is a closed automated Quantum ® cell expansion system . This system consists of a robust
automated hollow fiber bioreactor system and it is used to eliminate manual cell culture processes
such as feeding and harvesting [122]. The system provides a constant and controlled environment
to maintain an adequate feeding rate of cells, eliminating waste and exchanging gases until the
process finishes [123][124][125]. Chantal Lechanteur and her team demonstrated that the
Quantum® device produces therapeutic h-MSC of high-quality standards [124]. Cells showed
excellent immunosuppressive and differentiation capacities, and this device performed an
excellent scalable and reproducible production. The total cell yield was increased by
approximately 12 times in 7 days. Although this automated technology has been proven
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advantageous for the manufacturing of h-MSC [123][126] [124], still the amount of cells generated
is not sufficient to support the high demand of h-MSC for clinical studies, which continues to
increase from year to year [123]. Thus, other strategies that further stimulate cell growth must be
combined to increase total cell yields while retaining a high cell quality.

Another challenge of GMP is the expansion of h-MSC in xeno-free culture conditions. The
use of xeno-free components minimizes the risks of transmitting unpredicted pathogens from cellbased products [64]. As previously mentioned, that researchers have begun to work with human
blood-derived products to avoid the use of media supplemented with animal-derived products.
Their results have demonstrated that human blood-derived products, such as h-PL or t-PRP, have
demonstrated advantages that using FBS or FCS could not provide [65][66][127]. Expansion of hMSC can be achieved in xeno-free culture conditions, however xeno-free culture does not
necessarily guarantee a production of high-quality h-MSC.

Novel technologies should be

implemented in each phase of the manufacturing process to continuously assess cell quality and
segregate those who do not meet the quality standard to eliminate cells not favorable for clinical
applications. Markers of cell quality must be identified, and detection strategies must be placed.
Lastly, combining manufacturing process should take advantage of both physical and biochemical
cues to enhance cell quality, potency, and clinical efficacy.

1.1.8. Ethics Factors of Manufacturing

Despite the promising therapeutic potential of h-MSC [128], the clinical application of stem
cells raises some ethical and safety concerns. The un-predictive nature of h-MSC in response to
external stimuli as well as the lack of methods to track and remove these cells after delivery have
been the main point of discussion in the clinical field due to the potential long term safety
implications [129][130][131]. Within the context of cell manufacturing, one of the main challenges
of stem cell studies is the lack of scientific rigor [132]. Published studies in basic science typically
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evaluate a limited amount of stem cell sources and donors, and thereby do not account for donorto-donor variability, interactions associated to the tissue source, and the potential implications of
demographic data such as age, race, ethnicity, and gender. This issue impairs the generalizability
of the study outcomes and could lead to unforeseen changes in cell behavior during the
manufacturing process and post-cell delivery to patients, compromising cell potency and safety.
This problem is further exacerbated by the lack of regulatory standards for both pre-clinical and
clinical interventions using h-MSC. Thus, while standards for stem cells are developed by
regulatory agencies [130], it is advisable for researchers to increase the scientific rigor of their
studies as much as possible within the constraints of their budget and design their pre-clinical
studies to meet or exceed the standards established for drug development.

Another safety concern in the cell manufacturing process is the use of animal-derived
products in cell culture. The supplementation of animal-derived factors can contain pathogenic
entities such as prions that can be passed to the cell and represents unknown/increased health
risks. Several studies have moved towards xeno-free culture conditions [133], but such
approaches are cost-prohibited for basic research and scale-up processes, decreasing the
affordability of manufactured therapies. This challenge may be addressed through the design of
synthetic substrates with added capabilities for intrinsic stimulation of cell adherence and growth
in h-MSC cultures.
1.1.9. Conclusions
Researchers have explored different mechanisms involved in the manufacturing process
in hopes of increasing the scale of the h-MSC expansion and production. Because of the
implementation of biochemical, chemical, and physical stimulus during the cell culture,
researchers have discovered clear correlations between their use and an increase in the cell’s
productive properties. However, these discoveries have yet to be translated to larger scales
relevant to the manufacturing process. The impact of culture conditions is relevant at larger
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scales, and other process considerations must be considered (such as reactor design, flow
conditions, etc.) when translating these stimuli. There are many available alternatives to promote
h-MSC expansion, enhance potency, and ultimately produce more clinically relevant cells. These
alternatives include modification of cell culture substrate, the addition of cytokines or small
molecules, or combination of both. However, the effect of these alternatives must be explored at
larger scales. These processes still need optimization. Moreover, the community must develop
standards in each step of the h-MSC manufacturing process for cell therapies from the isolation
step to final infusion on the patients, to guarantee high therapeutic potential.
1.2.

Electrospun Collagen Scaffolds

1.2.1. Abstract
Nanofibrous collagen scaffolds developed via electrospinning have revolutionized the field
of designing useful biomaterials for regenerative or tissue engineering. Electrospun collagen
scaffolds allow for the replication of the extracellular matrix of tissues with regards of their
chemical, physical, and mechanical characteristics. Because collagen is the most abundant
protein found in tissues, it can be the base for an ideal scaffold to mimic the majority of soft or
hard tissues such as bone, which contains an organic component composed of collagen and a
mineral component. The physical and mechanical properties of the collagen nanofibers are of
vital importance to promote the necessary and specific signals of the cellular or tissue
environment supporting different cellular processes. This section describes the fabrication and
modulation of the physical and mechanical properties of electrospun collagen nanofibers and their
biomedical applications.
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1.2.2. Introduction
In the field of tissue engineering, many researchers have focused their studies on
fabricating biodegradable polymeric scaffolds, attractive to the cellular environment, and that
would have the capacity of promoting tissue regeneration [134]. In the beginning, their efforts
were focused on mimicking the shape, structure and composition of the cellular environment,
developing scaffolds in the form of hydrogels [135][136], sponges [137], nanolayers [138] and
nanofibers [139], composed of polymers such as chitosan [140], hyaluronan [141], pullulan [142],
dextran [143], among others. Elaborated scaffolds based on these polymers and presented in the
different known models, have evidenced positive results at a cellular level. Demonstrating that
these can overcome cytotoxicity analysis, adhesion, proliferation and cellular differentiation,
indicating the importance for them being considered useful for biomedical applications [144]. An
important challenge in this field of research is the mimicking of the physical and chemical
characteristics of the extracellular matrix (ECM) of tissues. In general, the ECM is composed of a
variety of polymeric biomacromolecules, among these are glycoproteins, proteoglycans, and
polysaccharides [145]. Being collagen the most abundant component of the ECM [146], which
contributes to the strength and structure of the ECM, directly interacting with cells and other ECM
molecules [147].
The electrospinning technique has the capacity of creating scaffolds with the ability to
replicate the physical characteristics of the ECM, such as the fibrous morphology, the diameter
of the fibers, and their orientation [148]. Compositional characteristics have also been abundantly
studied with the use of polymers and proteins found in the ECM to fabricate nanofibers, allowing
for the modulation of other properties such as mechanical properties. These have been supported
with the use of chemical agents for crosslinking [149], in addition to fabricating collagen scaffolds
[150]. Collagen fibrous scaffolds fabricated by the electrospinning process have proven to
possess excellent biocompatibility and the mechanical properties necessary to be used in the
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field of tissue engineering [151]. Electrospun nanofibers have shown to have a high surface area
to volume ratio, mimicking the ECM of native tissue and therefore facilitating cell proliferation and
attachment [152]. These can be applied for the regeneration of nerve [153], bone [154], skin [139],
tendon/ligament tissue [155], and vascular grafts [156], among others. They provide promotion of
function and tissue repair, both in vivo and in-vitro. In addition to serving as an artificial ECM for
growing cells, these scaffolds can be used to deliver bioactive agents to promote regeneration of
tissue [157][158].
This section describes the history of the fabrication of collagen nanofibers, highlighting
from the conventional electrospinning method to their fabrication through the green
electrospinning process to preserve the secondary structure of collagen. Because the physical
characteristics are of vital importance to recreate a cellular environment attractive for the native
cells in the tissue, in this section different works that have been published that modulate fiber
diameter, orientation, and mechanical properties are highlighted. Finally, several biomedical
applications of collagen nanofibers useful for the regeneration of tissues in the human body are
presented as well as the process towards scale-up and industrialization of electrospun collagen
nanofibers.
1.2.3. Collagen Nanofibers: Use of Toxic Solvents to Benign Solvents
The fabrication of nanofibrous scaffolds have gained a greater reputation and importance
in the field of bioengineering, this because these types of scaffolds have demonstrated that they
have the capacity to replicate the structural characteristics and composition found in the ECM of
tissues [159]. Other scaffold presentations, such as gels and polymeric nanolayers, also offer
characteristics and properties to promote tissue repair, but these types of scaffolds have shown
limitations and disadvantages in comparison with nanofibrous scaffolds [144]. The biggest
advantage of nanofibrous scaffolds lies on the fact that it is possible to replicate the scale,
morphology, geometry and orientation of the nanofibers, composition, while also modulating the
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mechanical properties of tissues, which is known that they vary depending on the type of tissue
in the human [160][161][162].
By early 2000’s, Bowlin and his research group fabricated electrospun collagen nanofibers
[163] to be used as a scaffold mimicking; (1) the physical characteristics of the extracellular matrix
(nanofibrous structure) and (2) the composition. When overcoming the challenge of finding a
solvent that would dissolve collagen and would be useful for the electrospinning process, they
focused on finding an optimum ratio of collagen type I dissolved in 1,1,1,3,3,3-hexafluoro-2propanol (HFP) solvent. Experimenting with different concentrations of collagen, they found that
0.083 g/mL resulted in being the appropriate concentration for nanofiber formation, operating the
electrospinning equipment at 25 kV, 125 mm distance from the collector, and 5 mL/h of injection
flow. Electron microscopy images demonstrated the successful obtainment of collagen type I
nanofibers, which possessed a diameter of 390 ± 290 nm [163]. Experimenting with collagen type
III, they were also able to obtain nanofibers with a solution composed of 0.04 g collagen III/mL
dissolved in HFIP. They could obtain an average nanofiber diameter of 250 ± 150 nm, maintaining
the same conditions of operation of the electrospinning equipment used for the obtainment of
collagen type I nanofibers [163].
When examining the different parameters of the equipment, they found that it might be
possible to obtain random and aligned nanofibers by adjusting the rotation velocity of the
cylindrical collector of the equipment [163]. Using a high velocity of rotation of 4500 RPM, it was
possible to have a control over the alignment of the nanofibers, opening the doors to the possibility
of mimicking not only tissues that have random collagen nanofibers, but also other tissues such
as cardiac and nervous, which contain aligned nanofibers [164][165][166].
Bowlin’s group developed an in-vitro study to prove the viability of the prepared scaffold,
using aortic smooth muscle cells. The cells were seeded on the nanofibrous membrane after
being crosslinked in glutaraldehyde vapor for 24 h and sterilized. This crosslinking process was
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necessary to maintain the morphologic stability of the nanofibers obtained because when
contacting water, they would dissolve. The in-vitro results demonstrated that the nanofibrous
scaffold obtained, using HFIP as a solvent, promoted the adhesion and cellular growth. This
immediately resulted in being able to say that this scaffold would be ideal and potentially useful
for tissue engineering, since the collagen nanofibers could replicate in large proportions the
structural and compositional properties in addition to the biological functions of the ECM [163].
Shields et al. [167] fabricated collagen type II nanofibers from chicken sternae which was also
dissolved in HFIP. Their results showed that a scaffold cultured with chondrocytes could promote
the cells’ ability to infiltrate the scaffold surface and interior. By this time, it was possible to
fabricate nanofibers of all three main types of collagen mainly found in the tissues of the human
body.
Once it was demonstrated that it was possible to fabricate collagen nanofibers,
researchers such as Byung-Moo Min and his group in 2006 [139], decided to continue
investigating the potential of collagen nanofibers. They obtained nanofibers from a solution of 8%
w/v collagen in HFIP. Their investigation was focused on studying the cytocompatibility and cell
behavior including cell attachment and spreading of normal human keratinocytes seeded on the
collagen nanofibrous matrix, and other ECM components such as fibronectin and laminin. They
also evaluated in vivo the effect of the collagen scaffold on open wound healing in rats. In their
in-vitro studies, they seeded cells over collagen only, collagen nanofibers, and nanofibers covered
with type I collagen, bovine serum albumin, fibronectin, and laminin. Their results showed the
ability of the collagen nanofibers covered with collagen type I, which promoted cell adhesion and
spreading of normal human keratinocytes in comparison to the “collagen nanofibers” obtained
and the other coatings of different proteins evaluated. Their results determined that the
components generated the highest promotion for cellular processes following the ratio: type I
collagen > laminin > fibronectin > uncoated collagen nanofibers. Observing a level of cellular
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adhesion of almost double in collagen nanofiber covered with type I collagen in comparison with
“collagen nanofibers” fabricated by them without any coating. These results opened the doors to
a variety of uncertainties. Why collagen nanofibers without any additional coating do not have the
same effects than those with the additional collagen coating? Is the use of the HFIP solvent having
a negative effect over the chemical structure of collagen? Is the crosslinking process ideal?
A year later, in 2007, Lin Yue Lanry Yung and his team [168], wanting to keep replicating
the ECM of tissues decided to fabricate collagen nanofibers containing glycosaminoglycan
(GAG), which are also part of the native tissues in humans. In their research, they used
chondroitin-6sulfate as the GAG. The fabrication of collagen/chondroitin-6sulfate nanofibers was
successful, with a concentration of 4 wt. % of chondroitin-6sulfate and 10 wt. % of collagen,
dissolved in a mixture of solvents composed of 2,2,2-trifluroethanol and water in a ratio of 4:1.
Their in-vitro study reported that the proliferation of rabbit fibroblasts exhibited high density of
cells in the crosslinked scaffold (glutaraldehyde) in comparison to non-crosslinked. The collagen
scaffold with GAG crosslinked reported a higher effect over the proliferation than collagen
nanofibers without GAG, demonstrating that the more you can replicate the cellular environment,
cellular activities are favored.
By the year 2008, Jan Feijen and his group reported a problem over the collagen
nanofibers fabricated with fluorinated solvents. They demonstrated, from their study with circular
dichroism (CD) spectroscopy, a decrease of 45% of collagen’s triple helical structure after
electrospinning using HFIP as the collagen dissolvent [150]. Works where fluorinated solvents
such as trifluoroacetic acid, [201] trifluoroethanol, [168] and 1,1,1,3,3,3-hexafluoro-2-propanol
(HFIP) were used [163][167] to produce “collagen nanofibers” did not preserve the chemical
structure of collagen. These fluorinated solvents disrupt collagen’s secondary structure,
converting the electrospun collagen into gelatin [169].
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Because of these findings, by the year 2009, Wnek and his group [170], proposed the
fabrication of collagen nanofibers using benign solvents to replace toxic solvents that
demonstrated the destruction of the chemical composition of collagen. They were able to dissolve
collagen type I and III in a mixture of phosphate-buffered saline and ethanol, effectively generating
a useful solution for the electrospinning process, which helped them obtain the collagen
nanofibers while conserving the chemical structure of native collagen. Following this, several
groups present alternatives to prepare collagen nanofibers using benign solvents. In 2010, Sing
Yian Chew and his group [171], reported the production of collagen nanofibers using acetic acid,
with a solution that consisted of 25 wt. % collagen in 40% (v/v) acetic acid. This solvent also
prevented the degradation of collagen, demonstrating the advantage over toxic solvents.
V.R. Giridev [172][173] with the purpose of preparing other formulas, proposed the
alternative of preparing a collagen solution mixed with other polymers, to facilitate the
electrospinning process. V.R. Giridev in his study used a mixture of COL/PCL and Li-Ming Zhang,
on the other hand, used a mixture of collagen and zein, using acetic acid as the dissolvent. In
both studies, they could obtain nanofibers but the possibility of facilitating the electrospinning
process was not significant, because of difficulties in the preparation, in the morphology of the
nanofibers, and in the use of approximately 50% of another polymer.
By 2014, new recipes supported by the solution preparation of Lin et al. [173] with the use
of acetic acid, were reported. Andrea Maria Letizia Focarete and her research group [174],
generated electrospun mats dissolving collagen in acetic acid/water (20/80 v/v) at a concentration
of 30% (w/v), being able to achieve and conserve the chemistry of collagen type I. Kazanci [175],
who was able to prepare collagen nanofibers with 40% w/v collagen in 40% v/v acetic acid.
In 2015, Anuradha Elamparithi, demonstrated the fabrication of nanofibers using glacial
acetic acid and DMSO to dissolve collagen at a ratio of 93/7 (glacial acetic acid/DMSO) with a
concentration of 10% collagen [176]. In their work, they did a biocompatibility study of the
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nanofibrous scaffold obtained, using rat skeletal myoblasts (cellular line L6). Their results showed
that the scaffold could support the cells, allowing them to carry out their normal functions. This is
due to the evidence ventricular cardiomyocytes of primary neonatal rats (NRVCM) seeded were
able to maintain their contractile function of a 17-day period. Indicating that it could be a promising
scaffold for the field of tissue engineering, when learning about its potential, demonstrated in the
evaluation with different types of cells.
By 2016 [148], in our most recent work we were able to report the obtainment of collagen
nanofibers using collagen in acetic acid (90% v/v in water) to a final concentration of 20% w/v
(Figure 1-2). This was done with the purpose of demonstrating the preservation of the chemical
composition and secondary structure of collagen in the obtained nanofibers, with the use of
benign solvents. FTIR spectroscopy was used to study changes in the secondary structure of type
I collagen and the results are presented in Figure 1-2.

Figure 1-2. (a) FTIR spectra of pure type I collagen sponge, electrospun collagen, and denatured
(200 °C treatment) collagen and in-vitro cellular evaluation of nanofibers.
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Figure 1-2. (Cont.) (b) SEM image of collagen nanofibers. (c) SEM image of fibroblasts cultured
on collagen nanofibers after 24 h. (d) Fluorescent microscopy images of 3T3 fibroblasts (green:
nuclei) cultured on collagen nanofibers (red). Reprinted from Macromolecular Materials and
Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno
B., Loyo L., Shipmon J., Aldo A., and Almodovar J., Engineering of a Stable Collagen Nanofibrous
Scaffold with Tunable Fiber Diameter, Alignment, and Mechanical Properties, 1064-1075,
Copyright 2016, with permission from WILEY‐VCH Verlag GmbH & Co. KGaA.

Figure 1-2A shows the spectra of pure collagen, electrospun collagen, crosslinked and
denaturalized collagen nanofibers. Indicating that the characteristic bands of type I collagen were
clearly observed. Obtaining that for all the spectra evaluated the amide I (1700–1600 cm−1), amide
II (1600–1500 cm−1), and amide III (1300– 1180 cm−1) are present. Demonstrating that the
chemistry of collagen in the nanofibers with and without crosslinking is stable, when observing
the spectra showing that these are identical to the native collagen without processing.
A study about the secondary structure of the obtained nanofibers consisted in evaluating
the changed of the comprised bands in the amide I region from 1700 to 1600 cm−1. The second
derivative of the amide I data reported the location of four intense peaks in 1683 cm−1, 1652 cm−1,
1624 cm−1, and 1617 cm−1, which have been reported in the literature to belong to the bands (βsheets), (α-helix), (triple helix), and (side chains), respectively [177][178][179]. Indicating that the
secondary structure of collagen in the collagen nanofibers with and without crosslinking is
maintained, in comparison to the denaturalized nanofibers, in which changes in the absorption
were shown from 1620 to 1640 cm−1 indicating a loss in side-chain structures (at 1617 cm−1) and
in parallel β-sheets (1624 and 1628 cm−1). Once the stability of the chemical and secondary
structure of the nanofibers was confirmed, we performed an in-vitro study using 3T3 fibroblasts
cultured over crosslinked nanofibers, to evaluate the capability of the scaffold to promote cellular
adhesion. Figure 1-2 C and D show a large number of cells that adhere and spread on the
produced electrospun collagen fibers. Because of the rise of using benign solvents to prepare
nanofibers through electrospinning, a new concept has risen called “green” electrospinning
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[180][181]. This concept has opened the doors to the preparation of nanofibrous scaffolds that
replicated the different tissues using benign solvents.
Focused on applying the concept of “green” electrospinning, we decided to prepare
nanofibers that would replicate osseous tissue. By mid-2016, [148][182] we were able to report
the obtainment of collagen nanofibers containing hydroxyapatite, which have been previously
developed using toxic solvents. The electrospinning solution consisted of 0.6 g of collagen, 0.3 g
of hydroxyapatite dissolved in 3 mL of acetic acid/water at 90%, obtaining the nanofibers under
an injection flow of 3 mL/h and a voltage of 47 kV. Nanofibers that presented a morphology and
rough surface, by action of hydroxyapatite immersed in the collagen, in comparison to the pure
collagen nanofibers. Since the fabrication of the nanofibers was based in the principles of “green”
electrospinning, this assures the preservation of the chemical structure, in addition to the capacity
to promote cellular adhesion of the seeded preosteoblast [148][182].
In summary, through the application of “green” electrospinning, it is possible to generate
a collagen nanofibrous that mimic to a large degree the characteristics of the extracellular matrix
of tissues, preserving the chemical and secondary structure of collagen. This way allowing to offer
a promising scaffold to the field of engineering, with the ability of supporting the different cells that
compose tissue in the human body.
1.2.4. Properties of Collagen Nanofibers

The components of a polymeric solution are key elements towards the outcome of
nanofibers, mainly because of the influence of electrospinning parameters on the polymeric
solution [161]. Many researchers have focused on variable compositions, solvents, and
components that affect solution conductivity to understand how each factor helps tune the
diameter of the nanofibers [183]. For example, polymer concentration in the solution affects the
solvent evaporation rate and viscosity which is linked to the fiber stretching, diameter and
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morphology [183]. The alignment of the electrospun nanofiber has high correlation with cell
adhesion, growth direction, proliferation and mechanical properties of the tissue [184][185]. This
has aroused interest on figuring out how to control the development of aligned electrospun fibers
through the electrospinning parameters [186]. Once the collagen scaffold is developed through
the electrospinning process, in order to preserve its integrity, the crosslinking process is
implemented. Crosslinking serves to control the mechanical properties, preserve its nanofiber
morphology and improves degradability, all to mimic body conditions. Up next a discussion
focused on diameter tuning through concentration variation of the polymeric solution; fiber
orientation, and diameter tuning through electrospinning parameters and preserve collagen
scaffold integrity via crosslinking.
1.2.5. Nanofiber Diameter Tuning Using Polymeric Solution Blends
As many efforts to develop an environment capable of mimicking the ECM to foment
cellular activity, a variety of polymeric blends are an option to modify scaffolds morphology.
Collagen plays an important role on the ECM and its biological properties such as cell recognition,
making it an ideal material to use in the development of nanofibrous scaffolds but with limited
mechanical properties [187]. Several works present how the addition of collagen influences
solution composition and therefore, nanofiber diameter, as is the case of a blend of two
biopolymers, such as thermoplastic polyurethane (TPU) and collagen. This blend overcomes the
limitations of the collagen mechanical properties with the addition of the excellent mechanical
properties of TPU as shown by Chen et al. [184]. Before the scaffold preparation TPU and
collagen (80–100 kDa) were dissolved in 1,1,1,3,3,3-hexafluo ro-2-propanol (HFP) separately,
and then blended at the desired weight ratios and stirred at room temperature. The variables
studied were weight ratio and concentration, and the results indicate that the fiber diameter is
influenced by both. An interesting trend is that weight ratios with higher quantity of collagen
develops smaller average diameter fiber, with diameter distribution of 0.10–0.20 μm compared to
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pure TPU with a diameter distribution between 1.2 and 1.6 μm. The reason for diameter
distribution is that collagen increases conductivity, which increases the stretching of the solution,
resulting on smaller diameter fibers [184][188]. To investigate the concentration factor (from 1.5
to 9 wt. % at equal intervals) a fixed weight ratio (TPU/collagen 80:20) was established. The
outcome was that diameter increases as the concentration factor increases: 1.5 wt. %: 0.08–
0.12 μm, 3 wt. %: 0.15–0.20 μm, 4.5 wt. %: 0.2–0.3 μm, 6 wt. %: 0.3–0.4, 7.5 wt. %: 0.3–0.4 μm,
and 9 wt. %: 0.3–0.4 μm. In the two limits, high and low concentration, beads were developed
because of chain entanglements. The appropriate concentration, after experimentation was
4.5 wt. %, with a diameter range from 0.2 to 0.3 μm, for a homogeneous nanofiber. This blend
solution could produce an effective tissue engineered scaffold, with improved porosity and
hydrophilicity, and with a diameter dependent on the concentration.
Another type of polymeric solution is a blend between type I collagen and
polycaprolactone (PCL) [172]. The ratio between the collagen type I and PCL in the solution was
used to analyze its effect on the nanofiber diameter, varying ratio percent from 100 to 0. The
average diameters for the collagen percent in the solution blend are: 75%: 115 ± 38 nm, 50%:
130 ± 30 nm, 25%: 148 ± 30 nm, 0%: 160 ± 35 nm, indicating an increase in diameter as the
content of collagen decreases, in other words the content of PCL increases. SEM analysis shows
that the addition of PCL adds a globule structure to the nanofibers while also increases the
diameter. The explanation for this diameter increment is attributed to the increase in viscosity of
the solution that forms the electrospun nanofibers. Zhang and his group, in a similar work,
corroborates that the scaffold diameter decreased from 987 ± 274 to 689 ± 299 nm as the
collagen content increased compare with PCL [189]. These approaches served to understand
how a balance of natural and thermoplastic material are mixed to achieve a biodegradable
substrate. An example was the strength contributed by PCL and natural structural composition by
collagen. Different blends of polymers give a variety of results and all of this is indicative of the
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sensitiveness of the electrospinning process. An approach for vascular regeneration is using a
poly-l-lactide (PLLA) and collagen type I blend (1:1) blend. This scaffold proved to differentiate
mesenchymal stem cells into endothelial cells by the expression of proteins such as platelet
endothelial cell adhesion molecule-1 (PECAM-1 or CD31) and Von Willebrand factor (vWF) [190].
The blend of PLLA/collagen type I (1:1), produced fibers of 210 ± 160 nm, in a different proportion,
PLLA/collagen type I (3:1) produced fiber of 270 ± 120 nm when compared with PLLA fibers
430 ± 90. The reason for a decrease of diameter with presence of collagen is due to an increment
on solution conductivity, which plays an important role in the electrospinning process. Pore
analysis resulted in 0.273, 0.340 and 0.721 μm for PLLA/collagen type I (1:1), PLLA/collagen type
I (3:1) and PLLA, respectively. Pore diameter is proportional to fiber diameter, and SEM images
are shown in Figure 1-3. The presence of collagen on the PLLA and collagen scaffold decreased
the diameter and was found to have 256% higher proliferation than PLLA scaffold and prove the
potential of mesenchymal stem cells to differentiate in-vitro in the presence of differentiation
media. The approach of tuning the nanofiber diameter through the solution composition is proved
to have a direct impact. A balance between biological and mechanical properties was reached by
the addition of collagen and synthetic polymers respectively, to develop an optimal scaffold. The
most common synthetic polymers are: TPU, PCL, PLLA, and tend to blend homogenously with
collagen. The overall tendency is that the presence of collagen decreases the diameter of the
electrospun nanofiber and is attributed to the increases in conductivity. The presence of collagen
on the blend increased proliferation and the scaffold proved to be a viable solution for in-vitro
experiments and could further serve as ideal scaffolds for tissue regeneration.
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Figure 1-3. SEM images of electrospun (a) PLLA, (b) PLLA/COL (3:1) and (c) PLLA/COL (1:1).
Reprinted from Materials Science and Engineering C, 33, Jia, L., Prabhakaran, M. P., Qin, X.,
and Ramakrishna, S., Stem cell differentiation on electrospun nanofibrous substrates for vascular
tissue engineering, 4640–4650, Copyright 2013, with permission from Elsevier.
1.2.6. Electrospinning Parameters Impact on Nanofiber Alignment and Diameter
A variety of approaches have been investigated to obtain aligned electrospun fibers with
collagen nanofibers and hexafluoro-2-propanol, such as: spinning onto a rotating drum, spinning
onto a sharp edge of thin rotating wheel, introducing an auxiliary electrode or electric field, and
others are proposed to develop aligned nanofibers [166]. Nanofiber orientation is mostly
controlled by the type of collector, for example, a rotating collector for aligned and flat collector
for random orientation [164][165][166][185][191]. In addition to the type of collector, tuning of the
electrospinning parameters can also directly influence nanofiber orientation [148][192][193].
The solution composition, as mentioned above, contributes to the diameter of the scaffold.
Nevertheless, the complexity of the solution also influences fiber orientation making the outcome
of the nanofibers less predictable. A blend of collagenchitosan-thermoplastic polyurethane (TPU),
can be categorized as a complex mixture which means that the morphology of the scaffold is not
only controlled by the electrospinning parameters, but also strongly by the conductivity imparted
by components of the solution [191].
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Figure 1-4. SEM micrographs of (a) random oriented collagen-chitosan-TPU and (b) aligned
oriented pure TPU (control) 5000× magnification. Reprinted from Colloids and Surfaces B:
Biointerfaces, 82, Huang, C., Chen, R., Ke, Q., Morsi, Y., Zhang, K., and Mo X., Electrospun
collagen-chitosan-TPU nanofibrous scaffolds for tissue engineered tubular grafts, 307–315,
Copyright 2011, with permission from Elsevier.
The conditions to generate aligned nanofibers by Huang et al. [191] was a rotating drum
(6 cm diameter) at a rotating speed of 4000 rev/min and 12 cm away from tip. The nanofibers
resulted with average diameter of 256 ± 145 nm. SEM images of scaffold obtained with the
complex mixture confirmed that a fully aligned scaffold is not obtained, when compared with TPU
control, Figure 1-4. The cause, for not aligned nanofibers, is attributed to all the interaction
between the components of the complex mixture of collagen-chitosan-thermoplastic
polyurethane. The random orientation was obtained using a flat collector plate wrapped with
aluminum foil at 12–15 cm, with nanofibers average diameter of 360 ± 220 nm. This work
highlights the fact that electrospinning is a complex system and that solution components play an
indispensable role in the determination of fiber morphology by means of contribution to molecular
weight, conductivity, viscosity and others. The generated scaffolds were cultured for 3 days with
porcine iliac artery endothelial cells (PIECs) and Schwann cells (SCs). The PIECs cells showed
a slight orientation on aligned fibers, compared with SCs that seem to be more responsive to the
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seeding matrix, with a spindled-shaped morphology on aligned. This confirms that cells are
influenced by the orientation of the scaffold and sensitive to the morphology.
A flexible wheel with high rotational speed 10–20 m/s is the proposed assembly by Zhong
et al. [166] to achieve aligned nanofibers. The focus was to study the effect of alignment on cell
orientation and cell-scaffold interaction. The control group were random nanofibers prepared by
a nonmoving metal collector. The average diameter for aligned was 180 and 250 nm for random
and the morphology is confirmed with SEM micrographs. The aligned scaffolds have lower
porosity due to less overlaying of fibers compared with the random. It is important to mention that
this research group did an optimization experiment and concluded that a rotation speed of 5 m/s
does not generate aligned fibers and high rotational speed of 25 m/s is too strong of a force and
breaks the fibers. Therefore, it was established that 15 m/s as an appropriate rotational speed.
This established rotational speed generates thinner aligned fibers because it exerts a pulling force
on the solution jet when compared with a static collector.

Figure 1-5. Electrospinning assembly. Adapted from Journal of Biomedical Science, 20,
Meimandi-Parizi, A., Oryan, A., and Moshiri A., Role of tissue engineered collagen based
tridimensional implant on the healing response of the experimentally induced large Achilles
tendon defect model in rabbits: A long term study with high clinical relevance, 28 Copyright 2013,
with permission from BMC part of Springer Nature.
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Collagen’s versatility is taken in advantage by developing a composite collagen structure
[194]. The combined technologies are gel and electrospinning to achieve a three-dimensional
hybridized collagen implant to mimic tendon architecture. The reason for the composite is to
obtain a more voluminous collagen scaffolds, a requirement for tendon implants. This is achieved
by the addition of a collagen gel to collagen fibers both being promising matrixes for tissue
engineering [195]. The polymeric solution consists of acetic acid and collagen type I, 7.5 w/w %
collagen. The aligned collagen fibers were constructed via an assembly consisting of two dual
plates device, 2.5 × 0.5 cm copper strips, 4 cm away from needle tip, attached with Gluseal to
1 cm gap of quartz glass [194] Figure 1-5. The fibers alignment is attributed to the electrical
resistivity of the gap substrate, quartz glass with 1020 Ωm, in which the fibers were collected.
Also, the distance between the gap contributes to fiber alignment with the tendency that narrow
plates developed more aligned fibers. The potential difference is incremented with the additions
of an insulating material between the copper strips and is increased by decreasing the distance
of the gap which leads to the align fiber organization along the quartz glass surface. The aligned
fiber resulted with a diameter of 272 ± 183 nm, and later was mixed in a chamber with collagen
solution to develop the collagen composite, overall to induce proper healing and recovery,
attributed to the presence of the types of collagen, gel and fibers. Nanofibers develop by
Prabhakaran et al. [196], consisted of poly(3- hydroxybutyrate-co-3-hydroxyvalerate (PHBV) and
collagen. Two different ratios were evaluated PHBV:collagen solution 8 w/v. % at 75:25 and
50:50. The solution preparation is not directly discussed only that is blended and deposited on
syringe. Random fibers were produced by a flat aluminum collector (Figure 1-6A) and the aligned
fibers by the collection of the fiber on a rotating drum set to 2400 rpm, (Figure 1-6B). The
electrospinning parameters consisted of 12 cm as the distance between flat tipped spinneret, flow
rate 1 mL/h, and 15 kV. The syringe containing the polymeric solution as assembled in a vertical
position, ejecting down towards the collector. The aligned fibers using a rotating cylindrical drum,
had diameter between 205 ± 50 nm for 75:25 ratio and 229 ± 65 nm for 50:50 ratio and the
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random fibers had an overall diameter of 472 ± 85 nm. The cell-scaffold interaction was analyzed
using PC-12 cells at day 8, higher proliferation of 34.30% for random and 40.00% for aligned
fibers relative to PHBV nanofibers.

Figure 1-6. Electrospinning assembly; (a) random fibers on flat aluminum collector; (b)
aligned fibers on rotating drum collector. Adapted from Biotechnology and Bioengineering, 110,
Prabhakaran, M. P., Vatankhah, E., and Ramakrishna, S., Electrospun aligned PHBV/collagen
nanofibers as substrates for nerve tissue engineering, 2775–2784, Copyright 2013, with
permission from Wiley Periodicals, Inc.

Ouyang and his group were able to develop a seamless 3D nanofibrous nerve conduit
due to collagen’s high biocompatibility and the strength of the synthetic polymer poly(lactic-coglycolic acid) [197]. The focus was aligned nanofibers produced via a new approach of the
electrospinning technique. The polymeric solution is a blend 25/75 collagen/PLGA; 8% collagen
and 12% PLGA were first dissolved separately overnight on 1,1,1,3,3,3-hexafluoroisopropanol
(HFIP). The mandrel that served as the collector for the aligned nanofibers was composed of
three parts: two metal sides and an insulator that separated the two metal sides. The general
mechanism that made possible the fibers alignment is by the potential difference developed by
the insulating material and the two metal sides causing the deposit fibers to align along the
longitudinal axis of the mandrel as it rotates (Figure 1-7) [197]. The advantage of this assembly
is that diameter of the nanofiber can be modified through mandrel sizes, and nanofiber diameter
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can range from 1 to 10 mm. The obtained average diameter of aligned and random
collagen:PLGA was 766 nm and 834 nm, respectively. Once again, this highlights the versatility
of electrospinning which eliminates the process of conduit rolled that provoked discontinuous joint
and inconsistent size. A brief in vivo experiment was developed to regenerate 13 mm sciatic nerve
defects, and these were compared between randomly, aligned conduits and autograft. Results
confirmed that alignment promotes better motor function, axonal conduction and Schwann cell
morphology when compared with random. The autograft resulted better on axon regeneration,
myelination, action potential propagation, neuromuscular transmission and functional recovery,
when compared with aligned seamless 3D nanofibrous nerve conduit.

Aligned nanofibrous array

Figure 1-7. Electrospinning assembly. Reprinted from Journal of Biomedical Nanotechnology, 9,
Ouyang, Y., Huang, C., Zhu, Y., Fan, C., and Ke, Q., Fabrication of seamless electrospun
collagen/PLGA conduits whose walls comprise highly longitudinal aligned nanofibers for nerve
regeneration, 931–943, Copyright 2013, with permission from BMC part of Springer Nature.
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In our most recent work, the objective was to evaluate the effect of the flow rate and
voltage in the diameter and orientation of the electrospun fibers [148][182]. The particularity of
this work when compared to others is the composition of the polymeric solution. The components
of the solution are: pure collagen type I and a non-toxic solvent, acetic acid. Previous presented
literature had the necessity to use a blended polymeric solution of synthetic and natural polymers
to produce electrospun nanofibers and achieve promising mechanical properties.
The experiment consisted on varying the flow rate from 0.5 to 3.0 mL/h, at a constant
voltage of 45 kV and another round varying the voltage from 25 to 45 kV, with a constant flow rate
of 1.5 mL/h. The observed trends were decrease in diameter, from approximately 400 to 200 nm,
as the voltage increases and increase in diameter, from approximately 160 to 350 nm,
proportional to the flow rate (Figure 1-8). A trend for fiber orientation was observed: for a constant
voltage of 47 kV, aligned fibers were obtained with high flow rate 5 mL/h and random fibers with
low flow rate of 1 mL/h, both validated with SEM. The orientation is confirmed with orientation
histograms and normalized orientation index (NOI). A 58.9% NOI correspond to random
orientation and 90% NOI to aligned orientation. The average fiber diameter for aligned orientation
was 202.47 nm and for random 117.52 nm. The aligned nanofiber had a larger diameter because
it was produced with a high flow rate which means more solution available at the tip of the syringe
for the same voltage to stretch. Is important to mention that the collector used was a rotational
drum, what suggests that random and aligned fibers can be obtained with a rotation drum by
controlling the flow rate, even though other researchers used rotational drum only for aligned
electrospun fibers.
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Figure 1-8. SEM (a) Average fiber diameter versus applied voltage for fix flow rate of 1.5 mL/h.
(b) Average fiber diameter vs. flow rate for fixed voltage at 45 kV. Values plotted and error bars
in (a, b) correspond to the average and standard error of three independent experiments,
respectively. Reprinted from Macromolecular Materials and Engineering, 301, Castilla-Casadiego
D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno B., Loyo L., Shipmon J., Aldo A., and
Almodovar J., Engineering of a Stable Collagen Nanofibrous Scaffold with Tunable Fiber
Diameter, Alignment, and Mechanical Properties, 1064-1075, Copyright 2016, with permission
from WILEY‐VCH Verlag GmbH & Co. KGaA.

The overall electrospinning parameters based upon recent literature are the following: flow
rate of 1 mL/h, voltage range from low as 15 kV and a maximum of 47 kV, tip-collector distance
range from 10 to 15 cm, needle-inner diameter 21-G and 22-G. The type of polymers used goes
from natural to synthetic and all contribute in different ways to the end product and each of the
components interacts differently with the electrospinning parameters [198]. Variation in polymer
concentration along with the solvent, tunes the diameter size of the electrospun fibers
[172][189][190]. It is important to emphasize that fiber orientation and diameter define the scaffold
morphology which provides the biochemical and biomechanical cues for the cell environment,
and further stimulate tissue regeneration [198]. Fiber orientation is mainly achieved through a
rotational drum as a fiber collector, although our most recent work serves a platform to evaluate
that alignment can be modified through the flow rate [148][164][166][182][185]. Electrospinning
parameters clearly impacts fiber diameter and alignment along with polymeric solution
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concentration. This technique along with natural polymer collagen combined to truly innovate and
contribute to the future of biomaterial to mimic ECM.
1.2.7. Mechanical Properties in Relation to Crosslinking
The structural integrity of collagen is key to simulate the native collagen and its
morphology is preserved through the crosslinking process, which allows collagen scaffolds to
withstand body conditions [199]. Crosslinking agents also known as crosslinkers are molecules
that form covalent bonds with functional groups (primary amines, sulfhydryls, etc.) [200]. Some of
the ones often found in literature are: glutaraldehyde, formaldehyde, and N-(3-dimethylaminopropyl)-N′-ethyl carbodiimide hydrochloride (EDC) [166][201]. The products developed by
electrospinning possess high degradability, especially the ones in which the main component is
collagen, due to the low melting point and quick denaturation [166]. This high degradability limits
the product to endure an aqueous environment, like in-vitro conditions, and body temperature
[202]. The crosslinking technique not only improves the degradability of nanofibers; it also impacts
the mechanical properties. The tensile strength of a specific tissue can be simulated on a
biomaterial by variation on the type of crosslinkers, method of application and time of reaction
[203]. The assembly for the crosslinking technique is not mentioned in most of the literature.
Presented below are several crosslinkers, mechanical properties, and possible assemblies that
have been found in literature. Zhong and colleagues developed electrospun fibers with collagen
nanofibers and hexafluoro-2-propanol (HFIP). The scaffold was crosslinked with 30%
glutaraldehyde vapor for 48 h at room temperature to obtain a physically stable product and study
its effects in-vitro with fibroblast culture [166]. To remove the unreacted glutaraldehyde, an
additional solution of 0.002M glycine is added, followed by a wash with deionized water for 20 min.
Glycine is an amino acid which is used to quenched the residuals of crosslinkers such as,
glutaraldehyde and formaldehyde [204]. SEM images confirmed the integrity, meaning
unchanged orientation and overall porous morphology of the fibers. The surface roughness of the
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nanofiber was analyzed by atomic force microscopy (AFM), in Ra which is the arithmetic mean
value of the surface roughness. The results for crosslinked random fibers was 60 Ra, and for
uncrosslinked random fibers, 90 Ra. The water content, which is measured in water contact angle,
was increased from 13° to 30°, which confirms the effectiveness of the crosslinking process. The
surface roughness analysis shows that the crosslinked nanofiber had smoother surface compared
with uncrosslinked nanofiber, due to the washing steps needed on the crosslinking method, for
both random and aligned [166]. Increase in water contact angle measurements helped confirm
the reduction of the hydrophilicity and prove the reaction of the glutaraldehyde and collagen amine
groups. The contact angles for aligned collagen fiber and random collagen fiber were 26° and
11°, respectively. After crosslinking the new contact angles for the collagen fibers were: 41° for
aligned and 30° for random. The morphology of the electrospun fiber influence on the water
contact angle, for example, larger contact areas on random oriented fibers leads to higher surface
spreading and a lower contact angle (higher wettability). The applied crosslinking process with
30% glutaraldehyde vapor for 48 h gave positive results being able to enhance the structural
integrity of the electrospun fibers.
Products for wound healing application, first needed to go through crosslinking. Rho et al.
[139] has a very similar product and also applied a very similar crosslinking process as Zhong
et al. [166]. Nanofibers of collagen type I and 1,1,1,3,3,3-hexafluo ro-2-propanol (HFIP) were
exposed to less time of reaction 12 h, 0.1M glycine instead of 0.002M glycine and glutaraldehyde
solution was 25% rather than 30% [139]. Overall results showed a decrease in porosity from 89%
to 71%. It is important to understand that each variation will have a different impact on the
mechanical properties of the fibers and because of that, it is crucial when those parameters are
being defined. This research group used a very simple yet important test that helps define the
appropriate time of crosslinking reaction needed to prove its effectiveness. This weight loss (%)
of collagen matrix consist of weighting the dried fiber before and after immersion on distilled water
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for 1 h for different times of crosslinking exposure and example of the plot is shown on Figure 19A.

Figure 1-9. (a) Weight loss of the collagen nanofibrous matrix by cross-linking time. Weight loss
of the collagen nanofibrous matrix by cross-linking time. (b) Collagen non-crosslinked fibers. (c)
Collagen crosslinked nanofibers. Reprinted from Biomaterials, 8, Rho, K. S., et al., Electrospinning
of collagen nanofibers: effects on the behavior of normal human keratinocytes and early-stage
wound healing, 1452–61, Copyright 2006, with permission from Elsevier.
The crosslinking time of reaction defines the time of exposure in which the covalent bonds
between the glutaraldehyde and amine collagen are formed [199]. This is very useful to determine
the time in which the nanofiber is no longer absorbing significant quantities of water, proving the
effectiveness of the crosslinking, which was identified to be 12 h. The SEM images on Figure 19 before crosslinked (b) and after crosslinked (c) represent the reduction in porosity from 89 to
71%, along with the pore volume decreased from 9.328 to 1.566 mL/g, although it is believed that
the matrix achieved higher dimensional stability in aqueous medium. The mechanical test of
tensile strength matches commercialized products, at dry state, as the collagen matrix (0.2 mm
thick) tensile strength was above 10 MPa, although when wet, the tensile strength was
7.40 ± 1.17 MPa, less than commercially product Resolut ® LT with 11.72 MPa. Shape and
stability were maintained under in vivo procedure and this proved the effectiveness of the
crosslinking technique. As mentioned earlier, the assembly for the crosslinking technique remains
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a mystery but Huang et al. [191] work is one on the few that mentioned several details about the
assembly for the crosslinking process. It consisted of a desiccator, Petri dish with 10 mL of 25%
glutaraldehyde and a fixed membrane on a glass frame in the upper layer of the desiccator, at
room temperature for 2 days. The main purpose was to solve the issue of the collagen-chitosanTPU scaffold degradation for application as a tubular scaffold to mimic the native artery, which is
reported to have a tensile strength of 1.5 MPa. The crosslinking with glutaraldehyde had a positive
influence on the tensile strength but a negative influence on the average elongation at break,
making the scaffold stiff and brittle.
The thermoplastic TPU is a key component that solved that issue, since it helped to
improve elasticity depending upon the ratio, which was set to be higher than 25% [191]. Both
tensile strength and elongation at break had significantly different results based on the type of
direction being analyzed, parallel or perpendicular. The tensile strength results for aligned scaffold
on parallel direction was, 14.93 ± 0.59 and 5.04 ± 0.95 MPa for perpendicular. The elongation at
break for parallel direction was 58.92 ± 15.46% and for perpendicular direction was 8.20 ± 0.84%.
This marked difference is attributed to the orientation of the fracture. This indicates the importance
of fiber orientation combined with crosslinking. The elongation at break for random noncrosslinked fibers was 61.30 ± 3.88 and 9.87 ± 1.77% for crosslinked fibers. A variety of synthetic
and natural crosslinking agents impact the dimensional stability and cytocompatibility of
electrospun collagen scaffolds, [201]. The synthetic and natural crosslinking agents that have
been used are: genipin, glutaraldehyde, EDC and EDC with N-hydroxysulfosuccinimide (EDCNHS). The structural integrity of the scaffolds was evaluated by an in-vitro immersion study for
3 months and cytocompatibility with human mesenchymal stem cell. Two methods were
implemented, glutaraldehyde vapor and liquid (immersion) for genipin, EDC, and EDC with EDCNHS. The composition of the prepared crosslinking agents were: glutaraldehyde (0.5%) in
deionized water (DI) for 19 h exposure, 200 mM EDC in ethanol for 18 h, 200 nM EDC with 200 m
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NHS in ethanol for 4 h, and genipin in (1, 5, and 10%) in ethanol for 72 h at 37 °C. The collagen
scaffold retained fiber morphology for 10% genipin and EDC, EDC-NHS for up to 3 months.
Genipin concern was that it required extra washing step, which is dependent upon the amount
used of genipin, this is important cause it affects the cytotoxicity in culture medium. The
degradation of the scaffolds crosslinked with EDC, EDC-NHS is related with the content of free
amino groups which was slowly with time. Overall results indicate that EDC and EDC-NHS not
only retained fiber structure long-term but also support cell viability.
EDC is a widely used crosslinking agent, and for the first time it was compared with 1,4butanediol diglycidyl ether (BDDGE) [174]. Is the first time that BDDGE is used as crosslinking
agent, especially for collagen electrospun fibers, and is less toxic than glutaraldehyde, because
of residual and unstable glutaraldehyde polymers may be retained in the crosslinking procedure
[205]. For the two agents, EDC and BDDGE, the solution was 5% w/v in EtOH, the methodology
consisted of scaffold fix at CellCrown® 24 plastic rings and immersed in crosslinking solution 37 °C
for 7 days. Two types of collagen fibers were developed one using tri-fluoroethanol (TFE) as
solvent and other fibers using acetic acid (AcOH) as solvent to evaluate the effect of crosslinking
in both. The nanofibers developed with TFE as solvent had 10 wt. % collagen concentration and
resulted in fiber diameter 320 ± 80 nm and the ones prepared with dilute acetic acid (AcOH) with
30 wt. % collagen concentration with a diameter of 150 ± 30 nm. SEM characterization revealed
that collagen scaffold crosslinked with BDDGE retained fiber morphology, unlike the collagen
scaffold crosslinked with EDC that lost its porous morphology because of fiber swelling. The
mechanical properties are dependent upon the crosslinking agents (EDC and BDDGE) and
solvents (AcOH and TFA). EDC crosslinking agent resulted with the highest elastic modulus and
stress at break when compared with BDDGE agent. The elastic modulus results for EDC
crosslinking agent were the following: 870 ± 160 MPa for electrospun fibers with AcOH solvent
and 860 ± 80 MPa for TFE solvent. The elastic modulus results for BDDGE crosslinking agent
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were the following: 590 ± 190 MPa for AcOH solvent and 160 ± 30 MPa for TFE solvent. The
stress at break results for EDC agent had no significant difference between solvents with a value
of 12.3 ± 0.1 MPa. The stress at break for BDDGE agent had a different value for each of the
solvents 6 ± 1 MPa for AcOH and 12 ± 3 MPa for TFE. Both crosslinking agents improved the
mechanical properties of non-crosslinked electrospun which had an average elastic modulus of
86 MPa and a stress at break of 1.5 MPa. Clearly crosslinking improved the mechanical
properties of the electrospun collagen scaffold by orders of magnitude.

Figure 1-10. (a) Crosslinked nanofibers, (b) crosslinked nanofibers after exposure to water at
37 °C. Reprinted from Macromolecular Materials and Engineering, 301, Castilla-Casadiego D. A.,
Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno B., Loyo L., Shipmon, J. Aldo, A., and
Almodovar J., Engineering of a Stable Collagen Nanofibrous Scaffold with Tunable Fiber
Diameter, Alignment, and Mechanical Properties, 1064-1075, Copyright 2016, with permission
from WILEY‐VCH Verlag GmbH & Co. KGaA.

On our most recent work on crosslinking collagen electrospun fibers, we compared the
mechanical properties of the electrospun nanofibers with two crosslinking techniques: immersion
and vapor exposure both using a 25% glutaraldehyde solution [148][182]. The assembly consists
of a hollow top in which the scaffold is fixed to avoid shrinking. On the bottom of the container the
glutaraldehyde solution was placed, and the humidity was controlled between 35 and 50%. The
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time of exposure for the vapor method was 18 h, and 1 min for the immersion method. SEM
characterization Figure 1-10 confirms the integrity of collagen nanofiber after vapor exposure (a)
and after thermal test with 37 °C water (b). The immersion technique has a Young’s modulus of
4.1 ± 0.5 MPa and an elongation at break of 29 ± 15%. The vapor method reported a Young’s
modulus of 2.7 ± 0.7 MPa and an elongation at break of 38 ± 7%. These results help understand
how each method can be used to deliver water stable fibers with tunable mechanical properties
in order to adapt it to the native tissue.
The crosslinking impact on the electrospun fibers depends upon the components, external
parameters, and many other factors [199]. Crosslinking is a very sensitive method, and each
researcher should test and prove each technique to evaluate the results of their product. The
most common crosslinking agents are glutaraldehyde, by the vapor method, and EDC by
immersion. These findings contribute to tissue engineering; it opens the possibility to generate
and modify a scaffold that eventually will help regenerate and reestablish tissue functions. The
crosslinking method is a crucial step in order to achieve the biomaterial capable to possess the
mechanical properties of the native tissue [200].
1.2.8. Biomedical Applications

Nanofibrous collagen scaffolds fabricated using the electrospinning process have shown
to possess excellent biocompatibility and properties that are necessary for tissue engineering
[151] and have been presented throughout this chapter. They have been able to mimic the ECM
of native tissue, facilitating cell proliferation and attachment [152]. These scaffolds can, therefore,
be applied for the regeneration of nerve [153], bone [154], skin [139], tendon/ligament tissue [155],
and vascular grafts [156], among others, by providing promotion of function and tissue repair,
both in vivo and in-vitro. This section focusses on several biomedical applications of collagen
nanofibers that are useful for tissue regeneration and function.
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1.2.8.1.

Nerve

The nervous system has a leading role in the human body, controlling the function of the
different organ systems and physiological processes. Injuries to the central and peripheral
nervous systems can cause many problems to a patient’s everyday life and could therefore benefit
from different tissue engineering strategies to facilitate regeneration, such as electrospun collagen
nanofibers, providing a good platform for nerve repair [151]. Because nerve regeneration in an
injured spinal cord is usually limited, it contributes to the devastating outcome of neurologic
impairment below the site of injury and these tissue-engineered scaffolds have evolved as a
potential treatment method [151].
Nanofibers mimic the natural extracellular matrix and have therefore been evaluated as
potential applications for spinal cord injury both in vivo and in-vitro by [151][171]. These
researchers had two main goals, to evaluate topographical effects on astrocyte behavior and to
demonstrate the feasibility of using electrospun nanofibers for the treatment of acute spinal cord
injury (SCI) using a rat hemi-section model. Type I collagen aligned,and random nanofibers were
fabricated using collagen extracted from rat-tails with 90% acetic acid, instead of HFIP, to prevent
the denaturation of collagen [171]. Primary astrocytes from rat embryos were first seeded in
collagen-coated class and randomly oriented or aligned collagen nanofibers [171]. The best
response of astrocytes was observed in aligned nanofibers, which exhibited an elongated
morphology. Nonspecific orientation on randomly oriented fibers and collagen-coated glass only,
was observed [151, 171]. In addition, the elongation factor and cell shape index were significantly
higher when using aligned nanofibers than those with random fibers or glass cover slips. Although
cell shape index on aligned fibers was significantly higher, they suggested that astrocytes did not
truly demonstrate morphological changes and that a higher cell shape index could have been
likely caused by the elongated morphology in response to aligned nanofibers instead of enhanced
cell activation [171]. Dorsal root ganglia were also seeded onto sterilized random and aligned
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scaffolds and coated glass. Neurite outgrowth from dorsal root ganglia explants followed the
orientation of aligned fibers [171]. They then proceeded to form collagen scaffolds into spiral
tubular structures by rolling the wet crosslinked scaffolds into tubes of four to five layers.
These researchers created the lesion on a rat hemi-section model and implanted the
tubular structure. At days 10 and 30 post implantation, cellular penetration into the collagen fiber
constructs was observed. Scaffolds with aligned fibers appeared more structurally intact at day
30 [151][171]. They evaluated the lesions for 30 days due to previous research that indicated that
30 days should be enough to observe significant neural regeneration useful for analyses of
structural recovery of the lesion [206].
Fluorescent images of the implanted area were taken after 10 and 30 days on both
aligned and random nanofibers. Immunofluorescent staining showed a large number of
macrophages on day 10 and a drastic increase by day 30. This significant decrease in cell density
by day 30 allowed this group of researchers to suggest that there was a reduction in acute
inflammatory response and therefore that the collagen scaffolds were biocompatible with the
native tissue. Astrocytes with GFAP staining, were found in the borders of the implanted area.
This is very significant because it has been demonstrated that astrocytes, like other glial cells,
prevent the successful regeneration of the axon after a spinal cord injury [171]. Therefore, it is
important for these astrocytes not to appear in the implanted area. Coupled with the ability to
support and direct neurite outgrowth, electrospun collagen scaffolds may be more favorable than
collagen introduced in 2D format for SCI repair [171]. Finally, Masson’s trichrome staining results
indicated that the tubular structures were all retained after implantation and cell penetration into
the scaffolds was observed. These findings indicated the feasibility of fabricating electrospun
collagen nanofiber 3D spiral structures and their potential use for SCI repair [171].
Improving axonal regeneration by combining seeding cells with scaffolds has also been
an effective method [151]. Boecker and his research team implanted a predifferentiated MSC63

seeded micro-structured collagen nerve guide (Perimaix) in a 20 mm rat sciatic nerve defect [207]
and saw that these cells helped in axon regeneration into the Perimaix nerve guide. MSC-seeded
Perimaix nerve guide could lead to functional recovery similar to autologous nerve transplantation
[151]. Bozkurt et al. have also managed to achieve similar results using a 20 mm rat sciatic nerve
bridged with the same collagen-based nerve guide (Perimaix) but using Schwann cells as the
seeding cells [208]. These provided a valuable effect on myelination within the scaffold [208].
Additional research findings showed that supplementary physical stimulation such as
ultrasound [209], magnetic field [210], electric [211], and laser [212] could enhance functional
recovery of peripheral nerve injuries. These physical stimulations combined with electrospun
scaffolds could be introduced to promote the repair of injured nerves. Therefore, the use of
collagen nanofibers has provided biomimicking signals [171] in addition to showing the
topography, especially in aligned nanofibers, for neural tissue engineering and the enhancement
of Schwann cell maturation, among other types of cells [171].
Injuries in the nervous system can cause many problems in a patient’s life. Therefore,
advances like the ones observed here such as astrocyte behavior at the lesion site, macrophage
density decrease for spinal cord repair and axonal regeneration by combining cells with scaffolds,
could be beneficial to facilitate nerve regeneration [151]. Electrospinning of collagen nanofibers
for nerve repair have provided a good platform, due to their biomimicking signals, their topography
and their aligned morphology for neural tissue engineering in addition to enhancing cell
attachment and proliferation.
The nervous system has a leading role in the human body, controlling the function of the different
organ systems and physiological processes. Injuries to the central and peripheral nervous
systems can cause many problems to a patient’s everyday life and could therefore benefit from
different tissue engineering strategies to facilitate regeneration, such as electrospun collagen
nanofibers, providing a good platform for nerve repair [151]. Because nerve regeneration in an
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injured spinal cord is usually limited, it contributes to the devastating outcome of neurologic
impairment below the site of injury and these tissue-engineered scaffolds have evolved as a
potential treatment method [151].
1.2.8.2.

Bone

The main challenge of bone tissue engineering is the fabrication of a bone graft that can
mimic the ECM of tissues with the necessary bone mineralization [154]. To develop fibers with
these specifications, different biocompatible composite materials, such as nanohydroxyapatite
(HA) have been used to fabricate nanofibers, in addition to collagen [213][214]. Because collagen
and hydroxyapatite are two major components of the ECM, these have been highlighted to have
advantageous features when used for tissue engineering applications [213]. Prabhakaran et al.
fabricated composite nanofibers of PLLA, type I collagen and hydroxyapatite, using the
electrospinning technique [151]. They suggested that these membranes could improve the
proliferation and mineralization of osteoblasts, which could therefore help in bone regeneration
[154][213]. Figure 1-11 shows SEM images of PLLA, (a) PLLA/HA (weight ratio: 80:20), (b) and
PLLA/collagen/HA (weight ratio: 40:40:20) (c) composites, which displayed HA particles that have
been embedded in the nanofibers. The topography of the nanofibers play an important role in cell
behavior, for processes such as adhesion and proliferation [171]. In all the blends, HA is at a low
ratio in comparison to PLLA and collagen because the purpose is to obtain continuous nanofibers,
while having a large amount of HA can produce broken ones [213].
In their study, human fetal osteoblasts were cultured and seeded on PLLA, PLLA/HA,
PLLA/collagen/HA and tissue culture polystyrene as control. Cell proliferation was monitored
every 5 days for 20 days in total. These showed to adhere and actively grow on all combinations
of nanofibers, but the highest proliferation occurred on cells seeded over PLLA/collagen/HA
nanofibers [151]. These were found to be 41%, 24% and 11% higher compared to PLLA/HA
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scaffolds after day 10, 15 and 20, respectively [154]. These showed enhanced mineral deposition
of 57% higher than the PLLA/HA nanofibers [151][213].

Figure 1-11. SEM images. (a) PLLA (fiber diameter 860 ± 110 nm) (b) PLLA/HA (fiber diameter:
845 ± 140 nm) (c) PLLA collagen/HA nanofibers (fiber diameter: 310 ± 125 nm). Reprinted from
Acta Biomaterialia, 5, Prabhakaran, M. P., Venugopal, J., and Ramakrishna, S., Electrospun
nanostructured scaffolds for bone tissue engineering, 2884–2893, Copyright 2009, with
permission from Elsevier.

In another study by Chen et al., an internally structured collagen/HA scaffold was
fabricated. They found that the porosity and compressive modulus could be regulated depending
on the collagen proportion [151]. The porosity decreased while the compressive modulus
increased with an escalation in the collagen proportion [209]. The scaffold with a high collagen
proportion also had the best performance of MSCs’ viability, proliferation and osteogenic
differentiation in contrast to those with low proportion of collagen [151][209]. Finally, in vivo
studies demonstrated a significant effect in cell infiltration, meaning that controlling the internal
structure of a collagen/HA scaffold can provide an efficient carrier to repair bone [209].
To provide the necessary characteristics for a good bone graft in orthopedic applications,
a combination of structural, biological and mechanical properties are important for cell seeding,
proliferation and formation of new tissue. PLLA/collagen/HA scaffolds were fabricated by the
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electrospinning process and osteoblasts were grown on these scaffolds, showing cell adhesion.
In addition, studies have shown that as the collagen proportion increases, MSCs viability,
proliferation and osteogenic differentiation increases [151][209]. This allows for the conclusion
that these nanofibrous scaffolds show great potential for cell proliferation, adhesion and
mineralization, which could be promising for bone tissue engineering [154].
1.2.8.3.

Dermal (Skin) and Wound Healing

The skin is the largest organ in the body. Several of the most commonly used skin
substitutes, such as allografts and autografts, have shown that they are not able to solve for
problems caused by extensive skin loss. Therefore, many researchers have directed their work
to tissue engineering in order to promote the regeneration of the skin [151]. Collagen is the most
important dermal replacer used in various forms [215]. Rho et al. used the electrospinning of type
I collagen to yield nanofibers and observe if they accelerate early wound healing response [139]
[151]. They also observed the effects of cell behavior, cell and collagen nanofiber interactions and
examined open wound healing in rat [139]. Normal human oral keratinocytes (NHOK) were
isolated from epithelial tissue of healthy volunteers undergoing oral surgery, prepared and
cultured [139]. Their results showed that scaffolds promoted cell adhesion and the spreading of
human keratinocytes in-vitro. Because adhesion to nanofibers alone was relatively low, they
added several different ECM proteins such as fibronectin, type I collage and laminin to promote
adhesion and proliferation. Results of these studies showed that type I collagen and laminin are
both functionally active in cell adhesion of normal human keratinocytes [139]. Figure 1-12 shows
the results of open wound healing test where the collagen scaffold accelerated the disappearance
of the surface tissue debris and proliferation of fibroblasts in the early stages of wound healing
after 4 weeks [139]. As can be observed in the Figure 1-12 C, D, those containing the collagen
nanofibers, show the accelerated decrease in debris when compared to the controls at week 1
and 4, Figure 1-12 A, B, respectively. In addition, inflammatory cells disappeared, and connective
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tissue was able to form [139]. In another study, dermal injuries were done on adult guinea pigs
and treated with scaffold composed of electrospun type I collagen after being vapor crosslinked
to varying degrees [216]. They treated each wound with a scaffold and covered it with a piece of
silver gauze that was sutured in its place for 5–7 days. To track the healing process, the total
wound surface area as a function of time and treatment was measured [216]. Results showed
that when crosslinking was increased to 70%, wound surface area was increased dramatically,
which indicated increased regeneration.

Figure 1-12. Photomicrographs of wound healing of rat skin; control group at 1 week (a), control
group at 4 weeks (b), collagen nanofiber group at 1 week (c), and collagen nanofiber group at
4 weeks (d). Reprinted from Biomaterials, 8, Rho, K. S., et al., Electrospinning of collagen
nanofibers: effects on the behavior of normal human keratinocytes and early-stage wound healing,
1452–61, Copyright 2006, with permission from Elsevier.
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This metric has been used to analyze the results because interventions that reduce wound
contraction have been associated with less scaring and a more complete regeneration of tissue
[217]. Many researchers have directed their work to tissue engineering to help promote the
regeneration of skin [151]. Collagen has become one of the most important dermal replacers in
various forms. Therefore, a collagen nanofibrous scaffold was produced using the electrospinning
process and introduced for applications of wound healing. Results of these different studies have
shown that type I collagen and lamina are both active in adhesion of human keratinocytes [139].
In addition, as crosslinking is increased, wound surface area was increased, indicating increased
regeneration of tissue. These findings are very useful for advances in dermal repair and
regeneration.
1.2.8.4.

Tendon/Ligament Tissue

Tendons and ligaments are fibrous connective tissue and collagen forms 70–80% of them
[151][218]. They both have weak regenerative properties and do not completely recover from
lesions [151]. Therefore, a collagen scaffold can provide a good way to repair or regenerate
ligaments and tendons [151], because it is the main load-bearing component of the ECM and
contains the mechanical strength to provide the structural required [219]. Gigante et al. used an
oriented collagen type I membrane, because fiber orientation provides a pattern for cell growth
and alignment that mimics that seen in normal tendons, to study the regenerative properties of
tendons by grafting it into the central section of the patellar tendon of a New Zealand white rabbit
[155]. Twelve rabbits with a weight of 3 ± 0.5 kg were selected because of their similarity between
their knee and the human knee system [220]. The central part of the patellar tendon was explanted
from each animal and the collagen membrane was grafted.
Results showed the integration of both the collagen membrane with the native tissue and
the tendon with the collagen membrane [151][155]. Fibroblasts cells were detected on the surface
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and deeper layers of the membrane after 1 month of implantation. In addition, the orientation and
vascularization of collagen in treated tendons and controls were observed after 6 months. Lesions
containing the collagen nanofibers showed good orientation and a vessel in a dense connective
tissue, with a reduction in cell density. No inflammatory reactions were observed. Meanwhile,
control lesions demonstrated the formatted of a rough area, such as scars and vascularization
associated with a loose extracellular matrix [151][155].
This study indicated that a collagen type I membrane can serve as an effective tool for
tendon repair and healing without any adverse side effects. This because these fibers can mimic
the structure of tendons and ligaments [151], providing the necessary characteristics for
promoting cell attachment and proliferation and therefore help in the regeneration of
tendon/ligaments.
1.2.8.5.

Vascular Grafts

Many fabrication techniques have been used through the years to produce vascular
scaffolds [221][222][223]. These scaffolds have been created with the ideal characteristics
necessary for vascular grafts to be used for clinical purposes [151]. Lee et al. developed a fibrous
scaffold of a blend of PCL and collagen type I from calf skin using the electrospinning technique
[207] and crosslinked in 2.5% glutaraldehyde for 6 h to increase strength and stability. To study
the tensile properties of the scaffold, they were prepared into tubes of 15 mm length, 5 mm inner
diameter and 0.3 mm of thickness and measured using a uniaxial load test machine to achieve
results of yield strength, tensile strength, Young’s modulus and elongation at break from a stressstrain curve created [156]. On the other hand, to study the burst pressure strength, the pressure
was increased within the tubular scaffold until a failure occurred. For biological studies, smooth
muscle cells and endothelial cells from bovine carotid artery were seeded on the scaffolds,
performing MTS assays at days 1, 3, and 7 to determine cell viability. Biological activity was
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determined by studying the ability of these types of cells to proliferate in the scaffolds. Finally, to
evaluate cell morphology and adhesion, the cells were seeded on the scaffolds and incubated for
4 h to allow the cells to adhere. After 48 h, the cells that adhered were evaluated using SEM and
staining [207]. The bECs and bSMCs were able to attach to the surface of the PCL/collagen
scaffold. The bSMCs formed various cell layers on the outer region of the tubular scaffold, while
bECs formed a single layer on the inner surface of the scaffold. SEM images also showed a layer
of bECs on the lumen while bSMCs are seen on the outside of the scaffold.
This membrane’s uniaxial tensile properties showed that it initially has an elastic behavior,
but is followed by stiffening, which is not unlike the behavior observed in native tissue. The elastic
and elongation of this PCL/collagen scaffold was closer to that of native tissues, although ultimate
tensile strength and elongation at break were decreased when adding collagen to the PCL blend.
This membrane also resisted high degrees of pressure for longer periods of time, with a burst
pressure ranging between 4760 and 5070 mmHg, much greater that physiological blood pressure
seen in patients, demonstrating that these scaffolds have excellent strength and may be
developed to substitute native blood vessels [207]. In addition, this membrane provided a
favorable environment for the growth of vascular cells and showed excellent biocompatibility with
smooth muscle cells and bovine endothelial cells in comparison to latex, which is what these
researchers used as a control.
The fabrication of vascular scaffolds has been done through many different techniques, being the
most recent the fabrication of scaffolds with the ideal characteristics necessary for vascular grafts
to be used in clinical purposes. The results of the study explained above indicate that these
developed PCL/collagen scaffolds may be used with vascular cells to create vessels that would
be able to withstand physiological conditions due to their high burst pressure and their excellent
strength, among the many other characteristics evaluated [207].
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1.2.9. Future Studies
Electrospun nanofibers are rapidly moving towards commercialization due to their many
applications in a wide range of industrial fields such as biotechnology, pharmaceutics [224],
filtration, composite materials and medical [225]. Collagen has many properties that make it very
attractive for application in biotechnology, including its biocompatibility, biodegradability, low
inflammatory and cytotoxic responses, low antigenicity, high water affinity and availability from a
variety of sources [226]. It has become evident that a scaffold that mimics the mechanical
structure of the extracellular matrix is not enough to be successful for these applications, they
must also promote a natural state of differentiation of the cellular components [226].
The scaling-up process, therefore, has a lot of space to improve, starting with the
implementation of methods allowing for an increase of product reproducibility [224]. A high volume
of production is especially necessary for biomedical applications, like the ones collagen
nanofibers are intended to be used for, including the design of wound healing materials, useful
for medical treatment and antimicrobial purposes and drug-delivery for filtration [224]. In addition,
scaffolds that could be used in the market must go through rigorous in vivo studies before clinical
validations [227]. Most technological advances that have been explored for a high-volume
production of scaffolds are mainly based on modifications of the polymer injection system,
introducing the introduction of multi-spinneret components, allowing for multiprocessing [224].
These could be useful for the overall set-up, increasing the area of deposition [228].
Industrial-scale electrospinning equipment, although few, are available in the market. For
example, two industrial-scale instruments; a Nanospinner416 produced by Inovenso Ltd. and a
Nanospider produced by Elmarco have been used [224]. Although these are available, several
issues have risen from the use of these instruments such as productivity, a well-established
capacity of process monitoring and quality control. In addition, key requirements specific to the
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equipment are necessary to be able to commercialize, including price reduction, multi-functionality
and compactness [224]. Finally, it is important to point out that there is still a long way to go before
a collagen scaffold can be scaled-up and used in biomedical applications. Many studies must be
done to know the properties of these scaffolds and cellular responses in order to have a better
idea of what the best parameters would be to move to the industry. Nevertheless, studies such
as the ones presented in this chapter have shown how well these scaffolds can respond to assays
in animals in several biomedical applications such as tissue regeneration and drug delivery.
These open the doors to more trials to move to an industrial setting.
1.2.10. Conclusions
The development of nanofibers to mimic the native tissue is possible through the
electrospinning technique and has been experimented with throughout the years. In present day,
type I collagen nanofibers by “green” electrospinning have been successfully produced using a
non-toxic solvent, preserving the chemical and secondary structure of collagen. The versatility to
control the orientation and diameter of collagen electrospun nanofiber can be achieved through
tuning of the polymer concentration and via electrospinning parameters such as voltage and
polymeric solution flow rate. The orientation which is very important for cell growth direction can
be modified mainly through modification of the collector, a rotating collector for aligned nanofiber
and a static plate collector for random orientation. Collagen integrity is preserved after the
electrospinning process through crosslinking, which serves to tune the mechanical properties of
the collagen scaffold and withstand body temperature, crucial for implants and tissue regeneration
purposes. Finally, in several biomedical applications it has been possible to use these fabricated
nanofibers for nerve, skin, tendon/ligament, vascular grafts and bone regeneration. All of the
applications shown have been able to maintain or increase biocompatibility, mechanical
properties needed, promotion of function and tissue repair, showing great promise for the field of
tissue engineering.
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1.3.

Microneedle Patches for Drug Delivery

Although the most convenient method of drug administration is via the oral route, taking
oral medications is not the best technique for treating diseases in animals for several reasons
[229]. First, if the administration is done quickly, it can cause undesirable effects on the animal.
For example, once the oral medication is delivered to the animal, it cannot be withdrawn from the
bloodstream of the patient. Second, the oral administration of medications cannot be applied to
animals that have undergone surgery on the stomach or intestine. Likewise, it cannot be
administered to animals that are vomiting or having consciousness problems because the animals
may present problems to swallow the medicine. Additionally, if the animal is anesthetized, there
is a high risk of aspiration. Finally, this is a procedure that must be carried out more than once a
day, which can cause some stress on the animal.

The alternative of using oral administration has introduced the need to explore a better
approach for livestock drug delivery in an attempt to avoid any extra complication to the animal.
As a result of extensive studies in this field, researchers have proposed that a better option for
livestock drug delivery is through the transdermal application using polymeric microneedle
patches. A microneedle patch is a platform composed of needles uniformly organized and
designed to painlessly penetrate the skin at a controlled depth, avoiding stimulation of nerve
endings [230]. These patches are loaded with the drug that will be released in the skin and
delivered to the site of action by capillaries or lymphatic networks [230].

Microneedles systems have been recognized as one of the most promising options for
minimally invasive drug delivery, allowing the introduction of chemicals or DNA into the cell. In
the pharmaceutical field, microneedles have been used to deliver drugs, proteins, and vaccines
[230].
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Microneedle patches have been constructed from different types of materials (e.g., silicon
[231], glass [232], ceramics [233], metals [234], sugar [235] in the past; however, now,
polymeric microneedle patches have been demonstrated to provide better chemistry and
mechanical properties [236]. In particular, low-cost polymers such as chitosan or starch provide
a promising material platform for drug delivery and time-release mechanisms (e.g., through
polymer degradation, polymer morphology, or polymer chemistry). Chitosan, which is a byproduct
of chitin, is a polymer that has provoked the interest of scientists around the world for its potential
for biomedical applications. Because of its characteristics, including biocompatibility, nontoxicity,
polycationic properties, biodegradable ability, and antibacterial properties, chitosan has
demonstrated its ability to significantly improve cell activities such as adhesion, proliferation,
differentiation, and reduce the risk of infection in fabricating or coating implants [237]. For this
reason, chitosan has been amply used to produce solutions, hydrogels, fibers, powder, films,
fabrics, nano/microparticles, and sponges [237]. Chitosan-based microneedle patches have
been successfully proposed as a drug delivery method for humans [236], yet little work has been
proposed in the development of micro-patches for veterinary applications. Therefore, there is a
need to explore the transdermal application of using polymeric microneedle patches with the goal
of improving animal welfare and expanding the use of FDA-approved pain management
medications in the veterinary field.

Several researchers have proposed a variety of designs including different distributions of
the microneedles (square

[237], hexagonal [238], triangular [239], and rectangular

[240][241][242], different shapes [243], and consideration of microneedle dimensions (e.g.,
number of microneedles, microneedle radius, spacing, height, etc.) [244][245] to prepare an
optimal array for efficient transdermal drug delivery. Guang Yan and colleagues [246] evaluated
the microneedle length effect and microneedle density effect in skin pretreatment for transdermal
drug delivery of acyclovir. In this study, solid silicon microneedle arrays with different needle
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lengths ranging from 100 to 1100 µm and needle densities ranging from 400 to 11900 needles/cm2
were used. Their findings demonstrated that microneedle arrays with longer needles (>600 µm)
were more effective in establishing pathways across the skin and improving drug flux. Also,
microneedle arrays with lower needle densities (<2000 needles/cm2) were more effective in
improving drug flux if the microneedles had long enough needle length (>600 µm) [243]. These
results demonstrate that the design of an optimal microneedle array for efficient transdermal drug
delivery is crucial and possibly dependent on the drug.

Similarly, Ololade Olatunji and collaborators [244] evaluated the effect of geometry on the
drug transport behavior of fentanyl ﬂux into the skin. Their simulation results revealed that
increasing tip radius from 5 to 20 µm increased the ﬂux from 6.56 x 10 −6 to 7.02 x 10−6 mol/(m2s).
Likewise, the effect of the base radius of microneedles on peak blood concentration of fentanyl
showed the same behavior. Using microneedles with a base radius of 80 µm generated a blood
concentration of fentanyl of 2.4x10 -7 µg/ml while using a base radius of 90 µm, the concentration
of fentanyl was 2.6x10 -7 [245]. Also, Teo and colleagues reported that by changing the radius of
the microneedles, it is possible to increase the skin permeability [246]. Their results showed that
with changing a microneedle array with a radius of 0.005 cm to 0.015 cm, the transdermal
penetration was enhanced 10-fold.

Other researchers, such as Parket [247] and Stoeber [248], in separate studies, described
that the number of microneedles is an essential parameter in designing any microneedle array.
The authors both found that skin permeability increases by increasing the number of
microneedles. In other words, increasing the number of microneedles improves the efﬁciency of
transdermal drug delivery. Hence, these results demonstrate that the design of a microneedle
array plays a crucial role in the efficiency of transdermal drug delivery, revealing that each
dimension of the microneedle significantly contributes to increasing drug flux in the skin.
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These studies are a sample of what researchers in the veterinary field must explore to
transfer the microneedle technology that has been successfully applied to humans for animals.
Another subsequent challenge involves the optimization of transdermal drug diffusion, which must
be systematically investigated depending on the weight, age, sex, kind of cattle, and
environmental conditions of the area where the cattle are located. Otherwise, transdermal drug
diffusion will be difficult to control or regulate.

1.4.
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CHAPTER 2.

Simultaneous Characterization of Physical, Chemical, and Thermal

Properties of Polymeric Multilayers Using Infrared Spectroscopic Ellipsometry

2.1. Abstract
In this study, of multilayered ﬁlms of polyethylenimine/poly(sodium-p-styrene sulfonate)
(PEI/PSS) and type I collagen/heparin sodium (HEP/COL) were fabricated using the layer-bylayer technique, and fully characterized using Infrared Variable Angle Spectroscopic Ellipsometry
(IRVASE) to simultaneously analyze the chemistry, thickness, and roughness of the multilayers
with respect to changes in pH of the washing solution, and changes in temperature. Film
topography and Young’s modulus were obtained by atomic force microscopy (AFM) and
nanoindentation. Results showed that with IRVASE it is possible to analyze the thickness of the
multilayers prepared using a washing solution of pH 5, obtaining values of 71.7 nm and 40.3 nm
for three bilayers of PEI/PSS and HEP/COL, respectively. Film roughness varies between
multilayer systems, obtaining values of 37.76 nm for three bilayers of PEI/PSS and 33.58 nm for
three bilayers of HEP/COL. Increasing the pH of the washing solution for PEI/PSS yielded thinner
films that were less susceptible to thermal induced changes in film chemistry in the range of 25–
150 °C. PEI/PSS films decreased in thickness with increasing temperature up to 75 °C, whereas
above 75 °C film thickness increased. Through IRVASE, a transition temperature for the PEI/PSS
multilayers was observed at 75 °C. Temperatures above 37 °C drastically alter the chemistry and
the thickness of the HEP/COL multilayers indicating a possible degradation of the polymers.
Through nanoindentation, a Young’s modulus of 15,000 kPa and 9000 kPa for 12 bilayers of
PEI/PSS and HEP/COL, respectively. Finally, the surface charge of the polymeric multilayers
alternated from negative to positive, depending on the layer added.
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2.2.

Introduction
Layer-by-layer (LbL) is a technique used to produce thin layers or coatings on surfaces,

taking advantage of the sequence-specific electrostatic interactions between polyelectrolytes
[1][2]. It has been widely used for: biomedical applications [3], corrosion control [3], catalysis [4],
drug delivery [5], electrochemical sensing [6], protein purification [7], electrochromism [8],
ultrastrong materials [9], optics and optoelectronics [10], among others [11][12][13].
Physical and chemical properties of polymeric multilayers fabricated using the LbL
technique over different substrates have been characterized through different techniques.
Fourier-transform surface Plasmon Resonance (FT-SPR), Quartz Crystal Microbalance with
Dissipation (QCM-D), Variable-Angle Spectroscopic Ellipsometry, Scanning Electron Microscopy
(SEM), and Atomic Force Microscopy (AFM) have been widely used to evaluate film growth,
physical characteristics, morphology, thickness, and roughness [14][15][16]. Other techniques
such as UV-VIS spectroscopy, Circular Dichroism Spectrometry, and Zeta-potential Analyzer,
have been used to study the formation of multilayers [17][18][19][20][21]. Film chemistry has been
evaluated by techniques such as Fourier Transform Infrared Spectroscopy (FTIR), Xray
Photoelectron Spectroscopy (XPS) and Polarization Modulation Infra-Red Reflection Absorption
Spectroscopy (PM-IRRAS) [15][14][16][22]. Applying more than one technique and a larger
number of samples to fully characterize the physical and chemical characteristics of polymeric
LbL films.
Infrared Variable Angle Spectroscopic Ellipsometer (IRVASE) combines the principles of
spectroscopic ellipsometry and FTIR that allows the chemical and physical characterization of
thin films [23][24]. It is a powerful non-destructive surface technique, that allows the determination
of film thickness, optical constants (n, k), and chemical composition of ultrathin multilayered films
[24]. IRVASE also provides information of film characteristics such as: anisotropy, roughness,
nonuniformity, phonons LO and TO, and doping concentrations [23][24]. The versatility of this
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technique is also demonstrated with the possibility of coupling other accessories to the equipment,
such as a temperature stage, which allows the study of changes in film chemistry and thickness
with respect to temperature [25]. Today, literature has reported the use of IRVASE to measure
the dielectric function of substrates [26][27], determining the optical constants for lubricants [28]
and polymers [23] to measure concentration profiles of doped silicon wafers [29], to evaluate
physical-chemical properties of thin spin cast films [24], in studies of thermal stability of protein
monolayers and multilayers deposited by drops over silicon substrates [25] and in the detection
of inorganic compounds in nanolayers between 1–5 nm of thickness, like it was reported in our
most recent work [30]. Only one recent report is available in the literature using IRVASE as a
complementary technique to characterize LbL films composed of poly (ethylenimine) and poly
(acrylic acid) [31].
The use of IRVASE as a characterization technique for LbL multilayers has remain largely
unexplored. Here we present a full study on the formation and IRVASE characterization of
synthetic and natural polymeric multilayers. We demonstrate the simultaneous characterization
of the physical (thickness and roughness), chemical, and thermal properties of synthetic and
natural polymeric multilayers using IRVASE. Two multilayered systems are evaluated: synthetic
multilayers composed of polyethylenimine (PEI) and poly (sodium-p-styrene sulfonate) (PSS) and
natural multilayers composed of collagen type I (COL) and heparin (HEP). PEI/PSS LbL films
have been previously used as sorbents for CO2 capture [21], adsorption of prussian blue colloids
[32], and corrosion control [33]. The natural system of multilayers HEP/COL have been previously
used to help promote the blood-compatibility of titanium implants [34][35][36][37], vascularization
studies [38] and intravascular endothelialization with the functionalization of antibodies over the
multilayers [39][40]. IRVASE was used to study the effect of changes in temperature (25, 37, 50,
75, 100, 125 and 150 °C) and pH (2.7, 4, 5 and 6) of the washing solution used to prepare the
multilayers with respect to changes in thickness, roughness and chemical composition. AFM was
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used to validate thickness results obtained from the IRVASE in addition to obtaining information
on the morphology, roughness, and Young’s modulus of the multilayers, complementing results
obtained from the IRVASE.
2.3 Methodology
2.3.1

Materials
Polyethylenimine (PEI) (50% Solution in Water, Mw ≈ 750,000) of Sigma-Aldrich, poly

(sodium-p-styrenesulfonate) (PSS)(Mw ≈ 70,000) of Acros Organics, heparin sodium of Celsius
Laboratories, Inc., and lyophilized type I collagen sponges derived from cow tendon (generously
donated by Integra Lifesciences Holdings Corporation, Añasco, PR), were used to prepare
polymeric multilayers over a silicon substrate (resistivity of 5 – 10 Ohm – cm, thickness 356 – 406
µm, WRS Materials, San Jose, -CA) and tissue culture plastic (24 well plates). Sodium acetate
anhydrous was purchased from Fisher BioReagents. Acetic acid glacial (ACS Grade) was
purchased from Amresco. Ultrapure water at 18 MΩ - cm obtained from an ultrapure water system
directly from tap producing RiOs™ and Milli-Q® water (Darmstadt, Germany), was used to prepare
polymeric and wash solutions.
2.3.2

Construction of Polyelectrolyte Multilayers
Two systems, one composed of synthetic polymers and another composed of natural

polymers, PEI/PSS and HEP/COL respectively, were used in this work to prepare polymeric
multilayers using the LbL technique. For each combination of polymers, 3, 6, 9 and 12 bilayers
were generated over the silicon substrates. The solution used to the dissolve polymers consisted
of acetate buﬀer (0.1M sodium acetate anhydrous, 0.1M acetic acid, pH 5), which was also used
as the washing solution. The washing solution was also prepared at a pH 2.7, 4, 5, and 6 to
evaluate the eﬀect of changes in pH on the characteristics of the PEI/PSS multilayers. For
HEP/COL multilayers, a washing solution of pH 5 was evaluated. All polymeric solutions were
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prepared at a concentration of 1mg/mL. A robotic dipping machine, nanoStrata StratoSequence
VI (Tallahassee Florida), was used to develop the LbL ﬁlms. In this work, the sequence of forming
the multilayers consisted in submerging the substrate in a PEI solution for 15 min to establish an
anchor layer. Then PSS and PEI were deposited sequentially for 5 min per layer with a 3min wash
in between to remove molecules slightly adhered. The same process was performed for the
HEP/COL system. After multilayer preparation, a ﬁnal wash was performed using ultrapure water
at 18 MΩ - cm. The samples were left to dry at room temperature prior characterization.
2.3.3

Analysis of the Chemical Composition of Polymers and Multilayers
FTIR-ATR was used to conﬁrm the presence of functional groups of each polymer

dissolved in acetate buﬀer (0.1M sodium acetate anhydrous, 0.1M acetic acid, pH 5) and
deposited through drop casting over a silicon substrate. The infrared spectra of the samples were
collected using a PerkinElmer Spectrum Two FTIR in ATR mode, with a wavenumber range of
500 to 2000 cm-1 using 500 scans at 4 cm -1 resolution. Infrared Variable Angle Spectroscopic
Ellipsometry (IR-VASE® Mark II, J.A. Woollam Co., Inc. IR-VASE, Lincoln, Nebraska) was used
to study the chemistry of the individual polymers by drop casting and polymeric multilayers
constructed over the silicon substrate. The chemical composition analysis for all samples was
performed in a wavenumber range from 500 – 2000 cm−1. The measurements were taken using
a DTGS detector, an angle of incidence of 65˚ and 75˚, a spectral resolution of 16 cm −1, 15 scans
per cycle, 2 cycles, bandwidth of 0.01μm, minimum intensity ratio of 2, sample type as isotropic,
zone average polarizer, and single position RCE analyzer. A heating stage controlled by an
INSTEC – mk2000 coupled to the IRVASE was used to establish the controlled heat ramp. The
polymeric multilayers were heated to 25°C, 37°C, 50°C, 75°C, 100°C, 125°C and 150°C, with an
exposition time of 10 min for each temperature, programmed to heat up, maintain the
temperature, and then collect ellipsometric data.
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2.3.4

Analysis of the Physical Characteristics of Multilayers
The thickness and roughness of the multilayers formed over the silicon substrate were

determined using the IRVASE equipment (IRVASE® - Mark II, J.A. Woollam Co., Inc. IR-VASE,
Lincoln, Nebraska). The WVASE32 software within the IRVASE was used to analyze both
properties. Transmission test were done before analyzing the samples to make sure it was less
than 0.01%. Collected data were ﬁtted to ellipsometric models that are a function of ﬁlm thickness
and optical constants (n, k). The model consists of default layers of the 1mm silicon substrate
(si_ir) along with its native oxide layer (sio2_ntve_ir_g), followed by an infrared general oscillating
layer (genosc_ir) to model the polymeric bilayers. The thickness was displayed in nanometers
and the Mean Squared Error (MSE) and the depolarization were observed to be closest to zero.
The MSE is the error of the ﬁt to the collected data. The same collected data were ﬁtted to
ellipsometric models that are a function of ﬁlm roughness. The model consists of default layers of
the 1mm silicon substrate (si_ir) along with its native oxide layer (sio2_ntve_ir_g), followed by a
surface roughness layer (srough) to model the roughness of the polymeric bilayers. The
roughness was observed in nanometers and the MSE was observed to be closest to zero. In
addition, the n and k optical constants and the oﬀset were observed. These should remain
constant, or very similar, as the diﬀerent samples are analyzed. Lastly, the eﬀect on varying
temperature and pH over the morphology of the multilayers was also evaluated. Figure 2-S1 and
Tables 2-S1, 2-S2, 2-S3 and 2-S4 from the supporting information (Appendix A.1) provide the
results obtained for MSE, optical constants (n, k), and oﬀset, as well as a more in-depth
explanation as to what each means and what would be the expected results. It also contains an
example of the model ﬁt that the WVASE-IR provides after analyzing the data. Thickness and
roughness were calculated as a mean of three measurements and the error bars represent the
standard deviation. An Agilent Atomic Force Microscope (AFM), model 5500 (Keysight
Technologies, Santa Rosa, CA) was used for the topographical characterization, to study the
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changes in roughness, the mechanical properties on the polymeric surfaces and to corroborate
the thickness obtained through IRVASE analysis at the diﬀerent experimental conditions. To
analyze the topography and roughness of the multilayers, measurements were performed using
a silicon SPM (N9832B) sensor cantilever in contact mode. All measurements were carried out in
air, under ambient conditions and each image measurements on a sample correspond to 512×512
pixels. The scanning speed used was 1.96 lines/s. The size of the scanned area was 80x80μm.
For the topographic analysis, the surfaces were compared by means of the roughness parameters
(Ra). Thickness and roughness were calculated as a mean at three diﬀerent positions of two
samples and the error bars represent the standard deviation.
To analyze the mechanical properties and thickness of the sample a silicon SPM (N983A
ppp-cont: deﬂection sensitivity of 58.624 nm/V, and a force constant of 1 N/m) sensor cantilever
was used. For this analysis, ﬁrst, the sensitivity of the cantilevers was evaluated by pressing the
cantilever over a silicon substrate. Then, the force constant of the cantilever was measured and
the elasticity parameter (i.e. tip radius, Poisson ratio) was adjusted. The scan resolution was
512×512 pixels, the area of indentation was 80x80 μm with a speed of 1.19 lines/s, the duration
was 0.240s, data point was 2000 with a rate of 12.50 μm/s. For this analysis 20 indentations in
each point of two samples were performed and the error bars represent the standard deviation.
The 20-indentation per point was selected to corroborate that the cantilevers were touching the
silicon substrate and with this information the thickness of the multilayers were corroborated.
Afterwards, the Young’s modulus was calculated using the Hertz and Sneddon model (no
adhesion contribution).
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2.3.5

Statistical Analysis
The results are presented as a mean ± standard error of the mean (SEM). Comparisons

among multiple groups for physical−chemical properties studies and cytokine expression for hMSCs on HEP/COL multilayers were performed by two-way analysis of variance (ANOVA). For
h-MSCs proliferation response to HEP/COL multilayers, a nonparametric test was performed.
Graph Pad Prism 7.0 software for Windows was used for statistical analysis. A p-value < 0.05
was considered statistically signiﬁcant.
2.4

Results and Interpretation

2.4.1

IRVASE vs FTIR: Chemical Composition of Polymeric Surfaces
To demonstrate the potential of the IRVASE technique and its usefulness as a tool in the

characterization of the chemical composition of surfaces, in this study each of the polymers was
dissolved in acetate buffer (0.1 M sodium acetate anhydrous, 0.1 M acetic acid, pH 5) and
deposited on the substrate through drop casting. FTIR-ATR was used to validate the results
obtained through IRVASE. To confirm the chemical composition of the polymeric multilayers over
the silicon substrate, it was necessary to initially study the molecular structure of each polymer
individually to identify their characteristic functional groups and to later associate peaks in IR
spectra with vibrations in these groups. The polyelectrolytes used in this work were PSS & HEP
as the polyanions, and PEI & COL as the polycations. Their chemical structures are presented in
Figure 2-S2 from supporting information (Appendix A.1). The chemical structure of PEI, which is
a highly branched cationic polymer, is shown in Figure 2-S2A of supporting information
(Appendix A.1). This polymer contains in its structure a high density of ionizable groups
including primary amines (RNH2), secondary amines (R2NH), and tertiary amines (NR3) [41]. The
amines present in PEI gives its strong positive charge when protonated to NH3+. For this polymer,
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a pKa within 7.11 and 8.6 has been reported, allowing it to be considered as a strong polycation
at pH 5 [42].
Analyzing the FTIR-ATR and the IRVASE spectra of PEI in Figure 2-1A, it is possible to
identify the functional groups described in the chemical structure [41]. The characteristic peaks
for PEI observed are: 1635 cm -1 (NH2 group), 1544 cm −1 (N–H bending), 1402 cm −1 (CH 2
bending), 1050 cm −1 & 1017 cm −1 (C–N stretching) [41][43], and other strong absorptions
under 1000 cm -1 associated to CH2 [44][45]. Residual acetate buffer may correspond to the
COOH peak near 1700 cm -1 and to the CO peak near 940 cm -1 . Evaluating the spectrum
obtained by IRVASE and comparing it with the one obtained through FTIR-ATR, it is possible
to determine that they match, with only some slight displacements between a few bands. The
differences in spectra may be due to the limited penetration depth of the FTIR-ATR. IRVASE
can penetrate the entire thickness of the sample, over a larger area, generating a stronger
signal and reducing signal to noise ratio.
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Figure 2-1. IRVASE (Extinction coefficient) and FTIR-ATR (A.U.) spectrum of pure: A) PEI, B)
PSS, C) HEP and D) COL. Reprinted from Colloids and Surfaces A: Physicochemical and
Engineering Aspects , 553, Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M.,
Quiñones-Colón B. A., Suleiman D., and Almodovar J., Simultaneous characterization of physical,
chemical, and thermal properties of synthetic and natural polymeric multilayers using infrared
spectroscopic ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.

The structure of PSS (Figure 2-S2B from supporting information (Appendix A.1)) contains
a 1,4-substituted benzene ring with a sulfonate group. Since this molecule has a pK a near 1.0,
the sulfonate is deprotonated and negatively charged at pH values larger than 1, resulting in it
acting as a strong polyanion [46]. Evaluating both the IRVASE and FTIR-ATR spectra (Figure 21B), the characteristic peaks of PSS are observed including: the SO3- asymmetric stretching
vibrations at 1186 cm-1 and 1135 cm-1, and the SO3- symmetric stretching vibrations at 1049 cm 1

and 1018 cm-1 [47]. Similarly, the C=C group at 1566 – 1404 cm-1, which are part of the benzene

ring [47].
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Heparin is composed of a disaccharide repetitive unit that includes three acidic groups:
carboxyl, N-sulfonate, and O-sulfonate (Figure 2-S2C from supporting information (Appendix
A.1)). The carboxyl group has been found experimentally to have a pK a ranging from 2.79 to 3.13,
and it has been reported that the O-sulfo and N-sulfo are even more acidic than the carboxyl
group when heparin is dissolved in water [48]. Therefore, in a solution with a pH higher than the
pKa, it is expected that the heparin subunits will have the acidic groups deprotonated, resulting in
negative charge and heparin acting as a polyanion [14]. Other notable functional groups in HEP
are the hydroxyl and ether groups. Because HEP is a polysaccharide, it is expected that the
spectrum will show a peak between 1700 -1600 cm-1 and another between 1600 – 1500 cm-1,
corresponding to the NH2 group (Amide I) and the N-H, (Amide II), respectively [37]. The spectra
obtained by both IRVASE and FTIR-ATR for HEP are presented in Figure 2-1C. The spectra
shows bands at 1627 cm-1 and 1558 cm-1, corresponding to the amide I and amide II, respectively
[45]. Another peak is observed at 1420 cm -1 and is attributed to the CH2 scissoring, as well as the
peaks observed at 1350 cm-1 and just below 1000 cm-1 [44][45]. The C-N group is shown between
1100 cm-1 and 1000 cm-1 and at approximately 950 cm-1 the C-O-S stretching vibration is observed
[14][49].
Finally, the chemistry of collagen type I was also analyzed. Collagen is known as a fibrous
protein (See Figure 2-S2D from supporting information (Appendix A.1)), which is a succession of
amino acids joined together by peptide bonds [50]. IRVASE (Figure 2-1D), revealed a betterdefined spectrum than the one obtained through FTIR-ATR. The characteristic peaks of collagen
are seen in both spectra. Figure 2-1D shows the characteristic peaks of collagen, amide I (1700–
1600 cm-1), amide II (1600–1500 cm-1), and amide III (1300–1180 cm-1) in both spectra
[51][52].Thus IRVASE may be used to evaluate the chemical composition of synthetic and natural
drop cast polymers as confirmed by FTIR-ATR.
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2.4.2

Multilayered Film Growth: Chemical and Physical Characteristics of the Surface

by IRVASE
A robotic dipping machine was used to develop the polymeric multilayers of PEI/PSS and
HEP/COL systematically by programing the immersion of the silicon substrate for 5 min for the
polymeric solutions and 3 min for the washing solution. IRVASE was used to monitor film growth,
determine film composition/chemistry, and determine film thickness and roughness of the surface
modified for the polymeric multilayers. AFM was used to analyze the topography, roughness,
Young’s modulus, and to validate the thickness of the multilayers formed. The thickness was
determined by the difference between the contact points of force on the substrate and the
multilayers, as has also been reported by Domke and Radmacher, where they measured the
elastic properties of gelatin films, with a thickness of 1.4 µm (thick trace) and another of 180 nm
(thin trace) using AFM [53]. This was unlike the method employed by Lobo and colleagues, who
applied a ‘furrow method’ to evaluate LbL ultra-thin films with a thickness of at least 60 nm [54][55].
This method consisted in using the AFM to scratch the multilayers formed over the substrate,
producing a furrow, allowing to estimate the thickness of the multilayers through a direct
measurement of the height of the furrow [54][55]. In our work, 3, 6, 9 and 12 bilayers were
developed using a washing solution of pH 5, for both combinations of polymers.
Analyzing our results, Figure 2-2 shows that the surface of the silicon substrate was
effectively modified by the LbL technique as demonstrated by the presence of characteristic peaks
for PEI/PSS. The spectra for all bilayers are different from the neat silicon substrate spectrum,
generally showing characteristic absorption bands previously discussed for PEI and PSS.
Although slight displacements are observed, due to the interaction among polymers,
characteristic PEI peaks are observed at 1628 cm -1 for the NH2 group, 1527 cm −1 (N–H
bending), 1444 cm −1 (CH 2 bending), 1026 cm-1 (C–N stretching), and 1000 cm −1 (C–N
stretching) [41][43]. A zoom of Figure 2-2A is available in the Figure 2-S3 from supporting
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information (Appendix A.1) to better appreciate these peaks. For PSS, the SO3- asymmetric
stretching vibrations, are identified at 1203 cm -1 and 1157 cm-1. The SO3- symmetric stretching
vibrations are observed at 1110 cm -1 and 1056 cm-1. And the C=C vibration at 1519 cm -1 and
1404 cm-1 were also identified for PSS [47]. Choi and his group [56], developed LbL films of
PEI/PSS over a gold substrate. Through FTIR they also confirmed the formation of the PEI/PSS
multilayers, validating our results obtained through IRVASE. They reported peaks at 1200 cm -1,
1126 cm-1, 1035 cm-1, and 1008 cm-1 which were assigned to the asymmetric vibration of SO 3-,
benzene ring-sulfur vibration, symmetric vibration of SO3-, and in-plane bending vibration of parasubstituted benzene ring, respectively [56]. Our IRVASE spectra of the multilayers (Figure 2-2A)
revealed these peaks, which have also been reported in previous studies for PSS [57][58]. When
comparing the analysis of FTIR and IRVASE of the drop cast polymers (Figure 2-1A) it was also
possible to identify the characteristic peaks of PEI, as previously mentioned. These observations
confirm that the chemistry of these polymeric combinations is present and that the surface was
adequately modified compared to the spectrum of the silicon substrate. This confirms that LbL
film chemistry may be evaluated using IRVASE. Moreover, since the IR beam penetrates the
entire thickness of the sample the chemistry provided by IRVASE represents the chemistry of the
LbL film throughout its entire thickness, and not the chemistry of the final layer.
Figure 2-2A shows that a greater number of bilayers results in spectra with better defined
peaks. This may indicate that a larger deposition of polymers is being accumulated over the
substrate surface as bilayer quantity increases. This behavior was reported by Richards and his
group [21], who fabricated multilayers of PEI/PSS and confirmed their formation and chemistry
using energy dispersive X-ray analysis, confocal laser scanning microscopy, and ellipsometry. An
increase in PEI deposition was found with increasing PEI/PSS bilayer formation [21].
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Figure 2-2. Multilayer growth, chemical, and physical characteristics for PEI/PSS system by
IRVASE. A) Spectrum of plain substrate, 3, 6, 9, and 12 bilayers, B) Thickness vs. number of
bilayers, C) Roughness vs. number of bilayers and D) Surface morphology as measured by AFM
of: Substrate, 3 bilayers, 6 bilayers, 9 bilayers and 12 bilayers. The error bars indicate the
standard deviation of the samples as is described in the materials and methods section. The pvalues < 0.01 are represented by #, @, &, ψ and ϴ. The p-values < 0.05 is represented by $. The
bars that have the same symbol are statistically different.
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Figure 2-2. (Cont.) Reprinted from Colloids and Surfaces A: Physicochemical and Engineering
Aspects, 553, Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón
B. A., Suleiman D., and Almodovar J., Simultaneous characterization of physical, chemical, and
thermal properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.
S. Ravaine and colleagues studied the kinetics of monolayer formation, using infrared
spectroscopy to monitor the absorption of the Prussian blue (PB) colloids in PEI/PSS films. They
observed an increase in peak intensity in the infrared spectrum of a PEI/PSS film as a function of
the number of cycles of immersion in a 10 −3 M PB solution, followed by rinsing with water [32].
Spectroscopy (either infrared or ultraviolet) has been previously used to monitor LbL multilayer
construction.

Wang

and

collaborators

[59],

fabricated

multilayers

of

3,4-

poly(ethylenedioxythiophene) and PSS using PEI as an anchor layer, where they monitored film
growth by UV-VIS. Considering IRVASE uses the underlying principle of FTIR, we can exploit
this technique to monitor film growth by changes in the IR spectrum of the samples as well as
obtaining their thickness.
Thickness and roughness values were obtained with the lowest values corresponding to
3 bilayers, of 71.70 nm and 37.76 nm, respectively (Figure 2-2B-D). In Figure 2-2B, it is
noticeable that during the formation of the 6 bilayers first a significant difference of p < 0.05 in
thickness compared with 3 bilayers is observed. No significant difference was observed between
the 6 and 9 bilayers. But a p < 0.01 was obtained between 12 compared with 3, 6 and 9 bilayers.
This can be associated to the fact that the formation of the layers has a base stage over the
substrate, which helps in the effective formation and adhesion to modify the surface with
polymeric multilayers of PEI/PSS.
Kotov and his group fabricated PEI multilayers (branched, Mw ≈ 25,000 Da)/PSS (Mw ≈ 1
 106 Da), using LBL spin-coater [33][60]. They found that the thickness of the multilayers linearly
increases with a correlation coefficient of almost unity. They observed an average thickness per
layer pair of 6.7 nm, as measured by ellipsometry, for multilayers constructed using polymers
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dissolved in water at pH 3.7 and a concentration of 50 mg/mL and using acetonitrile as rinsing
solution [33].
Richards and his group [21], demonstrated that advanced solid sorbents can be fabricated
applying the LbL technique and that the absorption capacity is proportional to the number of layers
of PEI/PSS formed. They reported in their ellipsometric analysis, that the thickness of the
multilayers linearly increases with increasing number of PEI/PSS bilayers, obtaining that each
bilayer is approximately 8 nm thick. Therefore, a thickness of approximately 80 nm was obtained
for 10 bilayers [21], and in comparison, to the results obtained by Kotov, this estimated thickness
can be obtained with the fabrication of 12 bilayers. In our work, a 3 bilayered PEI/PSS film yields
a thickness of 71.70 nm. This value differs from the work of Kotov and the work of Richards. In
our work, PEI and PSS are dissolved at 1 mg/mL a lower concentration as compared to the works
of Kotov and Richards for the same polymeric system. The difference may arise in the
concentration of the polymers used and/or the molecular weight of the polymers [21][33]. Our
work uses high molecular weight branched PEI (Mw ≈ 750,000 Da) which may lead to thicker
films. Previous work has shown how strongly the molecular weight of the polymers influences the
thickness of the multilayers, such that increasing molecular weight yields an increase in film
thickness [61].
M. Elzbieciak and collaborators, studied the influence of pH in the polymeric solution over
the structure of the multilayers prepared from aqueous solutions using a standard dipping
approach [62]. They demonstrated that depending on the pH of the polymeric solutions, the
polyelectrolyte combinations that are weakly or strongly charged generated a linear or nonmonotonic increase in thickness. In their work using PEI (MW ≈ 70,000 Da) /PSS (MW ≈ 70, 000
Da) at pH 6 and a concentration of 10–3 g/L, they achieved an increase of 2.5 nm per bilayer for
the PEI/PSS bilayer film. This value less than the one reported Kotov [60] and Richards [21],
therefore M. Elzbieciak would have had to elaborate approximately 32 bilayers to obtain a
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thickness average of 80 nm [62]. These studies reveal the physical characteristics, such as the
molecular weight of the polymers used to generate the multilayers, their concentrations, and the
pH of the polymeric solutions and washes, are intimately linked to the formation and increase in
the number of multilayers.
A similar behavior of having a base stage in the formation of the multilayers has also been
reported in works of multilayers fabricated with other combinations of polymers. Wang and
collaborators [59], demonstrated by performing an ellipsometric study to evaluate the thickness
of PEDOT/PSS bilayers, that an increase in thickness begins around two or three bilayers,
corresponding to an interval in thickness of 6-10 nm. This is because the first layers show a
support stage, demonstrating a bi-lineal tendency in the thickness during an increase in the
multilayer films, which shows a thickness behavior that varies linearly with the number of bilayers
formed. In their previous work, Schaaf and colleagues prepared multilayers of PSS/polyallylamine
(PAH) [63] and associated this bi-lineal tendency to the substrate effects that influence the
packing density of the first few layers formed. This tendency has also been reported for multilayers
prepared of polymeric combinations composed of cationic-modified hyaluronan+/hyaluronan [64],
poly(L-lysine)/hyaluronan, and poly(L-lysine)/heparin [49]. Our results demonstrate that IRVASE
can characterize the thickness of the polymeric multilayers, obtaining the same behavior and
magnitudes reported in other works.
To validate our results of the thickness measurements obtained by IRVASE, we decided
to use AFM for indentation. To obtain the measurements of each sample, first the mechanical
properties of the substrate were measured, to acquire a value in which the indentation of the
multilayers over the substrate finalizes. Meaning that once the cantilever in the indentation
perceives the properties of the substrate, it will stop. Therefore, the thickness measurement will
be calculated by the distance of penetration from the surface of the multilayers to the surface of
the substrate. The indentation results (Figure 2-S4A from supporting information (Appendix A.1))
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demonstrated that the thicknesses obtained from the IRVASE is reliable. Obtaining a thickness
of 70.12 nm through indentation versus 71.7 nm with IRVASE for 3 bilayers and 217.5 nm versus
253.3 nm for 12 bilayers, respectively. In addition, AFM also confirms that the sample is not
damaged after IRVASE analysis, due to the similarity in the data. It is worth highlighting that
IRVASE covers a larger area of 176.71 mm2 when measured at an angle of 70°, in comparison
to AFM which covers 6.4 mm 2, allowing us to obtain a more precise thickness value. The range
of thicknesses that might be obtained through IRVASE is large. Thicknesses as small as ~1 nm
may be obtained [30]. The thickness of thick LbL films (more than 500 µm) may be evaluated
using IRVASE if the sample is homogenous and with minimal roughness. To ensure adequate
values for thickness, the depolarization of the film must be close to zero. Increase in depolarization
is observed with non-homogenous LbL films. The non-homogeneity of LbL films may be caused
due to impurities in polymer solution, polymers with large polydispersity index, large salt content,
or other effects.
IRVASE was also used to estimate the roughness of the multilayers formed over the
substrate. The same way AFM was used to validate the results obtained by the IRVASE. The
results of the topographic characterization by AFM are presented in (Figure 2-S4B from
supporting information (Appendix A.1)), showing how roughness progressively increases with the
number of bilayers. Obtaining a significant difference of p < 0.01 in the topography and its
roughness measure of the surface with 12 multilayers compared with 3, 6 and 9 bilayers, reporting
a roughness of approximately 12 nm for 3 bilayers in comparison to 130 nm for 12 bilayers (Figure
2-S4B from supporting information (Appendix A.1)). This behavior was also observed by IRVASE
in Figure 2-2C, obtaining a roughness of approximately 37 nm versus 240 nm for 3 and 12
bilayers, respectively, with a significant different p < 0.01. This shows a similar scale, but with a
magnitude of almost double for the values obtained by the IRVASE versus those obtained by the
AFM. This difference could be associated to the fact that the IRVASE does the analysis over a
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larger area of the surface, adjusting the average. However, these values in roughness are in the
range of previously reported polymeric LbL systems using a high-molecular weight PEI [65].
In addition, an analogous behavior over the thickness and roughness of the samples is
appreciated in Figure 2-2B and Figure 2-S4B from supporting information (Appendix A.1) which
shows the roughness data with respect to Figure 2-2B of the thickness. We observed two regions
of increasing roughness, where the roughness increases slightly between 3 and 9 bilayers.
Afterwards, a significant increase in roughness is observed between 9 and 12 bilayers. This
confirms the establishment of the base layers. This behavior could be associated to the amount
of polymer adhered to the surface of the substrate, which is intimately associated with the number
of bilayers formed. This has been reported by M. Elzbieciak and their group [62], where they
observed a change in topography and a higher roughness between 6 and 7 bilayers of PEI/PSS,
similar to our results.
AFM was also used to measure the mechanical properties of the multilayers. Figure 2S5A from supporting information (Appendix A.1) shows the Young’s modulus for 3, 6, 9 and 12
bilayers (the same samples used to measure topography and roughness in indentation). These
results demonstrated that as the number of bilayers increases, the Young’s modulus decreases.
We observed a statistically different (p < 0.05) in Young’s modulus of 18,929.0 kPa for 3 bilayers
and 14,664.8 kPa for 12 bilayers. This can be associated to the fact that the multilayers are softer,
also indicating that the surface of the substrate is completely modified, reigning the properties of
the multilayers with an increase in the bilayers formed. Therefore, these results demonstrate that
it is possible to simultaneously obtain the physical-chemical properties of a surface modified by
multilayers using the IRVASE, leaving the sample available for other analysis.
For natural multilayers of HEP/COL, it was also possible to characterize the physical,
chemical, and mechanical properties using IRVASE and AFM. Our results over the analysis of
the chemistry of the multilayers revealed the presence of the characteristic bands of both
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polymers. Figure 2-3A shows the spectrum of 3, 6, 9, and 12 bilayers. Similar to the PEI/PSS
system, the intensity of the peaks is more defined as the number of bilayers increases. For 12
bilayers of HEP/COL the spectrum is more defined, observing the characteristic peaks of both
polymers. For both collagen and heparin, the amide I or NH 2 peak 1628 cm-1, and the amide II
peak at 1512 cm-1 are observed [15][50][51][52] (A zoom of Figure 2-3A is available in Figure
2-S6 from supporting information (Appendix A.1) to better appreciate these peaks). In this
spectrum, it is also possible to identify other characteristic peaks of HEP such as: CH2 scissoring
at 1442 cm-1, SO3- at 1211 cm-1, C-N stretching at 1072 cm-1 & 1026 cm-1, and the C-O-S
stretching vibration at approximately 987 cm -1 [15][49]. Thus, the characteristic peaks of collagen
and heparin are observed. Similar results are presented by N. Huang and his team when they
prepared multilayers of collagen type I and unfractioned heparin over titanium substrates [35][34].
In these studies, they used HEP/COL films as an anticoagulant coating over titanium
cardiovascular implants [34]. They also investigated the effect on coagulation of the degradation
of the HEP/COL coating [35]. Of note, we were not able to obtain spectra of any of the multilayered
films using the FTIR-ATR equipment.
For HEP/COL films, the behavior of growth and roughness shows a linear tendency with
increasing number of layers (Figure 2-3B and 2-3C), contrary to PEI/PSS films. Thicknesses of
44.72 nm, 91.26 nm, 128.8 nm, and 162.44 nm, were obtained for 3, 6, 9 and 12 bilayers,
respectively (Figure 2-3B). An average of 12.66 nm in increase of thickness per bilayer was
observed, in addition to the fact that this system generates thinner multilayers than those obtained
in our PEI/PSS system. A significant difference of p < 0.01 in the thickness measurements
between 6, 9, and 12 multilayers compared with 3 bilayers is observed. Also, a significant
difference of p < 0.05 was obtained between 9 and 12 bilayers. Jian Ji and her team, who also
worked with a HEP/COL system [39], found the same linear behavior in the construction of the
films. In their work, they used low molecular weight heparin and collagen type I from bovine
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cartilage. They dissolved the polymers in acetate buffer solution (0.018 M NaAc, 0.082 M HAc,
0.14 M NaCl, pH 4.0) at 1 mg/mL. Their ellipsometric results showed a thickness of approximately
14 nm for one bilayer, which is close to our results.
Analyzing the roughness and the topographic images (Figure 2-3C and 2-3D), it is
possible to observe that as the number of bilayers increases the roughness also increases.
Although not enough to surpass the roughness obtained for the PEI/PSS system, which reaches
an average of 242 nm for 12 bilayers. The HEP/COL system has a less rough surface with an
average of approximately 208 nm for 12 bilayers. The minimum differences appreciated are due
to the physical characteristics of the polymers used. For 3, 6, and 9 bilayers of HEP/COL, our
results show roughness of 33.58 nm, 101.66 nm, and 163.06 nm, respectively. A significant
difference of p < 0.01 in the roughness measurements between 6, 9 and 12 multilayers compared
with 3 bilayers is observed. A significant difference of p < 0.05 was obtained between 6, 9, and
12 bilayers (Figure 2-3C). Chau-Chang Chou and his group [36] in one of their work evaluated 5
and 15 bilayers of HEP/COL to study the blood compatibility and adhesion of multilayers coated
on cp-Ti substrates. They used heparin sodium salt at 5 mg/mL in DI water and collagen type I
derived from bovine Achilles tendon dissolved in 0.2 M acetic acid at 2.5 mg/mL in DI water at pH
4. Their results obtained for roughness by AFM indicated an average of 110 nm for the multilayer
system composed of 5 bilayers, which resembles a close relationship to 101.66 nm obtained for
our polymeric system of 6 bilayers.
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Figure 2-3. Multilayer growth, chemical, and physical characteristics for HEP/COL system by
IRVASE. A) Spectrum of plain substrate, 3, 6, 9, and 12 bilayers, B) Thickness vs. number of
bilayers, C) Roughness vs. number of bilayers and D) Surface morphology as measured by AFM
of: Substrate, 3 bilayers, 6 bilayers, 9 bilayers and 12 bilayers. The error bars indicate the
standard deviation of the samples as is described in the materials and methods section. The pvalues < 0.01 are represented by #, @, &, ψ and ϴ. The p-values < 0.05 are represented by $, %
and !. The bars that have the same symbol are statistically different. Reprinted from Colloids and
Surfaces A: Physicochemical and Engineering Aspects, 553, Castilla‐Casadiego D. A.
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Figure 2-3. (Cont.) Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D.,
and Almodovar J., Simultaneous characterization of physical, chemical, and thermal properties of
synthetic and natural polymeric multilayers using infrared spectroscopic ellipsometry, 155-168,
Copyright 2018, with permission from Elsevier.

Using the same process used to measure Young’s modulus for the PEI/PSS system, an
analysis of the HEP/COL multilayers prepared over a silicon substrate, was performed. Figure 2S5B from supporting information (Appendix A.1) presents the results, demonstrating that as the
multilayers grow, the Young’s modulus decreases. These results show that the Young’s modulus
of the PEI/PSS system is greater than the HEP/COL system, obtaining a value of approximately
15000 kPa for 12 bilayers of the PEI/PSS system, compared to 9000 kPa reported for the natural
system of polymers HEP/COL. In comparison to PEI/PSS system, the surface with HEP/COL
multilayers showed a significant different p < 0.01 in the Young’s modulus measurement for 6, 9,
and 12 bilayers compared with 3 bilayers (Figure 2-S5B from supporting information (Appendix
A.1)). This difference can be associated to the chemical structure of the polymers and their bonds.
The high value of Young’s modulus for the PEI/PSS system can be associated to the structure of
PSS, which has a benzene ring and the double bonds of carbon. Therefore, stronger resistance
to deformation is exerted.
2.4.3

Eﬀect of the pH over the Physical-chemical Characteristics of the Polymeric Surface
In this study, the effect of changes in the pH of the washing buffer solution over the

formation of the layers and their physical-chemical characteristics of each surface was evaluated
using the IRVASE. Four pH values, 2.7, 4, 5 and 6, were investigated to study the effects over
the chemical and physical characteristics of 12 bilayers of PEI/PSS formed over a silicon
substrate. Results are shown in Figure 2-4. These pH values were selected since they are within
the pH range available for acetate buffer, and it has been previously shown that LbL films can
undergo significant changes with slight changes in pH [16][62].
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Figure 2-4. Effects in the variation pH of washing solution to prepare multilayers of PEI/PSS at
pH 2.7, 4, 5 and 6 by IRVASE. A) PEI/PSS spectrum, B) Thickness vs. number of bilayers and
C) Roughness vs. number of bilayers. All spectra and measurements correspond to 12 bilayers
and the error bars indicate the standard deviation of the samples as is described in the materials
and methods section. The p-values < 0.01 are represented by #, @, &, ψ and ϴ. The p-values <
0.05 are represented by $, % and !. The bars that have the same symbol are statistically different.
Reprinted from Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553,
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Figure 2-4. (Cont.) Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., QuiñonesColón B. A., Suleiman D., and Almodovar J., Simultaneous characterization of physical, chemical,
and thermal properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.
Analyzing the IRVASE spectra obtained for the polymeric combinations of PEI/PSS and
the variations in the pH, it is noticeable that the chemistry of the polymers that make up the
multilayers over the substrate is present as evident by the characteristic peaks previously
mentioned (Figure 2-4A). PEI/PSS films are stable to changes in pH of the washing solution in
this range as compared to Figure 2-2A. Evaluating thickness and roughness values of multilayers
of 12 bilayers, an increasing behavior is appreciated, with relation to an increase in pH of the
washing solution (Figure 2-4B). A statistically difference (p < 0.01) in thickness is observed in
the pH range of 2.7 to 5. At pH 6, a decrease in thickness is obtained. Average thicknesses of
140.82 nm, 189.59 nm, 303.42 nm, and 246.35 nm were obtained for washing solutions of pH
2.7, 4, 5, and 6, respectively. These differences could be associated to the fact that the washing
buffer solution at pH 6 exerts a decrease in the charge density of the functional groups of the
polymers that were evaluated here (PEI/PSS), which acts over the electrostatic forces of attraction
of the molecules, in comparison to the washing buffer solution at pH 5. Generating less
conformation of the polymers over the substrate, directly affecting the thickness and roughness
of the multilayers.
M. Elzbieciak and their group [62] evaluated the influence of pH of the polymeric solution
on the structure of multilayer films of PEI/PSS. They found that when maintaning a pH of 6 for
both solutions the thickness of the samples, reported by ellipsometric analysis, presented a linear
increase as the number of bilayers increases. For this experiment, their QCM analysis
demonstrated that the absorbed mass over the silicon substrate increases with increasing number
of layers. An unstable or non-monotonic behavior over the formation and increase in thickness of
multilayers was found when the pH of the PEI solution was changed to 10, maintaining a pH of 6
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for PSS. The ellipsometric analysis showed that the thickness considerably increased only
through the deposition of PSS, due to the fact that at pH 6 it is strongly charged, in comparison
to PEI, which at a pH of 10 it is slightly charged. Thus the pH of the polymeric solution plays an
important role over the formation and deposition of the multilayers.
Analyzing the roughness of samples, we observe that for the pH range between 2.7 and
6 the measurement show a tendency to increase with increasing pH (Figure 2-4C), reaching a
maximum value of 178.8 nm at pH 6. An increase in surface roughness is noticeable, with a more
heterogenous surface at pH 6, presented a different significant of p < 0.01 between multilayer
prepared at pH 2.7, 5 and 6. A p < 0.05 was observes between multilayer formed at pH 2.7 and
4 and pH 4 and 5 (Figure 2-4C). This effect of an increase in roughess can be associated to the
fact that a basic pH decreases the charge density of PEI, which has a pKa interval from 7.11 to
8.6 [42][62]. For PSS, it is possible that at a pH of 5 or 6 the effect is not significant because it
has a pKa of approximately 1 (basic pH increases the charge density of PSS) [46]. Therefore,
there is a smaller deposition of PEI due to a collapse of this polymer in the multilayers because
of the pH effect in the washing solution, promoting a more heterogeneous morphology, generating
a rougher surface.
2.4.4

Eﬀect of Temperature over the Physical-chemical Characteristics of the Polymeric

Surface
Among other abilities of the IRVASE, it also has the capacity of monitoring changes
structure, chemical composition, and physical properties of the films as a function of changes in
temperature. This was performed using a heating stage (INSTEC – mk2000), which was coupled
to the IRVASE equipment, allowing a controlled heat ramp. For this study, our experiments were
focused on analyzing the effect of exposing 12 bilayers of PEI/PSS prepared at a pH of the
washing solution of 2.7, 4, 5 and 6 to changes in temperature. These multilayers were exposed
to the following temperatures: 25 ˚C, 37 ˚C, 50 ˚C, 75 ˚C, 100 ˚C, 125 ˚C, and 150 ˚C. For the
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HEP/COL system, this same controlled temperature ramp was evaluated for a washing solution
of pH 5.
Figure 2-5 shows the results of the effect of changes in temperature of the PEI/PSS
system, over the chemistry of the bilayers, their thickness, and roughness. Our results over the
chemistry of the bilayers fabricated with different washing pH values, through IRVASE analysis
revealed that in this range of temperatures the bilayers preserve their chemical structure with
slight changes in the band under 1200 cm -1, which correspond to the SO3- group, the C-N
stretching and the C-O-S stretching vibration (Figure 2-5 A, B, C and D). Peaks corresponding
to the NH2 group (1628 cm-1), the N-H bending (1527 cm −1), and the CH2 bending (1444 cm −1 )
in PEI decrease with increasing temperature. This could be due to possible degradation or
decomposition of these functional groups. Increasing the pH of the washing solution appears
to increase the thermal stability of the PEI/PSS multilayers. At a pH value of 2.7, some changes
in the chemistry of the films are observed between 1700 – 1500 cm −1 when the temperature is
increased. However, these changes are not observed using a washing solution of pH 6. There is
little variation in the chemistry of PEI/PSS as a function of temperature when using a washing
solution at a pH 6.
Evaluating the changes in thickness and roughness of the PEI/PSS multilayers in function
of temperature (Figure 2-5E), our results indicate that low pH values exert a smaller resistance
to changes in physical and chemical properties of the surface. The multilayers at pH 2.7 and pH
4 revealed the greatest changes in loss of thickness in the range between 25 °C to 75 °C. A
decrease of approximately 16 nm for multilayers exposed to temperatures between 25 °C and 75
°C for these two pH values was observed, in comparison to a decrease of only 8 nm and 14 nm
for pH 5 and pH 6, respectively, under the same temperature range. A washing solution of pH 5
appears to be the ideal condition for construction of PEI/PSS multilayers. This is because at this
pH a good chemical stability of multilayers is observed and the physical properties report minor
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alterations to changes in temperature. Analyzing the influence of changes at a temperature of 75
°C, over the thickness of the multilayers, it is possible to notice that for all the pH values the
thickness begins to increase.

Figure 2-5. Effects of PEI/PSS 12 bilayers exposed to different temperatures (25 ˚C, 37 ˚C, 50
˚C, 75 ˚C, 100 ˚C, 125 ˚C and 150 ˚C) by IRVASE. A) Bilayer spectrum fabricated at pH 2.7 of the
washing solution, B) Bilayer spectrum fabricated at pH 4 of the washing solution, C) Bilayer
spectrum fabricated at pH 5 of the washing solution, D) Bilayer spectrum fabricated at pH 6 of the
washing solution, E) Measure of surface thickness of multilayer formed at pH 2.7, 4, 5 and 6.
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Figure 2-5. (Cont.) And F) Measure of surface roughness at pH 2.7, 4, 5 and 6. The error bars
indicate the standard deviation of the samples as is described in the materials and methods
section. Reprinted from Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553,
Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman
D., and Almodovar J., Simultaneous characterization of physical, chemical, and thermal
properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.
For pH 5 and pH 6, the final average thickness of multilayers reported a higher value than
the one initially obtained at 25 °C. Although the differences in thicknesses fall within the error
bars, the trend is observed consistently in all pH values. An increase of approximately 3% for the
layers treated with both pH values is observed. This can be related to the glass transition
temperature (Tg) of the multilayers, temperature at which it is possible for the polymers within the
multilayers to expand thus increasing the thickness of the films. Keddie [66], and Richard [67]
studied the effects on the glass-transition temperature of thin films composed of poly(methyl
methacrylate) (PMMA) and polystyrene (PS) using spectroscopic ellipsometry. They determined
that the glass transition temperature of thin films is related as a function of film thickness. They
found that the Tg of PMMA on a gold surface decreases with decreasing film thickness [67], this
was also observed in their results when fabricating thin films of polystyrene on silicon [66]. But, in
one of their previous works they related the determination of Tg by detecting with ellipsometry the
discontinuity in expansivity as the films are heated at a constant rate [68]. They prepared ultrathin PS films and their ellipsometric results of the change in thickness vs. temperature showed
two linear regions of thermal expansivity, which they related to the polymer glass and melt
temperatures. They report that the point that divides two regions was associated to the Tg of the
polymer [69]. Relying on these results and the behavior registered over the increase and
expansion of the thickness of the polymeric multilayers formed by the layer-by-layer technique,
we have attributed this behavior to the Tg of the multilayers. Our results for the PEI/PSS system
(Figure 2-5) showed a “point of inflection” at 75 °C, which we have attributed as an approximation
to predict the Tg of the polymeric multilayers of PEI/PSS.
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The results of the thermal effect over the roughness of the multilayers revealed that this
variable decrease approximately at a value of 8.3% at the range of temperatures from 25 °C to
150 °C, regardless of the pH of the washing solution (Figure 2-5F). We attribute this pattern to
the homogenous movement of the polymeric molecules, because of the effect in controlled
changes in temperature over the substrate.
Lutkenhaus and her group studied the thermal properties of LbL films of
poly(diallyldimethylammonium chloride)/poly(styrene sulfonate) (PDAC/PSS) [69]. They found
that different thermal transitions of the multilayers can be observed depending on the properties
of the solution used to prepare the multilayers; for example, the ionic force or whether they are
hydrated or not. Their results indicated that the hydrated films with an exponential growth reported
Tg values around 49-56 ˚C, while films formed with a linear growth do not have a detectable T g,
in addition to being glassy at room temperature. In the case of multilayers in a dry state, for both
types of growth these do not have a detectable T g up to 250 ˚C, and are glassy at room
temperature. From these results, they could conclude that the multilayers formed with an
exponential growth have a greater segmental mobility than that of linearly growing films. We can
associate our results to this hypothesis, observing that the exponential growth of multilayers in
our results was also perceived, as shown in Figure 2-2B. Therefore, we found that the changes
in the decrease of thickness and roughness as a function of temperature of our multilayers
reported in Figure 2-5 are due to the kinetic energy (mobility) of the molecules or polymeric chains
as well as a potential effect in dehydration, due to the induced heat. It is understood that as the
temperature increases, mobility increases, generating a shift in the polymeric chains [67].
Therefore, this mobility allows the polymers to rearrange, modifying the topographic environment
and hence the characteristics measured. Lutkenhaus, in another work [69], where 5, 6, and 8
layer pairs of poly (allylamine hydrochloride)/ poly(acrylic acid) were fabricated, monitored through
temperature-controlled ellipsometry the changes in thickness of the multilayers. They initially

123

obtained at 25 ˚C a thickness of the multilayers of 59 ± 3 nm, 119 ± 1 nm, and 183 ± 2 nm, for 5,
6, and 8 layer pairs, respectively. An increase in temperature generated a decreasing effect in
the thickness of the multilayers, reporting a final thickness at 275 ˚C of approximately 49 nm, 104
nm, and 159 nm, for 5, 6, and 8 layer pairs, respectively. They observed that when less multilayers
are formed, the decrease in thickness is greater, obtaining a decrease of 14 ± 1 %, 12.18 ± 0.01
%, and 9 ± 4 %, for 5, 6, and 8 layer pairs, respectively, up to a change of 275 ˚C. They attributed
the decrease in thickness of the multilayers to the loss of mass or to an increase in the density of
the multilayers [69]. In another work, Lutkenhaus [70], found that for 200 layer pairs of
poly(allylamine hydrochloride)/ poly(acrylic acid), the reduction of thickness of the LbL film is the
result of the formation of the anhydride and the amidation. This because both are produced when
heated [70].
In our work, we also evaluated the changes in chemistry and behavior of the physical
characteristics of the HEP/COL multilayers, fabricated at a pH 5 for the washing solution and
results are presented in Figure 2-6. It is possible to observe that significant changes in the stability
of the functional groups are perceived when exposed to temperatures above 37 °C (Figure 26A). HEP/COL multilayers exhibit a poor resistance to changes in temperature, in comparison to
PEI/PSS multilayers. Analyzing the influence of changes in temperature in each functional group,
it is evident that once again the bands that belong to absorption between 1700 cm -1 and 1500 cm1

, corresponding to the amide I and amide II, respectively, are strongly affected by changes in

temperature, indicating a possible degradation or decomposition of the polymers. The amide I,
amide II, and the CH2 groups showed a displacement to higher absorption values as well as a
decrease in intensity with increasing temperature. After 75 °C, these peaks almost disappear
indicating a possible degradation of the polymers or loss in the secondary structure of collagen.
Thus, HEP/COL films are more susceptible to changes in temperature, and cannot resist
exposure to temperatures above 37 °C.
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Figure 2-6. Effects of HEP/COL 12 bilayers exposed to different temperatures (25 ˚C, 37 ˚C, 50
˚C, 75 ˚C, 100 ˚C, 125 ˚C and 150 ˚C) by IRVASE. A) Bilayer spectrum fabricated at pH 5 of the
washing solution and B) Measure of surface thickness and roughness of multilayer formed at pH
5. The error bars indicate the standard deviation of the samples as is described in the materials
and methods section. Reprinted from Colloids and Surfaces A: Physicochemical and Engineering
Aspects, 553, Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón
B. A., Suleiman D., and Almodovar J., Simultaneous characterization of physical, chemical, and
thermal properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.

Analyzing the results obtained for thickness and roughness of HEP/COL films (Figure 26B), these show that an increase in temperature yields a decrease in both thickness and
roughness. Comparing this effect with the tendencies observed in the chemical spectra of the
multilayers (Figure 2-6A), we can say that the polymeric chains are not necessarily displacing
because of temperature effects, but rather because of the immediate decomposition of the
polymers. Contrary to the PEI/PSS system, presented in Figure 2-5, where an increase in
thickness of the multilayers is attributed to the displacement of their polymeric chains over the Tg
of the system. Analyzing the relation between roughness and thickness for both systems, we can
observe that for multilayers of HEP/COL the roughness reported values higher than the thickness
(Figure 2-6B), contrary to the PEI/PSS multilayer system (Figure 2-5). Showing that the synthetic
and natural multilayer systems have different behaviors or characteristics, even though the
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fabrication method is the same. Therefore, these differences can be attributed to the chemistry of
each polymer and the interaction of their functional groups between the polymers that compose
the multilayers. Our hypothesis over these observed characteristics in the HEP/COL system is
associated to the fact that there may be a heterogeneous charge distribution along the polymeric
chain. Having specific sites throughout the chain with a bigger charge, which promotes the
formation of a heterogeneous surface, which gradually increases with the formation of multilayers.
In summary, the IRVASE technique can also be a tool to evaluate the temperatures of transition
or decomposition of polymeric multilayers. This powerful tool allows for the simultaneous physical
and chemical characterization of multilayered films. This is because the analysis of both
properties complements and exposes the intermolecular phenomenon that is occurring. This
indicates the versatility of this technique and how practical it can be to analyze LbL polymeric
multilayers.
2.5 Conclusions
Infrared Variable Angle Spectroscopic Ellipsometry (IRVASE) can simultaneously
characterize the physical and chemical properties of polymeric multilayers fabricated by the layerby-layer technique. Our results show that it is possible to: (1) analyze the formation and growth
of the multilayers, showing an exponential increase for the PEI/PSS multilayers and a linear
increase for the HEP/COL polymer combination. (2) Study their chemical composition; IRVASE
spectra of the multilayers correlated with the characteristic bands analyzed by FTIRATR. (3)
Study their thickness; IRVASE revealed that it is possible to characterize the formation of
multilayers starting with a small amount for both systems, reporting that three multilayers of
PEI/PSS prepared using a washing solution of pH 5 had a thickness of 71.7 nm and 40.3 nm for
HEP/COL. (4) Study their roughness; the HEP/COL system demonstrated that they have a higher
roughness than PEI/PSS, obtaining values of 37.76 nm for three bilayers of PEI/PSS and 33.58
nm for three bilayers of HEP/COL. And (5) study the thermal stability; our results showed that for
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the PEI/PSS system an increasing temperature over the thickness described a temperature limit
(75 °C) that defines the point of reduction or expansion of the space between the polymeric chains
in the multilayers. Contrary to the HEP/COL multilayers, which have a chemistry that is drastically
altered by temperatures above 37 °C, indicating a possible degradation of the polymers. The
effect of the pH of the washing solution over the multilayers of PEI/PSS is intimately related to the
formation, thickness and thermal stability of the multilayers. A pH of 5 in the washing solution was
effective to obtain thicker multilayers. But, a pH of 6 demonstrated that it was more resistant to
changes in temperature. We observed that the synthetic multilayers resist changes in
temperature, and in fact they appear to reorganize when the temperature is increased; suggesting
a possible transition temperature for the multilayers. Conversely, multilayers composed of the
natural polymers collagen and heparin are highly susceptible to increasing temperature. Our
results were validated using atomic force microscopy to confirm values of film thickness and
roughness. Finally, 12 bilayers of PEI/PSS showed to have a Young’s modulus higher than that
of 12 bilayers of HEP/COL. This work adds a complementary technique to the LbL community to
simultaneously evaluate physical-chemical and thermal properties of multilayer films
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M. Elzḃieciak, S. Zapotoczny, P. Nowak, R. Krastev, M. Nowakowska, and P. Warszyński,
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CHAPTER 3.

Heparin/Collagen Coatings Improve Human Mesenchymal Stromal

Cell Response to Interferon Gamma

3.1 Abstract
Mesenchymal stromal cells (MSC) are a promising source for cell-based therapies as they
secrete a myriad of reparative factors in response to inflammatory stimuli. In this study, multilayers
of heparin and collagen (HEP/COL) were used as a bioactive surface coating to enhance human
MSC (h-MSC) response to soluble interferon-gamma (IFN-γ). Multilayers were formed, via layerby-layer assembly, varying the final layer between COL and HEP and supplemented with IFN-γ
in the culture medium. h-MSC adhesion, proliferation, and cytokine expression were assessed.
Infrared variable angle spectroscopic ellipsometry confirmed film chemistry, thickness, and
roughness. COL-ending films of 12 layers of HEP/COL had an average thickness of 129 ± 5.8
nm, and 13 layers (HEP-ending) were 178 ± 28.3 nm thick. Changes in temperature between
25−37 °C did not have significant effects on film chemistry, thickness, or roughness. An EdU
incorporation assay revealed that IFN-γ had an antiproliferative effect in all conditions evaluated
except when h-MSCs were cultured on HEP-ending films supplemented with IFN-γ. Moreover, hMSCs cultured on HEP-ending films supplemented with IFN-γ had a higher cytokine expression
as compared with cells cultured on tissue culture polystyrene, COL-ending films with and without
IFN-γ, and HEP-ending films without IFN-γ as measured by Luminex assay. Finally,
immunostaining revealed strong integrin binding and FAK phosphorylation for each condition.
This study shows that HEP/COL films can modulate h-MSC response to soluble factors, which
may be exploited in cell manufacturing practices.
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3.2 Introduction
The layer-by-layer (LbL) method is a useful strategy to functionalize surfaces of inert
materials which are commonly used in the biomedical field [1][2]. Using this technique, it is
possible to develop bioactive films or coatings composed of natural or synthetic polymers that
provide specific signals to cells, enhancing cellular behavior and potentiating their activities
compared to the surface without coating [3][4]. LbL involves sequence-specific electrostatic
interactions between

polyelectrolytes to

produce

films with

specific and

controlled

physical−chemical characteristics [5][6]. Our group [6][7] and others [8][9][10][11] have shown
that LbL film thickness, porosity, wettability, stiffness, and other parameters depend on polymer
selection and processing parameters such as solution pH, polymer concentration, and rinsing
solution. Moreover, the LbL process can be scaled up and automated, making it an attractive
technology from a manufacturing standpoint [12][13][14].
LbL films are stable when exposed to culture media with or without cells due to the strong
electrostatic interactions, although this stability is dependent on polyelectrolyte selection [15].
Through these properties, it is possible to engineer an active coating capable of providing multiple
stimuli for cell culture. LbL films can serve as a platform to present complex surfaces through the
functionalization of chemical agents or biochemical signals such as peptides [16] or growth factors
[17], to induce more effective signals by replicating the extracellular environment, enhancing
cellular behavior.
The extracellular matrix (ECM) of tissues is composed of a variety of biomacromolecules
that includes proteins, glycoproteins, proteoglycans, and polysaccharides [18]. ECM components
have been used to develop surfaces or scaffolds that mimic the cellular microenvironment and
promote cellular activities for bone cells [19], cardiac cells [20], myoblasts [10], and stem cells
[21], as potential alternatives for tissue repair or to address degenerative diseases. One of the
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most relevant proteins to develop scaffolds or surfaces is collagen, which is one of the main
components of the ECM of connective tissues [22].
Collagen also provides strength and structure to the ECM by directly interacting with cells
and other ECM molecules [23]. This protein has demonstrated significant cellular improvements
in its different presentations such as nanofibers [24], sponges [25][26] and LbL films [27][28].
Likewise, heparin is an essential polysaccharide with multiple contributions at the cellular level.
Heparin is a highly sulfated glycosaminoglycan present in the ECM and surface of cells [29]. This
polysaccharide regulates cell proliferation, cellular adhesion, matrix assembly, migration, immune
responses, lipid metabolism, angiogenesis, and wound healing [29][30][31]. Proteoglycans of
heparan sulfate are also recognized as ubiquitous protein ligands [30]. Therefore, their
functionality is strongly based on the capacity to recognize diverse proteins which offer a variety
of functional properties, from immobilization or protection against proteolytic degradation to
different modulations of biological activity [30]. Heparin is composed of strong anionic domains
enriched with glucosamine N-sulfate and iduronic acid, typically three to eight disaccharides long
[30]. Collagen and heparin have been used to prepare polymeric multilayers. Their use has been
centered on helping promote the bloodcompatibility of titanium implants [2][27][32][33]
vascularization studies [34], and intravascular endothelialization with the functionalization of
antibodies over the multilayers [35][36].
Interferon gamma (IFN-γ) is a cytokine produced by CD4+ lymphocytes and natural killer
cells involved in innate and adaptive immunity against viral infections, bacteria, and protozoa [37].
Its importance in the immune system lies in its capacity to inhibit viral replication [38][39][40][41]
and its immunomodulators [42][43]. The active form of this cytokine is a homodimer that consists
of two polypeptides of 143 amino acids [44]. IFN-γ binds to heparin [45], but it does not interact
with isolated Nsulfate domains [30]. The dimeric cytokine attaches to an oligosaccharide complex
that encompasses an N-acetylated domain rich in glucosamine and two sequences highly
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sulfated, each one which connects to a monomer of IFN-γ [29]. IFN-γ has been used for the
treatment and prevention of graft versus host disease [46], promotes the immunosuppressive
capacity of adult human mesenchymal stromal cells (h-MSCs) [47][48][49], and promotes the
migration of h-MSCs in-vitro [50]. It also regulates the proliferation and differentiation of MSCs via
activation of indoleamine 2,3 dioxygenase [51].
Stem cell manufacturing has emerged as a promising area to generate high-quality cells
for many cell-based therapies [52][53][54]. Studies have demonstrated the clinical potential that
stem cells offer to promote advances of new medical applications and therapies for the treatment
of diverse diseases and disorders, including Alzheimer’s disease [55], Parkinson’s disease [56],
lesions in vertebral disks [57], diabetes [58], muscular dystrophy [59], cancer [60],
myelodysplastic syndromes [61], autoimmune disorders [62], and other inflammatory diseases
[63]. However, challenges associated with large-scale manufacturing severely limit these
therapies. Therefore, there is a need for alternatives to promote the production of stem cells with
high therapeutic value, and at the same time, achieve control in reproducibility and cell quality
[52]. Increasing the capacity to obtain stem cells with high therapeutic value would eliminate the
limiting barrier of a shortage of these cells for the development of treatments that help in the
improvement of health and welfare of patients worldwide.
In search of approaches to exert control/improve production of h-MSCs, we evaluated hMSCs responses on polymeric multilayers composed of collagen (COL) and heparin (HEP) that
are either terminated in COL (12 layers HEP/COL) or HEP (13 layers HEP/COL) with and without
IFN-γ as a supplement in the culture medium. h-MSC proliferation, adhesion, and
immunomodulatory cytokine expression were evaluated as a function of polymeric multilayer
composition in the presence or absence of soluble IFN-γ. Our results show that heparin
terminated multilayers negate the antiproliferative effect of IFN-γ while enhancing cytokine
expression.
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3.3. Methodology
3.3.1. Materials
h-MSCs, from the NIH resource center at Texas A&M Institute for Regenerative Medicine,
were used between passages 4−6. Cells from a second donor and diﬀerent provider (RoosterBio)
were used in validation experiments. h-MSCs were grown in alpha-minimum essential media
MEM Alpha (1×) from Gibco (supplemented with L-glutamine, ribonucleosides, and
deoxyribonucleosides) (cat. no. 12561-056) containing 20% fetal bovine serum from Gibco (cat.
no. 12662029), 1.2% penicillin-streptomycin from Corning (cat. no. 30002CI), and 1.2% Lglutamine from Corning (cat. no. 25005CI). Formaldehyde at 3.7% was used to fix cells and
perform the established assay. CellTracker™ Deep Red and Hoechst were used to dye the cell.
For the proliferation assay, a Click-iT™ Plus EdU Alexa Fluor™ 488 Imaging Kit was used.
For the detection and quantification of multiple secreted proteins (cytokines, chemokines, growth
factors, etc.), a Luminex Multiplex Assay was used. Phosphorylated FAK (p-FAK) Y397 (Abcam
ab81298, source: rabbit, 1:150 dilution) using 488 goat antirabbit secondary antibody (ThermoFisher Scientiﬁc A11035, 1:200 dilution); beta-1 integrin (DSHB A11B2, source: rat, 1:100 dilution)
using 488 goat antirat secondary antibody (R&D systems A11006, 1:100 dilution) and beta-3
integrin (R&D systems AF2266, source: goat, 1:100 dilution) using 488 rabbit antigoat secondary
antibody (Life Technologies A11078, 1:100 dilution). AlexaFluor555 Phalloidin (Invitrogen
A34055, 1:100 dilution) and DAPI (Invitrogen A34055, 1:1000 dilution) were used in the staining.
Ascorbate, methylene blue, catalase, l-tryptophan, trichloroacetic acid, Ehrlich reagent (pdimethyaminobenzaldehyde) from Sigma Aldrich were used in the assay for extracellular IDO
activity.
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3.3.2. LbL Film Construction
Heparin sodium (HEP) purchased from Celsius Laboratories, Inc. (cat. no. PH3005) and
lyophilized type I collagen sponges (COL) derived from bovine tendon (generously donated by
Integra Lifesciences Holdings Corporation, Añasco, PR) were used to prepare polymeric
multilayers on sterile tissue culture-treated plates from Corning Costar (cat. no. 07-200- 740). The
solution used to dissolve the polymers consisted of acetate buffer (0.1 M sodium acetate
anhydrous, 0.1 M acetic acid, pH 5), which was also used as the washing solution. All polymeric
solutions were prepared at a concentration of 1.0 mg/mL. Ultrapure water at 18 MΩ·cm was used
to prepare polymeric and wash solutions. In this work, we evaluated layers of HEP/COL ending
in COL and HEP constructed using the layer-by-layer technique. The sequence for forming the
multilayers consisted in adding poly(ethylenimine) (PEI) (50% solution in Water, Mw ≈ 750000)
from Sigma-Aldrich (cat. no. P3143), for 15 min to each well on a 24-well plate. Then HEP and
COL were deposited sequentially for 5 min per layer with a 3 min wash in between. The volume
of each polymeric solution was 0.6 mL per well. Layers ending in COL were composed of a total
of 6 (HEP/ COL) bilayers or 12 layers. Layers ending in HEP were composed of 6.5 (HEP/COL)
bilayers or 13 layers. After multilayer preparation, a final wash was performed using DPBS 1×
without Ca2+ and Mg2+. Substrates were sterilized using UV for 15 min.
3.3.3. Experimental Design
We studied the effects of two factors on cellular response of h-MSCs: type of surface and
the presence or absence of IFN-γ in the culture medium. The surfaces evaluated were the
following: (i) a control surface of tissue culture plastic (TCP), (ii) 12 layers of HEP/COL (layers
ending with COL), and (iii) 13 layers of HEP/COL (layers ending with HEP). Conditions with
medium supplemented with and without IFN-γ recombinant human protein (ThermoFisher, cat.
no. PHC4031) at a concentration of 50 ng/mL were designated as +IFN-γ and −IFN-γ,
respectively. A bovine IFN-γ ELISA kit (Invitrogen, cat. no. KBC1231) was used to measure
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endogenous levels of IFN-γ in the fetal bovine serum used to grow h-MSCs (Figure 3-S1 in
supporting information (Appendix A.2)).
3.3.4. Chemical Composition of Multilayers
Infrared variable angle spectroscopic ellipsometry (IR-VASE - Mark II, J.A. Woollam Co.
IR-VASE, Lincoln, Nebraska) was used to study the chemistry of the polymeric multilayers
constructed over a silicon substrate as described in our previous work on dry films [6]. The
chemical composition analysis for all samples was performed in a wavenumber range from
800−1800 cm−1. The measurements were taken using a DTGS detector, an angle of incidence of
70°, a spectral resolution of 16 cm −1 , 200 scans per cycle, 2 cycles, bandwidth of 0.01 μm,
minimum intensity ratio of 2, sample type as isotropic, zone average polarizer, and single position
RCE analyzer.
3.3.5. Physical Characteristics of Multilayers
The thickness and roughness of the multilayers formed over the silicon substrate were
determined using the IRVASE instrument. The WVASE32 software within the IRVASE was used
to analyze both properties, as shown in our recent work [6]. To determine whether exposure of
the polymeric multilayers of HEP/COL to a temperature range between 25 and 37 °C exerts
significant effects in the physical−chemical properties of the multilayers, a heating stage
controlled by an INSTEC−mk2000 coupled to the IRVASE was used to establish controlled heat
ramps.
3.3.6. Cell Culture
h-MSCs, from the NIH resource center at Texas A&M Institute for Regenerative Medicine, were
used between passages 4−6. h-MSCs from a healthy 22-year-old male were used. The product
speciﬁcation sheet provided by the vendor shows that these cells were positive for CD90,
CD105, and CD73a h-MSCs identity markers (as tested by ﬂow cytometry), negative for CD11b,
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CD45, and CD34 (as tested by ﬂow cytometry), and could diﬀerentiate into fat and bone cells.
Cells from a second donor and diﬀerent provider (RoosterBio) were used in a validation
experiment (Figure 3-S2 in supporting information (Appendix A.2)). h-MSCs were grown in
alpha-minimum essential media MEM Alpha (1×) from Gibco (supplemented with L-glutamine,
ribonucleosides, and deoxyribonucleosides) (cat. no. 12561-056) containing 20% fetal bovine
serum from Gibco (cat. no. 12662029), 1.2% penicillin-streptomycin from Corning (cat. no.
30002CI), and 1.2% L-glutamine from Corning (cat. no. 25005CI).
3.3.7. h-MSCs Proliferation Response to HEP/COL Multilayers
For the proliferation assay, a Click-iT Plus EdU Alexa Fluor 488 Imaging Kit from Invitrogen
(cat. no. C10337) was used. h-MSCs (1400 cells/cm2) were seeded on each surface, and the EdU
kit was used after 3 days of culture. The medium was removed, and 10 mM EdU solution was
added to the samples. After 18 h, the samples were washed with DPBS without Ca 2+ and Mg2+,
followed by ﬁxation with 3.7% formaldehyde for 15 min at room temperature. After
permeabilization using 0.5% Triton X-100, the samples were incubated at room temperature for
20 min and washed with 3% BSA twice, the Click-iT reaction cocktail was added, followed by 30
min of incubation and a washing step. For nucleus staining, Hoechst 33342 solution was added
for 30 min, followed by extensive washing with DPBS. The samples were visualized using an
inverted ﬂuorescence microscope (Eclipse Ti, Nikon, U.S.A.) using a 495/519 nm
excitation/emission ﬁlters for the Alexa Fluor 488. Images were analyzed using ImageJ software
to determine the percentage of EdUpositive nuclei as a measure of proliferation.
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3.3.8. Cytokine Expression for h-MSCs on HEP/COL Multilayers
Cell culture supernatants from h-MSCs seeded on TCP and HEP/COL multilayers (10000
cells/cm2) with and without IFN-γ were collected after 3 days and stored at −80 °C. Human
Premixed Multi-Analyte Kit (Magnetic Luminex Assay) from R&D Systems (cat. no. LXSAHM-05)
was used to analyze multiple human biomarkers, including interleukin 10 (IL-10), vascular
endothelial growth factor (VEGF-A), ﬁbroblast growth factor (FGF2), colony stimulating factor 1
(M-CSF), and interleukin 6 (IL-6). All reagents were prepared according to the manufacturer’s
protocol provided. The assay was performed in a ﬂat-bottomed 96-well microplate. 50 μL of the
magnetic microparticle cocktail were added to each well of the microplate. Then 50 μL of standard
or sample (cell culture supernatant prepared to 2-fold dilution) were added per well. The
microplate was incubated for 2 h at room temperature (RT) on a horizontal orbital microplate
shaker set at 800 ± 50 rpm. The plate was placed on a magnet that immobilized the magnetic
microparticles and allowed for a buﬀered wash to be performed. Then 50 μL of the Biotin Antibody
Cocktail was added to each well followed by incubation for 1 h at RT on the orbital shaker set at
800 ± 50 rpm. Subsequently, 50 μL of diluted Streptavidin-PE was added to each well after
washing, followed by 30 min of incubation at RT on the shaker set at 800 ± 50 rpm. Finally, the
microparticles were resuspended by adding of 100 μL of drive ﬂuid to each well. Before reading
the plate, it was incubated for 2 min on the shaker, set at 800 ± 50 rpm. Each standard was added
in duplicate, and the samples were quintupled. All solutions were protected from light during
handling and storage. The plate was read on a MAGPIX Luminex instrument (Austin, Texas) and
analyzed using Millipore Luminex software version 2.0. The analysis software was set to acquire
data using 50 μL of sample per well, to collect a total of 1000 beads with an average of 50 events/
bead. The raw data was collected as median ﬂuorescence intensity (MFI). The lower limit of
quantiﬁcation was determined using the lowest standard that was at least 3 times above
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background. The concentrations of each cytokine were calculated using the MFI and from the
standard curve obtained.
3.3.9. Immunoﬂuorescence Staining
Layers of HEP/COL were prepared onto micro coverglass from Electron Microscopy
Sciences (cat. no. 72223-01). 6-well plates containing the micro coverglass with and without
multilayers were used to culture h-MSCs seeded at 10000 cells/cm2. Immunoﬂuoresence staining
for focal adhesions was performed for the detection of the following: phosphorylated FAK (p-FAK)
Y397 (Abcam ab81298, source: rabbit, 1:150 dilution) using 488 goat antirabbit secondary
antibody (Thermo-Fisher Scientiﬁc A11035, 1:200 dilution); beta-1 integrin (DSHB A11B2,
source: rat, 1:100 dilution) using 488 goat antirat secondary antibody (R&D systems A11006,
1:100 dilution) and beta-3 integrin (R&D systems AF2266, source: goat, 1:100 dilution) using 488
rabbit antigoat secondary antibody (Life Technologies A11078, 1:100 dilution). AlexaFluor555
Phalloidin (Invitrogen A34055, 1:100 dilution) and DAPI (Invitrogen A34055, 1:1000 dilution) were
used in the staining.
For p-FAK staining, samples were washed three times with Dulbecco’s phosphatebuﬀered solution (DPBS), followed by a wash with CSK buﬀer (10 mM PIPES buﬀer, 50 mM NaCl,
150 mM sucrose, 3 mM MgCl 2, 1 mM PMSF, 1 μg/mL leupeptin, 1 μg/mL aprotinin, 1 μg/mL
pepstatin), then the plates were placed on ice to inhibit protease activity for 1 min. Cell
permeabilization and cytoskeleton stabilization consisted of adding ice-cold CSK buﬀer with 0.5%
Triton X-100 (CSK+) for 1 min with two repetitions. CSK + buﬀer was aspirated and 4%
paraformaldehyde was added and incubated for 30 min at room temperature (RT). Samples were
then washed three times with DPBS, and blocked in 33% goat serum for 2 h at 4°C. The blocking
solution was aspirated, and the primary antibody was diluted in 33% goat serum and incubated
overnight at 4 °C in humidiﬁed dishes. The next day, the primary antibody was recovered and
washed three times with DPBS. Samples were counterstained using the secondary antibody,
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phalloidin, and DAPI, all diluted in 33% goat serum and incubated at RT for 1 h. Lastly, samples
were washed three times in DPBS.
For beta-1 and beta-3 integrin staining, the medium was aspirated, and the cells were
washed with DPBS and ﬁxed in 4% paraformaldehyde for 15 min at RT. Samples were washed
with DPBS and 2 mL of 0.1% Triton X100 was added per coverslip for 10 min at RT. After rinsing
in DPBS, samples were blocked in 5% bovine serum albumin (BSA) + 3% goat serum for 1 h at
RT. The blocking solution was aspirated, and the primary antibody was diluted in washing buﬀer
(DPBS + 0.5% BSA, 50 mL) and was added and incubated overnight at 4 °C in humidiﬁed dishes.
The next day, we recovered the primary antibody, and it was washed three times with wash buﬀer.
Secondary antibody, phalloidin, and DAPI were added and incubated at RT for 2 h. Samples were
washed three times with wash buﬀer and then twice with DPBS.
3.3.10. Immunosuppressive Capacity
Cell culture supernatants from h-MSCs were seeded on TCP, and HEP/COL multilayers
(10000 cells/cm2) with (50 ng/mL) and without IFN-γ were collected after 3 days and stored at
−80 °C. Human Premixed Multi-Analyte Kit (Magnetic Luminex Assay) from R&D Systems was
used to analyze multiple human biomarkers, including interleukin 10 (IL-10), vascular endothelial
growth factor (VEGF-A), ﬁbroblast growth factor (FGF-2), colony stimulating factor 1 (M-CSF),
and interleukin 6 (IL-6). All reagents were prepared according to the manufacturer’s protocol
provided. The assay was performed in a ﬂat-bottomed 96-well microplate. The plate was read on
a MAGPIX Luminex instrument (Austin, Texas) and analyzed using Millipore Luminex software
version 2.0. The concentrations of each cytokine were calculated using the MFI and from the
standard curve obtained.
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3.3.11. Immunomodulatory Factor Expression
Cell culture supernatants from h-MSCs were seeded on TCP, and HEP/COL multilayers
(10000 cells/cm2) with (50 ng/mL) and without IFN-γ were collected after 3 days. Cells from three
male donors (donor age: 21-25) provided for Rooster Bio were used in this experiment. The
immunosuppressive capabilities of h-MSCs were obtained by measuring the expression of
Indoleamine 2,3-dioxgyenase (IDO) after priming with IFN-γ. Cell extract (100 µL) will be mixed
with 100 µL reaction buffer (100 mM potassium phosphate buffer pH 6.5, 40 mM ascorbate, 20
µM methylene blue, 200 µg/ml catalase, 800 µM L-tryptophan). The mixture will be incubated at
37 °C for 30 min to permit IDO to convert L-tryptophan to N-formyl-kynurenine. Subsequently, the
reaction will be stopped by the addition of 40 µL of 30% (w/v) trichloroacetic acid. After hydrolysis
of N-formyl-kynurenine to kynurenine, 100 µL of supernatant will be mixed with 100 µL Ehrlich
reagent (0.4% p-dimethyaminobenzaldehyde/acetic acid). Absorbance at 490 nm will be read with
a microplate reader.
3.3.12. Statistical analysis
The results are presented as a mean ± standard error of the mean (SEM). Comparisons
among multiple groups for physical−chemical properties studies and cytokine expression for hMSCs on HEP/COL multilayers were performed by two-way analysis of variance (ANOVA). For
h-MSCs proliferation response to HEP/COL multilayers, a nonparametric test was performed.
Graph Pad Prism 7.0 software for Windows was used for statistical analysis. A p-value < 0.05
was considered statistically signiﬁcant.
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3.4. Results and Interpretation

3.4.1. Chemical and Physical Characteristics of the Bioactive Multilayered Surface
Heparin/Collagen (HEP/COL) multilayers were deposited on silicon substrates composed
of 12 and 13 HEP/COL layers. IRVASE was used to confirm film composition/chemistry and
determine the thickness and roughness of the films. Figure 3-1 shows the physical-chemical
properties of HEP/COL films evaluated at 25°C and 37°C. The IRVASE spectra for 12 layers
HEP/COL (layers ending in COL) and 13 layers HEP/COL (layers ending in HEP) are shown in
Figures 3-1A and 3-1B, respectively. Analyses of spectra revealed the presence of the
characteristic bands of both polymers, as was described in our recently published work [6]. Peaks
for collagen and heparin correspond to the amide I (1700–1600 cm−1) and amide II (1600–1500
cm−1) regions, characteristic of both proteins and polysaccharides [6]. In both spectra, it is also
possible to identify other peaks for HEP such as CH 2 scissoring at 1442 cm−1, SO3- at 1211 cm−1,
C-N stretching at 1072 cm−1 and 1026 cm−1, and the C-O-S stretching vibration at approximately
987 cm−1, as has been described in the literature [6].
When comparing the spectra presented in Figures 3-1A and 3-1B, we notice a significant
difference between the amide I (1700 – 600 cm−1) and amide II (1600 – 1500 cm−1). In the
spectrum shown in Figure 3-1B, multilayers terminated in HEP, present an increase in the
intensity of the corresponding peak of amide II between 1600 – 1500 cm−1 surpassing the intensity
of amide I in 1700 – 1600 cm−1, in contrast to the spectrum presented in Figure 3-1A for
multilayers terminated in COL.
This difference is related to the fact that the amide II band represents a significant
contribution to the heparin spectrum in comparison to amide I. The opposite is true for collagen.
The IRVASE and FTIR spectra of collagen and heparin dissolved in acetate buffer reported in our
previous work also showed the same results [6]. Therefore, IRVASE confirmed the characteristic
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peaks of COL and HEP, which could be observed in the spectrums obtained at 25 °C (temperature
of fabrication of multilayers) and 37°C (temperature of cell culture) when using a heating stage.
We note that changes in temperature between 25 – 37 °C do not induce a drastic effect on the
chemical composition of multilayers of 12 and 13 layers of HEP/COL consistent with our recent
work [6]. In our previous work, HEP/COL films were constructed using an automated robotic
dipping machine [6]. In this work, the multilayers were assembled manually by immersion of the
substrate. Although the films were constructed manually, similar results were obtained thus
confirming the LBL construction of HEP/COL films.
IRVASE analyses indicated an average thickness of 129 ± 5.8 nm for 12 layers and 178
± 28.3 nm for 13 layers at 25 °C (Figure 3-1C). Heating the multilayers to a controlled temperature
of 37 °C, replicating the temperature of cell culture, yielded a reduction in thickness of 5.4% for
12 layers; obtaining a thickness of 122 ± 4.8 nm. For 13 layers, there was an approximate
reduction of 12% over the measurement at 25 °C for a thickness of 157 ± 17.1 nm. In our previous
work [6], we observed the same trend in thickness reduction with increasing temperature. We had
attributed this thickness reduction due to the heterogenous charge distribution along the polymeric
chain yielding a heterogenous surface that is more susceptible to temperature changes. This
thickness reduction from temperature could also be due to water evaporation from the films. Of
note, thickness measurements were performed on dry films.
These films, constructed manually, yielded a larger thickness than those in our previous
work constructed using the automated dipping robot. In our earlier work, 12 layers of HEP/COL
films built automatically yielded an average thickness of ~90 nm [6]. Results for surface roughness
are presented in Figure 3-1D, obtaining an average of 168 ± 7.8 nm for 12 layers and 230 ± 32.2
nm for 13 layers. These films, constructed manually, yielded a higher roughness value than those
in our previous work built using the automated dipping robot [6]. The differences obtained in
thickness and roughness are attributed to the robotic dipping machine because it has a more
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controlled system of immersion in comparison to a manual immersion which was performed in
this work. This is because the robotic system maintains a velocity of immersion and extraction
constant, which is difficult to control manually. Velocity that can exert an influence over the
detachment of the molecules slightly adhered to the substrate, which therefore alters the physical
properties of the modified surface [64]. We were able to confirm that the changes in temperature
between 25 – 37 °C do not induce a drastic effect on the chemical-physical properties of the
polymeric multilayers of HEP/COL, but significant differences (p < 0.05) were observed between
multilayers ending in COL and HEP for both physical characterizations of the multilayers
(thickness and roughness), as can be observed in Figures 3-1C and 3-1D.
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Figure 3-1. Physical-chemical properties of the multilayers of HEP/COL as measured by IRVASE
at 25 °C and 37 °C. A) IRVASE Spectrum of 12 layers HEP/COL B) IRVASE Spectrum of 13
layers HEP/COL. C) Thickness vs. number of layers (12 and 13 layers), D) Roughness vs. number
of layers (12 and 13 layers). Data are presented as the mean ± standard deviation of n=4 samples.
p < 0.05 are represented by *. Reprinted from ACS Biomaterials Science & Engineering, 5,
Castilla-Casadiego D. A., García J. R., García A. J., Almodovar J., Heparin/Collagen Coatings
Improve Human Mesenchymal Stromal Cell Response to Interferon Gamma, 2793-2803,
Copyright 2019, with permission from ACS.
3.4.2. h-MSCs Proliferation Response to HEP/COL Multilayers
An EdU assay was used to measure the proliferation response of h-MSCs seeded onto
the multilayers of HEP/COL as well as a reference surface – tissue culture polystyrene (TCP). In
addition, the effects of IFN-γ in the cell culture media were also evaluated. To test whether the
FBS used in the culture media had endogenous IFN-γ, we used an IFN-γ bovine ELISA kit. We
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observed that the FBS used has undetectable amounts of IFN-γ (Figure 3-S1 in supporting
information (Appendix A.2)).
h-MSCs were seeded for each experimental condition. The percentage of EdU positive
cells was determined after 18 hr of incubation with the EdU solution. Figure 3-2 summarizes EdU
incorporation for h-MSCs cultured on COL-ending films, HEP-ending films, and TCP, with (50
ng/mL) or without IFN-γ supplemented in the cell culture media. We selected a concentration 50
ng/mL for soluble IFN-γ based on previous literature [65] and preliminary experiments. For hMSCs cultured on TCP without IFN-γ, approximately 30% of the cells were EdU positive. Addition
of IFN-γ suppressed proliferation for h-MSCs on TCP. This anti-proliferative effect for IFN-γ has
been reported for multiple cell types, including MSCs [51][66][67][68][69].

Figure 3-2. h-MSC proliferation response measured by the EdU assay on TCP, 12 layers of
HEP/COL (layers ending in COL), and 13 layers of HEP/COL (layers ending in HEP) using
medium supplemented with and without IFN-γ. A) Representative EdU assay images for each
condition, the blue color represents the nucleus (DAPI) and the green the EdU label. B) h-MSCs
proliferation response. Data are presented as the mean ± standard deviation of n=4 samples. The
p < 0.05 are represented by *. Reprinted from ACS Biomaterials Science & Engineering, 5,
Castilla-Casadiego D. A., García J. R., García A. J., Almodovar J., Heparin/Collagen Coatings
Improve Human Mesenchymal Stromal Cell Response to Interferon Gamma, 2793-2803,
Copyright 2019, with permission from ACS.
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For films composed of 12 and 13 layers of HEP/COL without IFN-γ, h-MSCs displayed
equivalent proliferation levels as the TCP reference. Also, significant differences were not
observed between multilayers with and without IFN-γ supplement, as can be appreciated in
Figure 3-2A and 3-2B. Our results on the percent of EdU positive cells for h-MSCs seeded over
the surfaces supplemented with IFN-γ reported an approximate value of 33%, 23%, and 22% for
HEP-terminated films, COL-terminated films, and TCP; respectively (see Figure 3-2B). HEPending layers supplemented with IFN-γ significantly enhanced the proliferation of h-MSCs as
compared to cells grown on the control TCP surface with IFN-γ supplemented in the culture
medium (p < 0.05). Similar proliferation levels are observed in HEP-ending films with IFN-γ as
compared to TCP without IFN-γ. Therefore, HEP-ending layers might be a suitable surface to preactivate h-MSCs in-vitro using IFN-γ without affecting their proliferation. IFN-γ activated h-MSCs
have been shown to exhibit antiviral, antitumor, or immunomodulary properties, that enhance their
therapeutic function [69][70]. To test the robustness of our technology, we performed a second
experiment using h-MSCs from a different donor and vendor. h-MSCs from a 25-year-old male
were obtained from RoosterBio. EdU experiments were performed as described above using the
same conditions. We observed that h-MSCs from RoosterBio had a high proliferation rate (~70%
EdU positive cells) in conditions without IFN-γ (see Figure 3-S2 in supporting information
(Appendix A.2)). In TCPS, the proliferation rate is greatly reduced to 20% when h-MSCs are
exposed to 50 ng/mL of IFN-γ. However, h-MSCs cultured on HEP/COL films experience a much
less reduction in proliferation, reaching levels of approximately 40%. This confirms that indeed
HEP/COL films negate the strong anti-proliferative effect of IFN-γ.
In literature, it has been reported that heparin is capable of binding with high affinity to a
variety of growth factors and cytokines including IFN-γ [71][72][73]. In this work, we did not
evaluate the capacity of HEP/COL films to act as a sink for IFN-γ. However, previous literature
has shown that LbL films of biopolymers do serve as a sink for different growth factors. We have
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shown that chitosan/heparin LbL films act as a depot for fibroblast growth factors, while poly-llysine/hyaluronic acid LbL films as act depot for bone morphogenetic proteins (2 or 7) and stromal
derived factor [74][75][76]. Heparin-binding growth factors strongly bind to heparin containing
films. Non-sulfated glycosaminoglycan also acts as depots. Given the natural affinity of IFN-γ to
heparin, we hypothesize that indeed HEP/COL films would act as a sink for IFN-γ. Other heparinbinding proteins in the culture media would also be deposited on the films. Our hypothesis
regarding the reduced anti-proliferative effect of IFN-γ when h-MSCs are cultured on HEP ending
films is due to the natural affinity that IFN-γ binds to both heparan sulfate molecules on the cell
membrane and to extracellular heparin [73]. It is also known that IFN-γ binds with high affinity to
heparan sulfate and heparin molecules through its carboxyl-terminal domain [77]. Maciag and
collaborators reported that heparin helps counteract the anti-proliferative effect of IFN-γ on
endothelial cells. They demonstrated that IFN-γ: inhibited alpha-endothelial cell growth factor and
induced endothelial cell proliferation with a simultaneous change in endothelial cell morphology.
However, the addition to the 5 µg/mL of heparin was able to overcome the anti-proliferative effects
of IFN-γ partially in the growth of human umbilical vein endothelial cells [78]. This effect is
mediated by the inhibition that occurs when cytokines are linked to heparin molecules on the
cellular surface. This is due to the direct competition between linking IFN-γ by soluble heparin
and heparin in the cellular surface, failing transduction of the normal receptor signal [45][79].
3.4.3. Cytokine Expression for h-MSCs on HEP/COL Multilayers
A Human Premixed Multi-Analyte Kit (Magnetic Luminex® Assay) assay was used for the
simultaneous detection and quantification of multiple human cytokines. We examined IL-6
because of its capacity in regulating proinflammatory and immunoregulatory responses that
contribute to the defense of the host against infections and tissue lesions [80]. VEGF-A plays a
role in normal physiological functions such as bone formation, hematopoiesis, wound healing,
and development [81]. FGF-2 controls cellular survival, proliferation, and differentiation [82]. M152

CSF plays an important role in proliferation, differentiation and survival of monocytes and
macrophages [83]. And IL-10 potentiates immunoregulation and inflammation [84]. h-MSCs were
cultured on TCP and HEP/COL multilayers with and without medium supplemented with IFN-γ
(50 ng/mL). Figure 3-3 shows results for cytokine expression. A heat map is shown in Figure 33E. IL-10 levels were below the detection levels for all experimental groups. Our results show that
the expression of IL-6 secreted by the h-MSCs increases due to the presence of IFN-γ for the
three different surfaces evaluated. IFN-γ is been known to increase IL-6 secretion in multiple cell
types including h-MSCs [85][86][87]. In Figure 3-3A, we can observe a significant difference in
p-values < 0.05 between the TCP surface with and without IFN-γ. We observed an increase (p <
0.001) in the expression of IL-6 on both types of multilayers when comparing conditions with and
without IFN-γ. Also, we noticed that the multilayers without IFN-γ supplement had a similar IL-6
expression than the TCP surface. Similar results were obtained for M-CSF expression (Figure 33D), where an up-regulation was observed in conditions with soluble IFN-γ. In Figure 3-3D, we
see that the expression of M-CSF was upregulated in conditions in which the h-MSCs were
seeded on the multilayers supplemented with IFN-γ in comparison to the TCP surface
supplemented with IFN-γ (p-values < 0.001). IFN-γ has demonstrated to increase the production
and receptor internalization of M-CSF [88]. For VEGF-A (see Figure 3-3B), we noticed that the
addition of IFN-γ causes a decrease in VEGF-A expression for cells cultured on TCP (p-values <
0.001). For cells cultured on HEP/COL films, VEGF-A secretion increases. COL-ending films had
a statistically significant (p-values < 0.001) increase in VEGF-A expression when stimulated by
IFN-γ. HEP-ending films showed no statistical difference in VEGF-A secretion when stimulated
with IFN-γ. These results suggest the HEP/COL films are enhancing IFN-γ’s activity by improving
the secretion of IL-6, M-CSF, and VEGF-A. HEP/COL films have the potential to be a suitable
surface for producing pre-activated h-MSCs with a higher immunosuppressive capability than
those cultured in TCP with soluble IFN-γ.
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Interestingly, FGF-2 expression is unaffected by the presence of IFN-γ, but its
expression drastically increases on HEP-terminated coatings with or without IFN-γ (see Figure
3-3C).

Figure 3-3. Cytokine levels as assessed by Luminex assay. Comparative protein expression of
h-MSCs seeded on TCP, 12 layers of HEP/COL (layers ending in COL), and 13 layers of
HEP/COL (layers ending in HEP) using medium supplemented with and without IFN-γ. A) IL-6.
B) VEGF-A. C) FGF-2. D) M-CSF. E) Heatmap representing the concentration values of
biomarkers expression individual in each condition evaluated. Blue, low expression: red, high
expression. Data are presented as the mean ± standard deviation of n=4 samples. The p-values
< 0.05 are represented by * and p-values < 0.001 by ***. Reprinted from ACS Biomaterials
Science & Engineering, 5, Castilla-Casadiego D. A., García J. R., García A. J., Almodovar J.,
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Figure 3-3. (Cont.) Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell
Response to Interferon Gamma, 2793-2803, Copyright 2019, with permission from ACS.

Previous literature suggests that heparin in solution activates the FGF-2 signaling
pathway in hMCSs (by phosphorylation of the FGF-2 receptors) and regulates cell cycle in a dosedependent manner [89]. Also, we have previously demonstrated that heparin containing coatings
can serve as reservoirs for FGF-2 and that bound FGF-2 modulates MSCs proliferation [74]. Invitro, FGFs are tightly bound to heparin proteoglycans, which regulates diffusion through the ECM
and serve as cofactors that regulate specificity and affinity for the FGF-2 receptor signaling [90].
These results suggest that HEP/COL coatings ending in HEP are activating the FGF-2 receptors
in h-MSCs and thus inducing FGF-2 secretion.
HEP/COL polymeric multilayers are potential platforms for enhancing the pre-activation
of h-MSCs using soluble IFN-γ, as shown by the enhancement in the secretion of key cytokines.
Analyzing Figure 3-3E, which corresponds to the heat map representing the concentration values
of biomarker expression in each condition evaluated, we can visually observe that the condition
that promotes higher values of expression of these proteins are multilayers ending in HEP with
IFN-γ supplemented in the culture medium. Multilayers ending in HEP could be used as a
bioactive surface to pre-treat h-MSCs. This pre-treatment could yield more robust and
therapeutically relevant h-MSCs. That is because HEP-ending layers supplemented with IFN-γ
can promote the production of cells with pro-inflammatory and immunoregulatory capacities.
To test the robustness of our technology, we performed a second experiment using hMSCs from a different donor and vendor. h-MSCs from a 25-year-old male were obtained from
RoosterBio. Luminex experiments were performed as described above using the same
conditions. We observed that h-MSCs from RoosterBio had a similar response in cytokine
expression when exposed to IFN-γ (see Figure 3-S3 in supporting information (Appendix A.2)).
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RoosterBio’s h-MSCs treated with IFN-γ showed an increase in expression of IL-6 and M-CSF for
all the tested conditions. For these cells, expression of IL-6 and M-CSF was unaffected by the
presence of the HEP/COL films. Although there are some slight differences in cytokine expression
between the different donors, in general we can state that IFN-γ enhances immunocytokine
expression, and HEP/COL films can boost the effect of IFN-γ on cells that have a low expression
of IL-6 and M-CSF. Expression of VEGF was suppressed in the presence of IFN-γ, however this
suppression was decreased by the HEP/COL films specially when terminated in HEP (see Figure
3-S3 in supporting information (Appendix A.2)). Lastly, FGF-2 expression was unaffected by IFNγ but was significantly enhanced for cells cultured on HEP/COL films (see Figure 3-S3 in
supporting information (Appendix A.2)). FGF-2 expression is significantly enhanced by the
presence of the HEP/COL films in both donors, in particular on HEP terminated surfaces. This
confirms an enhancing effect in h-MSCs proliferation by FGF-2 expression.
3.4.4. Analysis of Cell Adhesive Proteins
Integrins are the principal receptors for components of the extracellular matrix, implicated
in cellular adhesion and the regulation of diverse biological processes [91][92]. Because of the
critical role of integrins in modulating cell-material interactions, we examine the assembly of focal
adhesions containing beta-1 and beta-3 integrins for h-MSCs cultured on TCP and HEP/COL
multilayers. Beta-1 and beta-3 integrins are the major sub-families of integrins involved in cell
adhesion to the matrix. In addition, we examined the localization of phosphorylated FAK at
tyrosine 397 (p-FAK), an essential kinase regulating integrin signaling and various cell processes,
including cell migration, cell spreading, differentiation, survival, gene expression, cytoskeleton
protein phosphorylation, apoptosis and cell cycle progression [93]. Figure 3-4 presents high
magnification images for p-FAK, beta-1, and beta-3 immunostaining as well as phalloidin-labeled
actin fibers for h-MSCs cultured for 3 days on the different substrates in the presence and absence
of IFN-γ. Low power images are presented in Figure 3-S4 in supporting information (Appendix
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A.2). In the absence of IFN-γ, cells exhibited well-defined, punctate focal adhesions that stained
for p-FAK, beta-1, and beta-3 integrin. In contrast, exposure to IFN-γ resulted in differences in the
staining intensity for p-FAK, beta-1, and beta-3 integrin. The reduction in fluorescent intensity for
these adhesive proteins was observed across all substrates. Despite these significant differences
for adhesive proteins, no gross differences in actin cytoskeleton in response to IFN-γ were
evident.
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Figure 3-4. Analysis of h-MSCs adhesion after incubation for 3 days. A) Images of triple staining
with phalloidin for actin filaments (red); DAPI for nuclei (blue); and antibodies against p-FAK, Beta1, and Beta-3 (green) showed focal adhesion formation for h-MSCs cultured without IFN-γ. B)
Images of triple staining for h-MSCs cultured with IFN-γ supplement. C) Fluorescent images of
triple staining for h-MSCs seeded over the surface of 12 layers of HEP/COL without IFN-γ
supplement. D) Fluorescent images of triple staining for h-MSCs seeded over the surface of 12
layers of HEP/COL with IFN-γ supplement.
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Figure 3-4. (Cont.) E) Fluorescent images of triple staining for h-MSCs seeded over 13 layers of
HEP/COL without IFN-γ supplement. F) Fluorescent images of triple staining for h-MSCs seeded
over 13 layers of HEP/COL with IFN-γ supplement. Reprinted from ACS Biomaterials
Science & Engineering, 5, Castilla-Casadiego D. A., García J. R., García A. J., Almodovar J.,
Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell Response to Interferon
Gamma, 2793-2803, Copyright 2019, with permission from ACS.

3.4.5. Analysis of Immunomodulatory Factor Expression
The immunosuppressive capabilities of h-MSCs were obtained by measuring the
expression of Indoleamine 2,3-dioxgyenase (IDO) after priming with IFN-γ. h-MSCs were cultured
on TCP and HEP/COL multilayers with and without medium supplemented with IFN-γ (50 ng/mL).
Results demonstrated that h-MSCs on HEP/COL multilayers promote the immunosuppressive
capacity of h-MSCs (See Figure 3-5). Figure 3-5 shows that HEP/COL multilayers with IFN-γ
supplemented in the medium generate a high increment on the immunosuppressive capacity hMSCs. A P-value < 0.001 was obtained when comparing HEP/COL multilayers with the presence
of IFN-γ and the other conditions evaluated. These results suggest that HEP/COL coatings ending
in HEP can promote the production of cells with pro-inflammatory and immunoregulatory
capacities. Consequently, the system of polymeric multilayers of HEP/COL can be recognized as
a useful surface that plays a significant role in increasing the h-MSCs capacities.

Figure 3-5. Immunosuppressive capacity by IDO expression. A) Donor 1: 21 years old. B) Donor
2: 25 years old. C) Donor 3: 22 years old. Data are presented as the mean ± standard deviation
of n=4 samples. The p-values < 0.05 are represented by *, p-values < 0.01 by **, p-values < 0.001
by ***, and p-values < 0.0001 by *****
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3.5. Conclusions
A substrate composed of polymeric multilayers of HEP/COL terminating in COL (12 layers
HEP/COL) or HEP (13 layers HEP/COL) with IFN-γ supplementation in the culture medium was
able to promote the improvement of cellular behaviors of h-MSCs, as measured by the ability to
proliferate and increase in expression of IL-6, VEGF-A, FGF-2, and MCSF. h-MSCs cultured on
HEP/COL multilayers supplemented with IFN-γ demonstrated an enhanced behavior compared
to standard TCP. Using these coatings (especially HEP-ending films) allows the preactivation of
h-MSCs using IFN-γ to enhance their immunomodulatory properties and therapeutic potential
while eliminating IFN-γ’s antiproliferative effect. Our results suggest that this technology could be
implemented in h-MSC manufacturing by creating surfaces that allow their preactivation without
limiting their growth.
Future studies will focus on elucidating the mechanisms by which HEP-terminated films
enhance IFN-γ activity. Moreover, we will perform experiments to evaluate the translational
potential of this technology toward manufacturing by coating bioreactors and evaluating xeno-free
media. The demand for potent h-MSCs has significantly increased because of an increase in
clinical trials in the United States and as a result of cell therapies being approved in Europe,
China, and India [94], which have created large quantities of potent h-MSCs. h-MSCs therapies
have been proposed for the treatment of multiple diseases ranging from neurological disorders to
cancer. Typical dose sizes for these treatments are in the order of 10s to 100s of millions of cells
per patient [95]. This high dose requirement presents an opportunity to improve cell manufacturing
practices, to ultimately reduce patient costs and improve the lives of more patients. Preactivation
of h-MSCs cultured on HEP-terminated layer-by-layer surfaces may be a solution to produce large
quantities of potent h-MSCs. The layer-by-layer technology has strong translational potential due
to its simplicity, versatility, and scalability, making it attractive to cell manufacturing. This work

160

demonstrates how engineered surfaces may be used complementary to biochemical stimuli to
obtain more robust and therapeutically relevant h-MSCs.
3.6. Acknowledgments
This work was financially supported by the Engineering Research Center for Cell
Manufacturing Technologies (CMaT) of the National Science Foundation under Grant No. EEC1648035, the Army Research Office under Contract No. W911NF-15-1-0031, and by the
“Programa de Apoyo Institucional Para la Formacion en Estudios de Posgrados en Maestrias y
Doctorados de La Universidad del Atlantico, ́ Colombia” by providing DCC a scholarship. The
authors thank Luis C. Pinzon Herrera for his collaboration in the development of preliminary
experiments in the physical− chemical characterization of the HEP/COL multilayers and fruitful
discussions. The authors thank Integra LifeSciences for donating the collagen used in this work.
The authors thank Dr. Shannon Servoss, Dr. Lauren Greenlee, and Dr. Raj Rao from the
University of Arkansas for equipment access and help during the ELISA and second donor testing
experiments. The authors declare no financial interest.
3.7. References
[1]

J. Shi, Y. Liu, Y. Wang, J. Zhang, S. Zhao, and G. Yang, “Biological and immunotoxicity
evaluation of antimicrobial peptide-loaded coatings using a layer-by-layer process on
titanium,” Nature Publishing Group, vol. 5, p. 16336, 2015.

[2]

J. Chen, C. Chen, Z. Chen, J. Chen, Q. Li, and N. Huang, “Collagen / heparin coating on
titanium surface improves the biocompatibility of titanium applied as a blood-contacting
biomaterial,” Journal of Biomedical Materials Research Part A, vol. 95, pp. 341–349, 2010.

[3]

Z. Tang, Y. Wang, P. Podsiadlo, and N. A. Kotov, “Biomedical applications of layer-bylayer assembly: From biomimetics to tissue engineering,” Advanced Materials, vol. 18, pp.
3203–3224, 2006.

[4]

V. Gribova, R. Auzely-Velty, and C. Picart, “Polyelectrolyte Multilayer Assemblies on
Materials Surfaces: From Cell Adhesion to Tissue Engineering.,” Chemistry of materials :
a publication of the American Chemical Society, vol. 24, pp. 854–869, 2012.

[5]

F. Crespilho, V. Zucolotto, and O. O. Jr, “Electrochemistry of layer-by-layer films: a
review,” Int. J. Electrochem., vol. 1, pp. 194-214, 2006.
161

[6]

D. A. Castilla-Casadiego, L. Pinzon-Herrera, M. Perez-Perez, B. A. Quiñones-Colón, D.
Suleiman, and J. Almodovar, “Simultaneous characterization of physical, chemical, and
thermal properties of polymeric multilayers using infrared spectroscopic ellipsometry,”
Colloids and Surfaces A: Physicochemical and Engineering Aspects, vol. 553, pp. 155168, 2018.

[7]

J. Almodóvar, L. W. Place, J. Gogolski, K. Erickson, and M. J. Kipper, “Layer-by-layer
assembly of polysaccharide-based polyelectrolyte multilayers: a spectroscopic study of
hydrophilicity, composition, and ion pairing.,” Biomacromolecules, vol. 12, pp. 2755–65,
2011.

[8]

S. Boddohi, C. E. Killingsworth, and M. J. Kipper, “Polyelectrolyte multilayer assembly as
a function of pH and ionic strength using the polysaccharides chitosan and heparin,”
Biomacromolecules, vol. 9, pp. 2021–2028, 2008.

[9]

T. Crouzier and C. Picart, “Ion pairing and hydration in polyelectrolyte multilayer films
containing polysaccharides,” Biomacromolecules, vol. 10, pp. 433–442, 2009.

[10]

B. K. Ren, T. Crouzier, C. Roy, and C. Picart, “Polyelectrolyte Multilayer Films of
Controlled Stiffness Modulate Myoblast Cell Differentiation,” Advanced functional
materials, vol. 18, pp. 1378–1389, 2008.

[11]

P. C, “Polyelectrolyte Multilayer Films: From Physico-Chemical Properties to the Control
of Cellular Processes,” Current Medicinal Chemistry, vol. 15, pp. 685–697, 2008.

[12]

K. C. Krogman, R. E. Cohen, P. T. Hammond, M. F. Rubner, and B. N. Wang, “Industrialscale spray layer-by-layer assembly for production of biomimetic photonic systems,”
Bioinspiration & Biomimetics, vol. 8, p. 045005, 2013.

[13]

M. A.J., C. A.A., and G. J.C., “Large-Scale Continuous Immersion System for Layer-byLayer Deposition of Flame Retardant and Conductive Nanocoatings on Fabric,” Industrial
& Engineering Chemistry Research, vol. 53, pp. 6409–6416, 2014.

[14]

M. P. et al., “Automated Buildup of Biomimetic Films in Cell Culture Microplates for HighThroughput Screening of Cellular Behaviors,” Advanced Materials, vol. 30, pp. e1801097,
2018.

[15]

S. Y.N. et al., “What is really driving cell-surface interactions? Layer-by-layer assembled
films may help to answer questions concerning cell attachment and response to
biomaterials,” Biointerphases, vol. 11, p. 019009, 2016.

[16]

C. Picart et al., “Primary Cell Adhesion on RGD-Functionalized and Covalently
Crosslinked Thin Polyelectrolyte Multilayer Films,” Advanced Functional Materials, vol. 15,
pp. 83–94, 2005.

[17]

V. den Beucken et al., “Functionalization of multilayered DNA-coatings with bone
morphogenetic protein 2,” Journal of Controlled Release, vol. 113, pp. 63–72, 2006.

[18]

P. Lu, V. M. Weaver, and Z. Werb, “The extracellular matrix: a dynamic niche in cancer
progression.,” The Journal of cell biology, vol. 196, pp. 395–406, 2012.

162

[19]

X. B. Yang, R. S. Bhatnagar, S. Li, and R. O. C. Oreffo, “Biomimetic Collagen Scaffolds
for Human Bone Cell Growth,” Tissue engineering, vol. 10, pp. 1148–1159, 2004.

[20]

A. Dar, M. Shachar, J. Leor, and S. Cohen, “Cardiac Tissue Engineering Optimization of
Cardiac Cell Seeding and Distribution in 3D Porous Alginate Scaffolds,” Biotechnology
and bioengineering, vol. 80, pp. 305–312, 2002.

[21]

A. R. Brunelle, C. B. Horner, K. Low, G. Ico, and J. Nam, “Electrospun thermosensitive
hydrogel scaffold for enhanced chondrogenesis of human mesenchymal stem cells,” Acta
Biomaterialia, vol. 66, pp. 166–176, 2017.

[22]

R. Parenteau-Bareil, R. Gauvin, and F. Berthod, “Collagen-Based Biomaterials for Tissue
Engineering Applications,” Materials, vol. 3, pp. 1863–1887, 2010.

[23]

G. a. di Lullo, S. M. Sweeney, J. Körkkö, L. Ala-Kokko, and J. D. San Antonio, “Mapping
the ligand-binding sites and disease-associated mutations on the most abundant protein
in the human, type I collagen,” Journal of Biological Chemistry, vol. 277, pp. 4223–4231,
2002.

[24]

D. A. Castilla-Casadiego, C. A. Rivera-Martínez, B. A. Quiñones-Colón, and J. Almodóvar,
“Electrospun Collagen Scaffolds,” in Electrospun Biomaterials and Related Technologies,
2017, pp. 21–55.

[25]

F. Berthod, D. Hayek, and O. Damour, “Collagen synthesis by fibroblasts cultured within a
collagen sponge.,” vol. 14, pp. 749-754, 1993.

[26]

B. Zhang, Q. Luo, B. Deng, Y. Morita, Y. Ju, and G. Song, “Construction of tendon
replacement tissue based on collagen sponge and mesenchymal stem cells by coupled
mechano-chemical induction and evaluation of its tendon repair abilities,” Acta
Biomaterialia, vol. 74, pp. 247-259, 2018.

[27]

C.-H. Y. Chou, Chau-Chang, Hong-Jhih Zeng, “Blood compatibility and adhesion of
collagen/heparin multilayers coated on two titanium surfaces by a layer-by-layer
technique,” Thin Solid Films, vol. 549, pp. 117–122, 2013.

[28]

A. M. Ferreira, P. Gentile, V. Chiono, and G. Ciardelli, “Collagen for bone tissue
regeneration,” Acta Biomaterialia, vol. 8, pp. 3191–3200, 2012.

[29]

H. Sarrazin, S., Bonnaffé, D., Lubineau, A., & Lortat-Jacob, “Heparan sulfate mimicry a
synthetic glycoconjugate that recognizes the heparin binding domain of interferon-γ
inhibits the cytokine,” Journal of Biological Chemistry, vol. 280, pp. 37558–37564, 2005.

[30]

U. Lindahl, M. Kusche-gullberg, and L. Kjelle, “Regulated Diversity of Heparan Sulfate,”
Journal of Biological Chemistry, vol. 273, pp. 24979–24982, 1998.

[31]

M. Bernfield, M. Götte, P. W. Park, O. Reizes, M. L. Fitzgerald, and J. Lincecum,
“Functions of cell surface heparan sulfate proteoglycans,” Annual review of biochemistry,
vol. 68, pp. 729–777, 1999.

[32]

N. Chen, J. L.; Li, Q. L.; Chen, J. Y.; Chen, C.; Huang, “Improving blood-compatibility of
titanium by coating collagen – heparin multilayers,” Applied Surface Science, vol. 255, pp.
6894–6900, 2009.
163

[33]

J. Chen, N. Huang, Q. Li, C. H. Chu, J. Li, and M. F. Maitz, “The effect of electrostatic
heparin / collagen layer-by-layer coating degradation on the biocompatibility,” Applied
Surface Science, vol. 362, pp. 281–289, 2016.

[34]

K. Jin et al., “A biomimetic collagen / heparin multi-layered porous hydroxyapatite orbital
implant for in vivo vascularization studies on the chicken chorioallantoic membrane,”
Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 254, pp. 83–89, 2016.

[35]

Q. Lin, X. Ding, F. Qiu, X. Song, G. Fu, and J. Ji, “Biomaterials In situ endothelialization of
intravascular stents coated with an anti-CD34 antibody functionalized heparin – collagen
multilayer,” Biomaterials, vol. 31, pp. 4017–4025, 2010.

[36]

S. Lu et al., “Synthetic ePTFE Grafts Coated with an Anti-CD133 Antibody- Functionalized
Heparin / Collagen Multilayer with Rapid in vivo Endothelialization Properties,” ACS
applied materials & interfaces, vol. 5, pp. 7360–7369, 2013.

[37]

Ijzermans, J. NM, and Richard L. Marquet, “Interferon-gamma: A Review,”
Immunobiology, vol. 179, pp. 456–473, 1989.

[38]

F. I. De-simone, R. Sariyer, Y. Otalora, and S. Yarandi, “IFN-Gamma Inhibits JC Virus
Replication in Glial Cells by Suppressing T-Antigen Expression,” PLoS One, vol. 10, p.
e0129694, 2015.

[39]

P. Kokordelis et al., “An Effective Interferon-Gamma-Mediated Inhibition of Hepatitis C
Virus Replication by Natural Killer Cells Is Associated With Spontaneous Clearance of
Acute Hepatitis C in Human Immunodeficiency Virus-Positive Patients,” Hepatology, vol.
59, pp. 814–827, 2014.

[40]

J. R. Abend, J. A. Low, and M. J. Imperiale, “Inhibitory Effect of Gamma Interferon on BK
Virus Gene Expression and Replication,” Journal of virology, vol. 81, pp. 272–279, 2007.

[41]

J. R. Schoenborn and C. B. Wilson, “Regulation of Interferon- g During Innate and
Adaptive Immune Responses,” Advances in immunology, vol. 96, pp. 41–101, 2007.

[42]

W. J. Urba et al., “The in vivo immunomodulatory effects of recombinant interferon gamma
plus recombinant tumor necrosis factor-alfa.,” Journal of clinical oncology, vol. 9, pp.
1931–1939, 1991.

[43]

A. Jurado, J. Carballido, H. Griffel, H. K. Hochkeppel, and G. D. Wetzel, “The
immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses,”
Experientia, vol. 45, pp. 521–526, 1989.

[44]

R. Sadir, E. Forest, and H. Lortat-jacob, “The heparan sulfate binding sequence of
interferon-γ increased the on rate of the interferon-γ-interferon-γ receptor complex
formation,” Journal of Biological Chemistry, vol. 273, pp. 10919–10925, 1998.

[45]

H. Lortat-jacob, H. K. Kleinman, and J. Grimaud, “High-Affinity Binding of Interferon-ey to
a Basement Membrane Complex ( Matrigel ),” The Journal of clinical investigation, vol. 87,
pp. 878–883, 1991.

164

[46]

D. Polchert et al., “IFN‐γ activation of mesenchymal stem cells for treatment and
prevention of graft versus host disease,” European journal of immunology, vol. 38, pp.
1745–1755, 2008.

[47]

J. M. Ryan, F. Barry, J. M. Murphy, and B. P. Mahon, “Interferon-γ does not break, but
promotes the immunosuppressive capacity of adult human mesenchymal stem cells,”
Clinical and Experimental Immunology, vol. 149, pp. 353–363, 2007.

[48]

K. N. Sivanathan and S. Gronthos, “Interferon-Gamma Modification of Mesenchymal
Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy
in Allotransplantation,” Stem Cell Reviews and Reports, vol. 10, pp. 351–375, 2014.

[49]

M. W. Klinker, R. A. Marklein, J. L. lo Surdo, C. H. Wei, and S. R. Bauer, “Morphological
features of IFN-γ-stimulated mesenchymal stromal cells predict overall
immunosuppressive capacity,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 114, pp. E2598–E2607, 2017.

[50]

C. Strojny, M. Boyle, and A. Bartholomew, “Interferon Gamma – treated Dental Pulp Stem
Cells Promote Human Mesenchymal Stem Cell Migration In-vitro,” Journal of Endodontics,
vol. 41, pp. 1259–1264, 2015.

[51]

J. Croitoru-Lamoury et al., “Interferon-γ regulates the proliferation and differentiation of
mesenchymal stem cells via activation of indoleamine 2, 3 dioxygenase (IDO).,” PloS one,
vol. 6, p. e14698, 2011.

[52]

J. M. Cabral, C. L. da Silva, L. G. Chase, and M. M. Diogo, Stem Cell Manufacturing.
Elsevier, 2016.

[53]

D. C. Ding, Y. H. Chang, W. C. Shyu, and S. Z. Lin, “Review Human Umbilical Cord
Mesenchymal Stem Cells : A New Era for Stem Cell Therapy,” 2015, vol. 24, pp. 339–347,
2015.

[54]

J. R. Passweg et al., “Hematopoietic stem cell transplantation in Europe 2014: more than
40 000 transplants annually,” Bone marrow transplantation, vol. 51, pp. 786, 2016.

[55]

G. Turgeman, “The therapeutic potential of mesenchymal stem cells in Alzheimer’ s
disease: converging mechanisms,” Neural regeneration research, vol. 10, p. 698, 2015.

[56]

F. G. Teixeira et al., “Impact of the secretome of human mesenchymal stem cells on brain
structure and animal behavior in a rat model of Parkinson’s disease,” Stem cells
translational medicine, vol. 6, pp. 634–346, 2017.

[57]

A. Wei, B. Shen, L. Williams, and A. Diwan, “Mesenchymal stem cells: potential
application in intervertebral disc regeneration,” Translational pediatrics, vol. 3, pp. 71,
2014.

[58]

A. Pileggi, “Mesenchymal Stem Cells for the Treatment of Diabetes,” Diabetes, vol. 61,
pp. 1355–1356, 2012.

[59]

C. D. Markert et al., “Clinical Review: Current Concepts Mesenchymal Stem Cells:
Emerging Therapy for Duchenne Muscular Dystrophy,” PMRJ, vol. 1, pp. 547–559, 2009.

165

[60]

K. Shah, “Mesenchymal stem cells engineered for cancer therapy,” Advanced Drug
Delivery Reviews, vol. 64, pp. 739–748, 2012.

[61]

J. Wang and Z. Xiao, “Mesenchymal stem cells in pathogenesis of myelodysplastic
syndromes,” Stem cell investigation, vol. 1, pp. 16–19, 2014.

[62]

H. Munir and H. M. McGettrick, “Mesenchymal stem cells therapy for autoimmune
disease: risks and rewards,” Stem cells and development, vol. 24, pp. 2091–2100, 2015.

[63]

R. E. Newman, D. Yoo, M. A. LeRoux, and A. Danilkovitch-Miagkova, “Treatment of
inflammatory diseases with mesenchymal stem cells.,” Inflammation & allergy drug
targets, vol. 8, pp. 110–23, 2009.

[64]

L. E. Scriven, “Physics and Applications of DIP Coating and Spin Coating,” MRS
Proceedings, vol. 121, pp. 717, 2011.

[65]

W. H.M., T. M.A., G. S, B. L.M., D.-S. R., and V.-N. G., “The influence of hypizia and IFNg on the proteome and metabolome of therapeutic mesenchymal stem cells,” Biomaterials,
vol. 167, pp. 226–234, 2018.

[66]

S., Maher, A. Romero-Weaver, A. Scarzello, and A. Gamero., “Interferon: cellular
executioner or white knight?,” Curr. Med. Chem., vol. 14, pp. 1279–1289, 2007.

[67]

N. , Borsellino, M. Crescimanno, C. Flandina, v. Leonardi, L. Rausa, and N. D’Alessandro,
“Antiproliferative and chemomodulatory effects of interferon-gamma on doxorubicinsensitive and -resistant tumor cell lines,” Anticancer Drugs, vol. 4, pp. 265–272, 1993.

[68]

T. F. Gajewski, E. Goldwasser, and F. W. Fitch, “Anti-proliferative effect of IFN-gamma in
immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells
stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.,” The
Journal of Immunology, vol. 141, pp. 2635–2642, 1988.

[69]

L. Wall, F. Burke, J. F. Smyth, and F. Balkwill, “The Anti-proliferative Activity of Interferonγ on Ovarian Cancer: In-vitro and in Vivo,” Gynecologic Oncology, vol. 88, pp. S149–S151,
2003.

[70]

H. Lortat-Jacob, P. Esterre, and J. A. Grimaud, “Interferon-gamma, an anti-fibrogenic
cytokine which binds to heparan sulfate,” Pathology, research and practice, vol. 190, pp.
920–922, 1994.

[71]

U. Lindahl, K. Lidholt, D. Spillmann, and L. Kjellén, “More to ‘heparin’ than
anticoagulation,” Thrombosis research, vol. 75, pp. 1–32, 1994.

[72]

A., Schmidt et al., “Basic ﬁbroblast growth factor controls migration in human
mesenchymal stem cells,” Stem Cells, vol. 24, pp. 1750–1758, 2006.

[73]

S. J. Fritchley, J. A. Kirby, and S. Ali., “The antagonism of interferon-gamma (IFN-γ) by
heparin: examination of the blockade of class II MHC antigen and heat shock protein-70
expression,” Clin Exp Immunol., vol. 120, pp. 247–252, 2000.

[74]

J. Almodóvar, S. Bacon, J. Gogolski, J. D. Kisiday, and M. J. Kipper, “Polysaccharidebased polyelectrolyte multilayer surface coatings can enhance mesenchymal stem cell
response to adsorbed growth factors.,” Biomacromolecules, vol. 11, pp. 2629–39, 2010.
166

[75]

A. J. et al., “Spatial patterning of BMP-2 and BMP-7 on biopolymeric films and the
guidance of muscle cell fate,” Biomaterials, vol. 35, pp. 3975–3985, 2014.

[76]

D. F. et al., “The effect of delivering the chemokine SDF-1 in a matrix-bound manner on
myogenesis,” Biomaterials, vol. 35, pp. 4525–4535, 2014.

[77]

H. Lortat-Jacob, F. Baltzer, and J. A. Grimaud, “Heparin decreases the blood clearance
of interferon-gamma and increases its activity by limiting the processing of its carboxylterminal sequence.,” Journal of Biological Chemistry, vol. 271, pp. 16139–16143, 1996.

[78]

R. Friesel, A. Komoriya, and T. Maciag., “Inhibition of Endothelial Cell Proliferation by
Gamma-Interferon,” The Journal of Cell Biology, vol. 104, pp. 689–696, 1987.

[79]

S. J. Fritchley, J. A. Kirby, and S. Ali, “The antagonism of interferon-gamma (IFN-γ) by
heparin: Examination of the blockade of class II MHC antigen and heat shock protein-70
expression,” Clinical and Experimental Immunology, vol. 120, pp. 247–252, 2000.

[80]

T. Kishimoto and T. Tanaka, “‘Interleukin 6,’” Encyclopedia of Inflammatory Diseases. pp.
1–8, 2015.

[81]

A. M. Duffy, Bouchier-Hayes, D. J., and J. H. Harmey, “Vascular Endothelial Growth
Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF,”
VEGF and Cancer, pp. 133–144, 2004.

[82]

H. J. Ahn, W. J. Lee, K. B. Kwack, and Y. do Kwon, “FGF2 stimulates the proliferation of
human mesenchymal stem cells through the transient activation of JNK signaling,” FEBS
Letters, vol. 583, pp. 2922–2926, 2009.

[83]

E. R. Stanley et al., “Biology and Action of Colony – Stimulating Factor-1,” Molecular
Reproduction and Development: Incorporating Gamete Research, vol. 46, pp. 4–10, 1997.

[84]

Nakajima, M. et al., “Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote
Neuroprotection in Experimental Acute Ischemic Stroke,” Molecular Therapy: Methods &
Clinical Development, vol. 6, pp. 102–111, 2017.

[85]

L. Faggioli et al., “Molecular mechanisms regulating induction of interleukin-6 gene
transcription by interferon-y,” Eur J Immunol., vol. 27, pp. 3022–3030, 1997.

[86]

W. JE. Hotfilder M1, Knupfer H, Mohlenkamp G, Pennekamp P, Knupfers M, Van Gool S,
“Interferon-gamma increases IL-6 production in human glioblastoma cell lines,” Anticancer
Res., vol. 20, pp. 4445–4450, 2000.

[87]

R. Chinnadurai et al., “Potency Analysis of Mesenchymal Stromal Cells Using a
Combinatorial Assay Matrix Approach,” Cell reports, vol. 22, pp. 2504–2517, 2018.

[88]

P. Delneste, Y., Charbonnier, P., Herbault, N., Magistrelli, G., Caron, G., Bonnefoy, J. Y.,
& Jeannin, “Interferon-γ switches monocyte differentiation from dendritic cells to
macrophages,” Blood, vol. 101, pp. 143–150, 2003.

[89]

M. K. Furue et al., “Heparin promotes the growth of human embryonic stem cells in a
defined serum-free medium,” Proceedings of the National Academy of Sciences, vol. 105,
pp. 13409–13414, 2008.

167

[90]

D. M. Ornitz and N. Itoh, “The fibroblast growth factor signaling pathway,” Wiley
Interdisciplinary Reviews: Developmental Biology, vol. 4, pp. 215–266, 2015.

[91]

T. A. ; Haas and E. F. Plow, “Integrin-ligarid interactions: a year in review,” Curr. Opin.
Cell Biol., vol. 6, p. 656−662, 1994.

[92]

J. L. Guan, “Role of focal adhesion kinase in integrin signaling,” Int. J. Biochem. Cell Biol.,
vol. 8, p. 1085−1096, 1997.

[93]

D. D. Schlaepfer et al., “Tumor necrosis factor-α stimulates focal adhesion kinase activity
required for mitogen-activated kinase-associated interleukin 6 expression,” Journal of
Biological Chemistry, vol. 282, pp. 17450–17459, 2007.

[94]

K. P. ROBB, J. C. FITZGERALD, F. BARRY, and S. VISWANATHAN, “Mesenchymal
stromal cell therapy: progress in manufacturing and assessments of potency,”
Cytotherapy, vol. 21, pp. 289–306, 2019.

[95]

T. R. Olsen, K. S. Ng, L. T. Lock, T. Ahsan, and J. A. Rowley, “Peak MSC—are we there
yet?,” Frontiers in medicine, vol. 5, p. 178, 2018.

168

CHAPTER 4.

Engineering of a Stable Collagen Nanofibrous Scaffold with Tunable

Fiber Diameter, Alignment, and Mechanical Properties

4.1 Abstract
The effect of varying electrospinning parameters is reported for the production of collagen
nanofibers from acetic acid with controlled fiber diameter, orientation, and mechanical properties.
Nanofibers with a range of diameters of 175–400 nm are obtained by varying either the voltage
or the flow rate. An increase in nanofiber alignment is observed by increasing injection flow rate.
Mechanical testing of these fibers reveals that the elasticity modulus can be tuned in the range of
2.7–4.1 MPa by the selection of the crosslinking method. Fourier transform infrared spectroscopy
reveals that the secondary structure of collagen is preserved after electrospinning and
crosslinking. Lastly, in-vitro testing reveals that a high number of fibroblasts attach to the collagen
matrices indicating, that they are suitable for mammalian cell culture.
4.2 Introduction
The extracellular matrix (ECM) is a complex microenvironment that provides structural,
mechanical, and biochemical cues to cells, which ultimately dictate their fate [1][2]. The ECM is
composed of a variety of polymeric biomacromolecules, varying between different tissues. In
general, ECM components include: proteins, glycoproteins, proteoglycans, and polysaccharides
[3][4]. Collagen is one of the main components of the ECM of all connective tissues [5]. In tissues,
collagen is presented as fibers, but its morphological features such as fiber diameter and
organization vary between different types of tissues. For instance, collagen forms highly aligned
fibers in cardiac tissues, while in some regions of cartilage collagen forms a random structure with
a diameter range between 10 to 100 nm [6]. Collagen provides strength and structure to the ECM
by directly interacting with cells and other ECM molecules [7]. Cell-matrix interactions imply cells
interact with collagen, indicating that cells contain receptors for specific collagen peptide
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sequences [5]. Collagen is considered a family of closely related but genetically distinct
molecules. There are 28 different types recognized, but 80-90% of collagens in the body belong
to types I, II and III [8]. Type I collagen is found abundantly in the skin, bone, tendon, ligaments
and cornea [9]. Type II collagen is present in the eye vitreous humor, in the nucleus pulposus of
the vertebral discs, and is the main component of cartilage [9]. Type III collagen is abundant in
the loose connective tissue on the walls of blood vessels, the skin dermis, and the stroma of
various glands [9]. Due to its abundance in nature, collagen has become an attractive biopolymer
for the engineering of ECM mimetic scaffolds to be used in tissue regeneration.
Towards fabricating a scaffold that would mimic the physical, chemical and mechanical
properties of tissues in the human body, researchers have focused their studies in manufacturing
collagen-based scaffolds, including sponges [10], hydrogels [11], membranes [12], and
nanofibers [13]. Nanofibrous collagen scaffolds are of particular interest due to its resemblance
to native ECM in composition, scale, orientation, and geometry [11]. One of the most popular
techniques to produce collagen nanofibers is electrospinning. Electrospinning is a technique
where a polymeric solution is exposed to a high voltage by pumping the solution through a needle
attached to a high voltage power supply (Figure 4-1). The applied voltage generates an electric
field between the needle and a metallic collector in which a thin polymer fiber travels until
collected. The polymer solution flows through the needle forming in the tip a cone-like structure
(i.e. Taylor cone) produced by action of the electric field. Once the repulsive electrical force
overcomes the force of surface tension, a jet of electrically charged solution is expelled from the
tip of the Taylor cone. This jet travels to the metallic collector and as it moves in the air the solvent
evaporates, yielding polymeric nano-sized fibers [14]. The electrospinning process is controlled
by several parameters, which in turn control fiber structure. It has been shown—using synthetic
polymers—that fiber diameter depends on solution viscosity, applied voltage, flow rate,
temperature, humidity, and tip-to-collector distance, among others [15]. Moreover, fibers may be
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aligned by electrospinning onto a rotating collector [16]. Electrospun nanofibrous mats have been
shown to be ideal ECM mimetic scaffolds for the culture of mesenchymal stem cells [17], and
cells derived from different tissues such as neural [18], cardiac [19], and musculoskeletal [20].
Electrospinning of collagen is challenging due to its limited solubility. Several reports
successfully present electrospun collagen nanofibers from fluorinated solvents such as
trifluoroacetic acid [21], trifluoroethanol [22] and 1,1,1,3,3,3,-hexafluoro-2-propanol (HFIP)
[23][24][25][26]. However, fluorinated solvents disrupt collagen’s secondary structure [27][28],
effectively converting the electrospun collagen into gelatin [29]. In fact, one group reported a
decrease of 45% of collagen’s triple helical structure after electrospinning from HFIP [30]. Several
efforts to electrospun collagen from benign solvents have been proposed including blends with
other synthetic polymers [31][32], and a phosphate buffer and ethanol mixture [27]. Recently,
weak acids—such as acetic acid—have been proposed as an attractive solvent for the production
of collagen nanofibers because they are able to generate stable fibers with uniform morphology
that preserve collagen’s secondary structure [28][32][33][34][35][36][37].
Here we perform an exhaustive investigation on multiple properties and characteristics of
electrospun collagen nanofiber scaffolds that can be modified by changing the parameters of the
electrospinning process, using acetic acid as the solvent in the solution preparation. Adequate
conditions to successfully electrospun either randomly oriented or highly aligned collagen
nanofibers with a homogenous morphology, are presented. An investigation of fiber diameter and
alignment as a function of flow rate and voltage is also performed. We compare and contrast
crosslinking by immersion in a glutaraldehyde solution or exposure to gluteraldehyde vapor to
measure their mechanical properties. Lastly, we demonstrate that the produced collagen
nanofibers retain their secondary structure after electrospinning and crosslinking, and that they
support mammalian cell culture.
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4.3 Methodology
4.3.1 Materials
Lyophilized type I collagen sponges derived from cow tendon (generously donated by
Integra Lifesciences Holdings Corporation, Añasco, PR) was used for the fabrication of the
nanofibers. Ethanol, methanol, acetone, dichloromethane, glutaraldehyde (25%v/v) and acetic
acid (99.8%) were purchased from Acros Organic. Ultra-pure water at 18 MΩ was obtained from
a NANOPURE unit (Thermo scientific, Marietta, OH.). Cell culture media consisted of: Dulbecco’s
minimum essential medium (DMEM) containing 4500 mg/L dextrose & 4.0 mM L-glutamine
(Sigma), 10% calf serum (Bionalytica), 1% penicillin-streptomycin (Sigma), and 2.7 g/L of sodium
bicarbonate (Sigma). Phosphate buffered saline (PBS), formaldehyde, and Trypsin-EDTA (0.25%
Trypsin, and 0.53 mM EDTA) were purchased from Sigma. CellMask Deep Red plasma
membrane stain and SYTO 9 green fluorescent nucleic acid stain were purchased from Life
Technologies.
4.3.2 Solution Preparation
The solution was prepared by dissolving collagen in acetic acid (90% v/v in water) to a
final concentration of 20% w/v. The solution was stirred for 96 hours at room temperature. To
decrease the dissolution time, the solution was placed in a heating plate set at 60 °C for 3 hours,
followed by 33 hours of stirring at room temperature. Samples produced with and without solution
heating showed no discernable differences in their FTIR spectra. The collagen solution shear
viscosity was measured at 25 °C with an Anton Paar MCR302 rheometer using a plate-plate (25
mm) geometry and subjecting the sample to shear rates from 0.1 to 100 s -1. The gap between the
parallel plates was set to 0.8 mm. Three samples were tested to give the corresponding average
viscosity.
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4.3.3 Electrospinning Collagen
The electrospinning equipment consisted of a power supply (GAMMA, Ormond Beach,
FL), an injection pump (New Era, Farmingdale, NY), a rotating drum, a 3 mL Luer-lock syringe
(BDTM, VWR INTERNATIONAL), and a 23 gauge capillary steel needle of 1.5 inches in length
(CML Supply). The collagen solution was loaded in a plastic 3 mL syringe connected to a capillary
blunt type steel needle. The syringe was placed in the syringe pump, and the needle underneath
the grounded rotating drum collector at a distance of 10 cm (Figure 4-1A). The rotating drum
velocity was maintained at 1554 rpm. The positive pole of the high-voltage power supply was
connected to the needle and the negative pole to the rotating drum. The production of nanofibers
was obtained by action of the induced voltage and injection pump, which pushed the solution.
Initially, we produced nanofibers by electrospinning either at 1 mL/h or 5 mL/h of injection flow,
55% relative humidity, and a 47 kV supply. To investigate the effect of voltage and flow rate on
fiber diameter, we performed experiments using an injection flow from 0.5 mL/h to 3 mL/h, and a
voltage range from 25 to 45 kV, maintaining the humidity between 50 and 60%.

Figure 4-1. A) Schematic of the electrospinning process and B) experimental set up for the
crosslinking using glutaraldehyde vapor. Reprinted from Macromolecular Materials and
Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno
B., Loyo L., Shipmon J., Aldo A., and Almodovar J., Engineering of a Stable Collagen Nanofibrous
Scaffold with Tunable Fiber Diameter, Alignment, and Mechanical Properties, 1064-1075,
Copyright 2016, with permission from WILEY‐VCH Verlag GmbH & Co. KGaA.
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4.3.4 Fiber Diameter Study
The experimental setup for the study of the effect of voltage and flow rate on the nanofiber
diameter was as follows: each experiment was performed at 20 °C with a relative humidity
between 50 and 60%. Solutions were spun at a tip-to-collector distance of 10 cm. A quantity of 3
mL of solution was placed in the syringe and the electrospinning process was carried out for
voltages of 30, 35, 40 and 45 kV. The solutions were fed at rates of 0.5, 1, 1.5, 2, 2.5 and 3 mL/h.
The fibers were collected on aluminum rectangular screens, which were used as targets.
Electrospun collagen fiber mats were stored in clean paper bags at 20 °C inside a desiccator until
scanning electron microscopy (SEM) analysis. Micrographs from the SEM were digitized and
analyzed using the DiameterJ (National Institute of Standards and Technology, USA) plug-in in
ImageJ 1.47v (National Institutes of Health, USA) to determine the average fiber diameters.
DiameterJ is a validated plugin for the measurement of nanofiber diameters from SEM
micrographs [38].
4.3.5 Fiber Orientation
At several conditions, we noticed some degree of alignment of the nanofibers, thus a
directional analysis of the SEM images was performed using OrientationJ, a plug-in of ImageJ.
The normalized frequency histogram of fiber orientation was obtained and presented. We
measured the normalized orientation index (NOI), a widely used metric to quantify the extent of
orientation of fibrous materials [39]. NOI was calculated using Equation (1), where OI represents
the degrees that contains one-half of the total orientations from the most prevalent orientation
angle (POA) in both directions [38][39][40]. Thus, A NOI close to 0% or 100% indicates highly
oriented fibers, while a NOI close to 50% indicates random orientation.

NOI =

(90 - OI) 100%
90
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4.3.6 Glutaraldehyde Crosslinking
Crosslinking was performed on the collagen nanofibrous membrane using two methods:
1) immersion, which consisted on exposing the nanofibrous membrane to a solution of 25% (v/v)
glutaraldehyde for 1 min and 2) glutaraldehyde vapor, which consisted on transferring 40 mL of
25% (v/v) glutaraldehyde into a container, then placing the nanofibrous membrane on top of the
open container and sealing with the hollowed container cap to allow vapor flow for 18 hours (see
Figure 4-1B). Both methods were carried out inside a room at 55% humidity producing insoluble
nanofibers.
4.3.7 Scanning Electron Microscopy (SEM)
Nanofiber morphology was observed on a JEOL JSM-6390 scanning electron microscope
operated at 5 keV. The nanofibers were coated with gold using a Denton Vacuum Desk IV sputter
coater to improve the conductivity of the samples and thus the quality of the SEM images.
4.3.8 Fourier Transform Infrared (FT-IR) Spectroscopy
FT-IR was used to confirm the presence of the functional groups of type I collagen. The
infrared spectra of the samples were collected using an ALPHA Platinum Bruker with a Diamond
ATR holder within a wavenumber range of 600 to 1800 cm -1 using 300 scans at 2 cm-1 resolution.
4.3.9 Secondary Structure Determination
Secondary structure determination was based on the amide I band (1700–1600 cm-1),
which is commonly used to study the secondary structure of the proteins [41][42][43]. The second
derivative of the absorption data was calculated using the central differences algorithm from Igor
Pro 612A software (Wave Metrics, Portland, OR). From the resultant derivative spectra, peak
locations corresponding to the different components of the collagen’s secondary structure were
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identified. In order to quantify the contributions of each structure component, the amide I band
was deconvoluted using the multipeak fitting package under the Analysis tool of the Igor Pro
software. Initially, the software automatically displays two peaks. Such peaks are associated with
the two more pronounced negative bands from the second derivative spectra located at 1624 cm 1

and 1652 cm-1 and corresponding to the β-sheet and α-helix structure components respectively

[44]. Three additional structure contributions were manually assigned that corresponded to side
chains, unordered structures, and triple helix; all of them present in the secondary structure of
collagen [44][45]. The proportions of each structure component with respect to the amide I band
were calculated with the individual peak area over the total amide I peak area multiplied by 100.
After selecting a cubic mode as a baseline and a Gauss representation to fit the peaks, correct
peak area values were obtained by adjusting peak-by-peak their widths and heights while the
locations were kept fixed. The Gaussian peaks were allowed to be automatically adjusted such
that the sum of the peaks equals the raw IR data in the amide I region.
4.3.10 Mechanical Testing
Un-crosslinked and crosslinked collagen membranes were mechanically tested in tension
mode with an Instron ElectroPuls model E3000, at a crosshead speed of 1.0 mm/s, and using a
10 N load cell. Measurements for the un-crosslinked samples were performed at room
temperature whereas the crosslinked samples were submerged in deionized water and tested at
37  0.2°C using a BioPuls Temperature Controlled Bath. For each sample, a number of 5 to 10
specimens with dimensions of 4 mm x 14 mm x 1 mm approximately for the un-crosslinked
samples, and 6 mm x 25 mm x 0.3 mm for the crosslinked ones, were tested. The values for the
Young’s modulus (extracted from the slope of the stress-strain curve in a strain range of 0-10%),
the ultimate tensile strength, and elongation at break are reported as averages of multiple
samples with their corresponding standard deviation. All specimen dimensions were measured
with a digital micrometer (digital no. 500 195 30; Mitutoyo, Kawasaki, Japan).
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4.3.11 In-vitro Studies
3T3 fibroblasts were used to evaluate cellular adhesion on crosslinked electrospun
collagen scaffolds. Collagen nanofibers, crosslinked with 25% glutaraldehyde vapor, were cut
with a punch hole to fit wells of a 96-well plate. The membranes were hydrated with PBS overnight
prior sterilization using UV light. The samples were sterilized by exposing the membranes for 15
minutes of UV light on each side. 3T3 (from ATCC) fibroblasts cultured in growth medium (DMEM
+ 10% calf serum) were seeded on the sterilized samples at 5000 cells/well and incubated for 12
hours. Once the incubation time was reached, cells were stained using a mixture of 1:1000 in
culture media of SYTOX® Green Nucleic Acid Stain (500 Ex/520Em) and 3:1000 of CellMask™
Deep Red Cell Membrane (649Ex/667Em) purchased from Life Technologies (WI USA). The
staining process was during 15 minutes, and then the samples were washed with PBS. Images
were obtained with a spinning disk 3i System (Denver, CO, USA) Olympus IX81 confocal
microscope (Olympus America; PA, USA), equipped with a Xenon Fl source for visualization.
Images were captured using Rolera EM-C2 camera (SN:Q31153) (Quantitative Imaging
Corporation, NC, USA). The Slidebook 6.0 software was used for image acquisition. For SEM
evaluation, the membranes were washed three times with PBS, and then fixed with 200 µL of
3.7% formaldehyde in water for 15 minutes. The formaldehyde was removed; the samples were
rinsed with PBS, dehydrated using ethanol solutions of sequentially increasing concentration
(30%, 50%, 70%, and 100%), and further dried in a desiccator overnight. The samples were
observed in the SEM as mentioned above.
4.4 Results and Interpretation
4.4.1 Solution Preparation
A study was performed in order to determine which solvents were suitable for the
dissolution and successful formation of type I collagen nanofibers by electrospinning. Ethanol,
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methanol, acetone, dichloromethane and ultra-pure water were used to prepare solutions at 2%
w/v concentration. Although, a partially homogeneous solution using ultra-pure water was
obtained, this solution was not suitable for electrospinning due to its slow evaporation rate. To
improve the solution evaporation rate, we evaluated using a water/ethanol solution at different
ratios (1:0.3, 1:0.5, 1:0.8, 1:0.9 and 1:2). In this case collagen partially dissolved in water and was
progressively agglomerated with increasing ethanol content, as evidenced by the formation of two
phases. The other solvents (methanol, acetone, dichloromethane) failed to dissolve the
lyophilized collagen sponge. We investigated the use of acetic acid (HAc) as a non-aggressive
solvent in the preparation of collagen nanofibers. This mild solvent has been previously proposed
for the preparation of collagen nanofibers by electrospinning [28][32][35][36][37]. Kazanci shows
that solutions of 40% (w/v) collagen/HAc allowed for the deposition of wet fibers on the target with
poor morphology, because of the slow evaporation rate of the acid and its strong affinity with
collagen [28]. Chakrapani et al. reported that nanofibers of pure collagen were not possible to
obtain using HAc as the solvent [32]. However, they demonstrated that using polycaprolactone
(PCL) as a carrier polymer allowed for the formation of collagen/PCL nanofibers. They
investigated several ratios of collagen/PCL (75/25, 50/50 and 25/75 %w/w) and obtained
successful nanofibers formation with globular structures [32]. Recently, it has been proposed that
mixtures of acetic acid and dimethyl sulfoxide allowed for the formation of electrospun type I
collagen nanofibers [36][37]. Fiorani and colleagues successfully electrospun type I collagen from
acetic acid without the addition of any other component [35]. Interestingly, they demonstrate a
significant decrease in triple-helix content due to the electrospinning process [35].
In this work, we decided to prepare type I collagen solutions at multiple concentrations
(2%, 5%, 7%, & 10% (w/v)) in aqueous acetic acid (90% v/v). Our results indicated that is not
possible to fabricate nanofibers at these concentrations due to their low viscosity. On the other
hand, if the solution is highly concentrated and viscous, nanofibers cannot be formed because
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obstruction of the capillary [46]. A solution of 15% (w/v), showed positive results as indicated by
the formation of the Taylor cone. We achieved nanofiber formation using a concentration of 20%
(w/v), producing randomly oriented fibers (Figure 4-2). It is observed—and supported by the
literature [14]—that the viscosity of the suspension is directly related to the spinning ability, and
is an important parameter that aids in the confirmation of fiber formation prior to the
electrospinning process. The viscosity of the collagen suspension at 20% w/v showed a
Newtonian behavior (i.e. constant) with a value of 0.420 Pa.s, within the studied shear rate range
of 0.1 – 100 s-1.
4.4.2 Nanofiber Morphology
Nanofibers were electrospun and their morphology, size of diameter, and orientation were
assessed from SEM images. Fiber orientation was evaluated using the normalized orientation
index (NOI). A NOI close to 0% or 100% indicates highly oriented fibers, while a NOI close to 50%
indicates random orientation. Our results (Figure 4-2A, C) indicate that at a flow rate of 1 mL/h,
a voltage of 47 kV, and using a rotating mandrel as the collecter successfully produces randomly
oriented nanofibers (NOI equal to 58.8%) with an average diameter of 117 nm. When the flow
rate was increased to 5 mL/h the SEM image (Figure 4-2B, D) displayed an aligned nanofibrous
structure (NOI equal to 90%) with larger fiber diameter (average diameter 202 nm). These aligned
nanofibers can be useful to regenerate highly aligned tissues such as cardiac tissue [47]. The
difference in the samples at these two experimental conditions motivated us to investigate the
influence of voltage and flow rate in diameter and orientation of the nanofibers.
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Figure 4-2. A) Randomly oriented (Q = 1 mL/h, V = 47 kV) and B) highly aligned (Q = 5 mL/h, V
= 47 kV) nanofibrous collagen structure. (C-D) Orientation histogram corresponding to the random
and aligned nanofiber images showed in A and B, respectively. (POA: prevalent orientation angle,
OI: orientation index, NOI: normalized orientation index, AD: average diameter). E) Average fiber
diameter vs. applied voltage for fix flow rate of 1.5 mL/h. F) Average fiber diameter vs. flow rate
for fixed voltage at 45 kV. Values plotted and error bars in E & F correspond to the average and
standard error of 3 independent experiments, respectively. Reprinted from Macromolecular
Materials and Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V.
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Figure 4-2. (Cont.) Herrera‐Posada S., Calcagno B., Loyo L., Shipmon J., Aldo A., and
Almodovar J., Engineering of a Stable Collagen Nanofibrous Scaffold with Tunable Fiber
Diameter, Alignment, and Mechanical Properties, 1064-1075, Copyright 2016, with permission
from WILEY‐VCH Verlag GmbH & Co. KGaA.

4.4.3 Fiber Diameter Study
The influence of the applied voltage was examined maintaining constant the tip-tocollector distance at 10 cm, the flow rate at 1.5 mL/h and varying the voltage between 25 and 45
kV (Figure 4-2E). It can be confirmed that the diameter of the nanofibers decreases with the
increasing applied voltage, from approximately 400 to 200 nm for voltages from 25 to 45 kV. This
behavior demonstrates that high applied voltage enhances the degree of the instability of the jets
throughout the working distance [48]. In addition, since the feeding rate is low the droplet
suspended at the end of the spinneret is small and the electrospun fibers are dried before they
reached the collection drum. This effect results in uniform nanofiber morphology with no beadlike defects [49]. The tool used for obtaining the average diameters was able of to count between
29,634 and 63,736 data points per image, which provides better confidence in fiber diameter
measurements. The above results show that the amount of charge existing on the jet determines
diameter of the deposited nanofibers. An increase in applied voltage give rise to high electric field
on the surface of the solution drop at the needle tip. This allows greater elongation of the solution
drop due to the presence of major Coulomb force in the jet and a strong electric field. Thereby,
the jet diameter decreases during the elongation process and the fibers become thiner [50].
Regarding the study of the influence of flow rate on fiber diameter, our results are
presented in Figure 4-2F, where an increase in fiber diameter with increasing flow rate is
observed. Adjusting the flow rate we obtain fiber diameter in the range of 175 nm – 350 nm. This
behavior has been previously observed in other reports using synthetic polymers [50][51][52][53].
Megelski and colleagues investigated the effects of flow rate on the structure of electrospun fibers
from a polystyrene/tetrahydrofuran solution and reported that fiber diameter increased with
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increasing flow rate [54]. When flow rate is high, larger droplets are produced at the end of the
capillary causing the jet solution to be electrosprayed without any sufficient elongation. Thicker
fibers are obtained since the electric field strength is not capable of stretching the ejected solution
[49]. Our results shows that we can finely tune the diameter of the electrospun collagen
nanofibers, which might be useful in the regeneration of various types of tissues with different
scale.
4.4.4 Fiber Orientation
Our results demonstrate, that at certain electrospinning conditions a prevalent orientation
is observed (Figure 4-3). We evaluated NOI values of samples electrospun at varying flow rates
and observed an increase in alignment with increasing flow rate. NOI values of 64.4, 67.8 and
83.3% were obtained for flow rates of 1, 1.5, and 2.5 mL/h respectively (Figure 4-3). Figure 43D, 4-3E and 4-3F show that the area under the curve was increasingly narrow as the flow rate
increases indicating that the OI decreased with increasing flow rate. These results are interesting
because we did not add devices to the electrospinner, such as an external magnetic field at the
collector region, in order to align the nanofibers [53]. Although we used a rotating mandrel, our
initial electrospinning conditions indicated that the produced fibers had a random distribution
(Figure 4-2A). However, by simply adjusting the flow rate (while maintaining all other
electrospinning parameters constant) we are able to control the fiber alignment. We hypothesize
that this effect is due to the relative velocity of the fibers travelling through the electric field. At
higher flow rates, we expect that the fibers will be drawn with higher inertial forces such that it
follows the rotational speed of the target. Also, at higher velocities the fiber will have more unevaporated solvent possibly increasing the adhesion with the metallic collector and facilitating the
alignment. High fiber alignment is attractive for cardiac tissue engineering, as the ECM of such
tissue is highly aligned and organized [55]. An aligned scaffold can guide cell growth or tissue
regeneration. Xu and coworkers showed that the adhesion and proliferation rate of human
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coronary artery smooth muscle cells (SMCs) on the aligned nanofibrous scaffold was better than
on the plane polymer films [19]. The SMCs attached and migrated in the direction of the fiber
orientation and expressed a spindle-like contractile phenotype [19].

Figure 4-3. SEM images of collagen nanofibers A) Q=1 mL/h, B) Q=1.5 mL/h, C) Q=2.5 mL/h
mL/h. D-F) are their tilt angle distribution histograms. Reprinted from Macromolecular Materials
and Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S.,
Calcagno B., Loyo L., Shipmon J., Aldo A., and Almodovar J., Engineering of a Stable Collagen
Nanofibrous Scaffold with Tunable Fiber Diameter, Alignment, and Mechanical Properties, 10641075, Copyright 2016, with permission from WILEY‐VCH Verlag GmbH & Co. KGaA.

4.4.5 Crosslinking Nanofibers
Initially, we observed that the as-spun collagen scaffold was insoluble in water at room
temperature. However, the scaffold would disintegrate when exposed to an aqueous environment
at 37 °C. In order to improve its stability, we investigated the use of glutaraldehyde vapor from a
25% (v/v) solution as the crosslinking agent. Figure 4-4A shows a SEM image of nanofibers after
crosslinking treatment. Figure 4-4B displays the nanofiber morphology after exposing the
crosslinked nanofibers in a container of deionized water at a controlled temperature of 37 °C.
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Both images show that the integrity of the nanofibers is maintained. Crosslinking with
gluteraldehyde vapor renders the collagen fibers insoluble.

Figure 4-4. A) Crosslinked nanofibers with 25% glutaraldehyde vapor B) Crosslinked nanofibers
after exposure to water at 37 °C. Reprinted from Macromolecular Materials and Engineering, 301,
Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno B., Loyo L., Shipmon
J., Aldo A., and Almodovar J., Engineering of a Stable Collagen Nanofibrous Scaffold with
Tunable Fiber Diameter, Alignment, and Mechanical Properties, 1064-1075, Copyright 2016, with
permission from WILEY‐VCH Verlag GmbH & Co. KGaA.
4.4.6 Nanofibers Composition and Secondary Structure Analysis
FTIR spectroscopy was used to study changes in the secondary structure of type I
collagen. Peak assignment was performed between the 1,800–600 cm-1 spectral range [43].
Figure 4-5A shows the spectra of pure and electrospun collagen, while Figure 4-5B shows the
spectra of crosslinked collagen nanofibers. As comparison, we denaturalized the collagen
nanofibers by heating them in an oven at 200 °C for 2 hours with and without crosslinking
(denaturation temperature of type I collagen ~ 39.45 °C) [9].
In both Figure 4-5A and 4-5B, the characteristic bands of type I collagen are clearly
observed. On Figure 4-5A, the characteristic absorption peaks of collagen [56][57]—amide I
(1,700–1,600 cm−1), amide II (1,600–1,500 cm−1), and amide III (1,300–1,180 cm−1)—are present
for both pure collagen and electrospun collagen. The denatured collagen nanofibers exhibit a
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dramatic decrease of the amide I and II peaks, and the disappearance of the amide III region.
Figure 4-5B shows IR spectra of the as spun nanofibers, crosslinked nanofibers, and denatured
crosslinked nanofibers.

Figure 4-5. A) FTIR spectra of pure type I collagen sponge, electrospun collagen, and denatured
(200 °C treatment) collagen. B) FTIR spectra of electrospun collagen, crosslinked collagen
nanofibers, and denatured crosslinked collagen nanofibers (200 °C treatment). C) Amide I second
derivative spectra for the different treatments. D-F) Amide I peak fitting for: D) Pure collagen, E)
collagen nanofiber, and F) crosslinked collagen. Reprinted from Macromolecular Materials and
Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S.,
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Figure 4-5. (Cont.) Calcagno B., Loyo L., Shipmon J., Aldo A., and Almodovar J., Engineering of
a Stable Collagen Nanofibrous Scaffold with Tunable Fiber Diameter, Alignment, and Mechanical
Properties, 1064-1075, Copyright 2016, with permission from WILEY‐VCH Verlag GmbH & Co.
KGaA.
Upon crosslinking with glutaraldehyde vapor, we observe a preservation of the amide I, II,
and III peaks. The denatured crosslinked nanofibers show a decrease on the width of the amide
II peak and a slight decrease of the amide III peak. The data suggests that crosslinking protects
to some extent the degradation of the collagen nanofibers.
To evaluate changes in the secondary structure of type I collagen, the second derivative
of the amide I region from 1,700 to 1,600 cm -1 was obtained (Figure 4-5C). Second-derivative
spectrum has been widely used to determine the global secondary structure type where
appearances of the largest negative peaks are indicative of its presence in the protein [58].
Components of the secondary structure of type I collagen have been identified in the literature
within the amide I band as follows: α-like helix (1,658 cm-1), β-sheets (1,679, and 1,626 cm-1), βturns (1,691 and 1,669 cm -1), triple helix (1,637 cm -1), side chains (1,608 cm -1), and unordered
structure (1,647 cm-1) [59]. From the second derivative (Figure 4-5C) spectra we can identify four
main peaks representing different secondary structure components of pure collagen as follows:
1683 cm-1 (β-sheets), 1,652 cm-1 (α-helix), 1624 cm-1 (triple helix), and 1617 cm -1 (side chains)
[43][44][60][61]. Upon electrospinning and crosslinking, we observe that those main four peaks
are preserved, indicating that the secondary structure of collagen is maintained (see Figure 45C). However, we observe a decrease in the peak intensity at 1617 cm -1 indicating a loss in sidechain structures. We also observe a decrease of two secondary peaks located at 1624 cm -1 and
1628 cm-1 possibly indicating a loss in parallel β-sheets. The same trend is observed when the
fibers are heated to 200 °C.
To further assess changes in secondary structure and quantify these changes for the pure
collagen, electrospun, and crosslinked nanofibers, we performed a curve fitting analysis in the
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amide I region by fitting a number of Gaussian peaks such that the sum of the peaks will yield the
amide I band. The obtained peaks are then assigned to secondary structure components. Initial
estimates for the peak location were obtained from the second derivate spectra (Figure4- 5C)
[43]. Figure 4-5 (D-F) shows the corresponding curve-fittings. On Figure 4-5D we can observe
that the secondary structure of the type I collagen used in our experiments has absorption features
that could be attributed as follows: 1,655 cm -1 (α-helix), 1650 cm-1 (unordered) 1,637 cm- 1 (triple
helix), 1626 cm-1 (parallel β-sheets), and 1,613 cm-1 (side chains) [59][61]. These peaks were also
identified on electrospun and crosslinked collagen nanofibers with different widths and intensity,
indicating slight changes in structure. Figure 4-5E shows that the amide I region for the
electrospun collagen had a slight change in the 1660-1640 cm-1 interval, corresponding to the αhelix and unordered absorptions. An improvement from these changes was achieved after
crosslinking as observed on Figure 4-5F. The evaluations of the area under the curve of the
amide I band for each case is presented on Table 1. The analysis of the areas confirmed that the
changes for the different absorptions in the electrospun collagen presented an average variance
of 4.3% in comparison to the pure collagen. This percentage was reduced to 1.2% after
crosslinking the collagen nanofibers. Based on these results we can say that the solution
preparation, electrospinning process, and crosslinking method do not affect the secondary
structure of the type I collagen used.
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Table 4-1. Secondary structure calculation. Reprinted from Macromolecular Materials and
Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno
B., Loyo L., Shipmon J., Aldo A., and Almodovar J., Engineering of a Stable Collagen Nanofibrous
Scaffold with Tunable Fiber Diameter, Alignment, and Mechanical Properties, 1064-1075,
Copyright 2016, with permission from WILEY‐VCH Verlag GmbH & Co. KGaA.

Location

Component

Pure
collagen
%

Nanofibers
%

Crosslinked
nanofibers
%

1613.2

β-turns

16.49

18.61

18.78

1626.4

β-sheets

21.09

26.27

19.68

1637.3

triple helix

18.92

21.01

18.54

1650.6

unordered

31.11

23.28

29.84

1655.0

α-helix

12.40

10.85

13.17

4.4.7 Nanofibers Mechanical Properties
The extracellular environment plays an important role on the behavior of tissues and cells
and the success of implants or scaffolds for tissue regeneration relies, amongst many other
factors, on the knowledge of their mechanical properties. In this regard, the electrospun collagen
membranes stiffness (Young’s modulus), which is a measure of the resistance of a material to
elastic deformation, the ultimate tensile strength (UTS) or maximum load under tension, and the
elongation at break were characterized. In order to provide conditions that were similar to the cell
environment, tensile experiments were performed in a temperature-controlled bio-bath (body
temperature). However, randomly oriented un-crosslinked samples dissolved in contact with
water, which is the reason as to why they were tested at room temperature in air. Results showed
that at these conditions, un-crosslinked samples undergo plastic deformation upon uniaxial
extension up to 55 ± 19% strain, having a tensile strength of 1.7 ± 0.3 MPa and stiffness or
Young’s modulus of 12.2 ± 3.3 MPa. While the elasticity modulus is in the range of some soft
tissues such as the articular cartilage (5-25 MPa) [62], the instability in aqueous environments is
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a limitation from an applicability point of view. To overcome this limitation, collagen membranes
were crosslinked as previously described by two methods, in the presence of glutaraldehyde
vapor and by immersion into a glutaraldehyde solution.

Figure 4-6. Representative stress-strain curves (displacement rate of 1 mm/s) of the collagen
membranes. Reprinted from Macromolecular Materials and Engineering, 301, Castilla-Casadiego
D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno B., Loyo L., Shipmon J., Aldo A., and
Almodovar J., Engineering of a Stable Collagen Nanofibrous Scaffold with Tunable Fiber
Diameter, Alignment, and Mechanical Properties, 1064-1075, Copyright 2016, with permission
from WILEY‐VCH Verlag GmbH & Co. KGaA.
On Figure 4-6, representative stress-strain curves are presented for the crosslinked
samples. It can be noticed from stress-strain behavior, that the crosslinking leads to materials
with an elasticity modulus in the range of 2.7 to 4.1 MPa (see Table 4-2), being the highest one
for the crosslinked by immersion in glutaraldehyde. The average tensile strength and maximum
deformation compared to the un-crosslinked samples are lower, whereas there is no significant
difference on these properties for the two-crosslinking methods. Current research on mechanical
properties of un-crosslinked aligned collagen type I scaffolds prepared by electrospinning
technique have reported stiffness of 52.3 and 26.1 MPa parallel and perpendicular to the fibers
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orientation axis respectively, and ultimate tensile strength of 1.5 and 0.7 MPa parallel and
perpendicular as well, measured at room temperature conditions under tension [23]. Both the uncrosslinked and crosslinked collagen scaffolds presented in this work are more compliant showing
large deformation percentages. Additionally, crosslinked membranes were stable in water at body
temperature, which is crucial for implants and tissue regeneration purposes and according to the
results; these membranes also have mechanical properties in the range of native articular
cartilage [63].

Table 4-2. Mechanical properties of collagen membranes. Reprinted from Macromolecular
Materials and Engineering, 301, Castilla-Casadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada
S., Calcagno B., Loyo L., Shipmon J., Aldo A., and Almodovar J., Engineering of a Stable Collagen
Nanofibrous Scaffold with Tunable Fiber Diameter, Alignment, and Mechanical Properties, 10641075, Copyright 2016, with permission from WILEY‐VCH Verlag GmbH & Co. KGaA.

Young's
Modulus
(MPa)

UTS
(MPa)

Elongation
at Break
(%)

Crosslinked
4.1 ± 0.5
by immersion

1.0 ± 0.4

29 ± 15

Crosslinked
by vapor

0.9 ± 0.2

38 ± 7

2.7 ± 0.7

4.4.8 In-vitro Cellular Evaluation
3T3 cells were cultured on electrospun collagen nanofiber mats, crosslinked with
gluteraldehyde vapor, for a period of 12 hours. After the culture period, the fiber mats were
observed under a fluorescence microscope and SEM to evaluate cellular attachment and
morphology. Figure 4-7 shows the results of the in-vitro study. The crosslinked electrospun
collagen scaffold retains its morphology after cellular culture in cell culture media with calf serum
at 37 °C (Figure 4-7A). The fibrous structure is well preserved as evident by the section of the
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scaffold that was in contact with the bottom of the well, i.e. that was not in contact with cells
(Figure 4-7C). Cell nuclei and membrane were stained and imaged (Figure 4-7B).

Figure 4-7. In-vitro cellular evaluation of nanofibers. A) Macroscopic image of the collagen
scaffold after 12 hours of cell culture. B) fluorescent microscopy images of 3T3 fibroblasts (green:
nuclei) cultured on collagen nanofibers (red). C) SEM micrograph of bottom of nanofibers that
were not in contact with cells. The nanofibrous structure is preserved after cell culture. D) SEM
micrograph of fibroblasts cultured on collagen nanofibers after 24 hours. E & F) SEM micrograps
of fibroblasts cultured for 3 weeks. Fiber integrity is maintained after 3 weeks of culture.
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Figure 4-7. (Cont.) Reprinted from Macromolecular Materials and Engineering, 301, CastillaCasadiego D. A., Ramos‐Avilez H. V., Herrera‐Posada S., Calcagno B., Loyo L., Shipmon J.,
Aldo A., and Almodovar J., Engineering of a Stable Collagen Nanofibrous Scaffold with Tunable
Fiber Diameter, Alignment, and Mechanical Properties, 1064-1075, Copyright 2016, with
permission from WILEY‐VCH Verlag GmbH & Co. KGaA.

Figure 4-7B shows a high number of cells attached to the collagen scaffold. However, the
cell membrane was not clearly observed. Instead, it appears as if the membrane dye stained the
collagen nanofibers. Thus, in order to evaluate cell morphology, we used SEM. Figure 4-7D
shows a high number of cells per area with a spindle-like morphology. We extended the culture
period for 3 weeks, and we observed that fibroblasts survive and proliferate the electrospun
collagen fibers, while the fibers maintain their integrity (Figures 4-7 E & F). These results show
that the electrospun collagen scaffolds support mammalian cell culture, indicating that these ECM
mimetic structures might be suitable for tissue engineering applications.
4.5 Conclusions
This work shows the preparation of a highly versatile type I collagen-based ECM mimetic
environment with control diameter, mechanical properties, morphology, and orientation, using the
electrospinning technique that has a potential for industrial upscaling [64]. The secondary
structure of collagen was successfully preserved when using acetic acid as the solvent. We were
able to modulate the fiber diameter in a range of approximately 175 – 400 nm by adjusting the
injection flow or the voltage. Nanofiber alignment increased with increasing injection flow rate,
which could be useful to serve as a scaffold for highly aligned tissues, such as cardiac tissue. We
observed that solution preparation, electrospinning process, and crosslinking methods, do not
significantly alter the secondary structure of collagen. Crosslinked membranes were stable in an
aqueous environment at body temperature, which is crucial for implants and tissue regeneration
purposes. According to our results, membranes obtained have mechanical properties in the range
of native tissues. The elastic modulus could be modulated in the range of 2.7 to 4.1 MPa by the
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selection of the crosslinking method. Lastly, an in-vitro study demonstrated that the nanofibrous
collagen scaffold supports mammalian cell culture, indicating potential promise in field of the
tissue engineering. Future work includes decorating these collagen nanofibers with biochemical
cues to induce tissue formation.
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CHAPTER 5.

“Green” Electrospinning of a Collagen/Hydroxyapatite Composite

Nanofibrous Scaffold

5.1 Abstract
In this work, composite nanofibers of collagen/hydroxyapatite were prepared by
electrospinning using mild solvents. Hydroxyapatite particles dispersed into a collagen/acetic
acid/water solution is electrospun to yield composite nanofibers. Scanning electron microscopy
reveals nanofibers with an average diameter of 342 ± 67 nm, and a rough surface brought upon
by the hydroxyapatite particles. Both X-ray and infrared spectroscopy confirms the presence of
the hydroxyapatite particles embedded in the collagen fibers. The inclusion of hydroxyapatite
particles does not alter the native collagen structure. Lastly, these composite nanofibers support
pre-osteoblast adhesion. These results showed how “green” electrospinning could be used to
generate nanocomposite scaffolds with potential biomedical applications.
5.2 Introduction
Electrospinning has quickly grown as an attractive method to generate polymeric
nanofibrous mats to be used for applications in biomedical engineering and tissue regeneration
[1]. Electrospinning offers the capacity of replicating the morphological characteristics of tissue
matrix in chemistry, mechanical properties, orientation, geometry, and scale [2][3]. The versatility
of this technique allows for the fine-tuning of the final properties of the scaffold by controlling the
different operational variables [4]. Electrospinning can be performed of biopolymers—including
proteins and polysaccharides—in order to replicate native soft tissues [4]. Moreover, the
electrospinning process allows for the inclusion of inorganic particles to obtain composite
nanofibers, opening the possibility of fabricating scaffolds that mimic mineralized tissues, such as
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bone. However, electrospinning of biopolymers, is challenging due to their limited solubility in
ideal electrospinning toxic solvents.
Collagen, which is the most abundant protein in the extracellular matrix (ECM) of human
tissues, has been previously electrospun from toxic solvents such as trifluoroacetic acid [5], and
1,1,1,3,3,3,-hexafluoro-2-propanol [6]. Although nanofibers are produced with these solvents,
they tend to denature the collagen, yielding a gelatinous scaffold [7]. Moreover, the use of these
solvents poses a risk to the manufacturer as toxic fumes are produced, requiring extra care and
proper facilities when performing the electrospinning process. Lastly, extensive post-processing
procedures must be performed to remove solvent traces prior contact with any biological agent.
To avoid problems associated with using harsh solvents, investigators have focused on
fabricating electrospun scaffolds using mild “green” solvents [8][9]. Recently, several researchers
[10][11][12][13][14] and our work [15] have demonstrated the formation of electrospun collagen
nanofibers using acetic acid as a mild solvent. The advantage of using acetic acid as an
electrospinning solvent for collagen is that it preserves the secondary structure of collagen [15].
Moreover, we have previously demonstrated that by adjusting the voltage or the flow rate, the
diameter and orientation of the electrospun collagen nanofibers can be adequately controlled. We
obtained a collagen nanofiber diameter ranging from 150 to 400 nm, by operating the
electrospinning equipment at conditions involving an applied voltage between 25 and 45 kV and
a solution flow rate of 0.5–3 mL/h [15]. We also demonstrated that it is possible to modulate the
elastic modulus of the nanofibers in the range of 2.7–4.1 MPa, by the selection of the crosslinking
method [15].
Electrospinning of composite inorganic/polymeric scaffolds for biomedical applications
also suffers from the same limitations of the requirement of harsh solvents. A
collagen/hydroxyapatite (COL/HA) electrospun scaffold would be ideal for bone tissue
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engineering applications, since the ECM of bone is composed of an organic phase (elastic
proteins that provide fracture resistance) and a mineral phase (inorganic mineral that contributes
to the rigidity in bones). The organic matrix of bone is composed of structural proteins, such as
collagen, which corresponds to 90% of the total protein content in bone ECM [16]. Of the different
types of collagen, the most abundant in bone tissue is type I collagen [16]. Its mineral phase,
which represents 70% - 90% of the bone, is primarily composed of hydroxyapatite [16].
Initial reports to produce electrospun COL/HA nanofibrous scaffolds use highly toxic
fluorinated solvents [17][18][19]. The use of these solvents limits the potential application of these
scaffolds in tissue engineering. Another approach to prepare COL/HA nanofibers is to include a
carrier polymer to aid during the electrospinning process. COL/HA blended with chitosan [20] and
polyvinyl alcohol [21][22] have been previously reported. As a way to overcome the limitations of
fabricating electrospun, COL/HA nanofibers using toxic solvents, Li and co-workers recently
fabricated a nanofibrous mat using a phosphate buffered saline/ ethanol mixture as the
electrospinning solvent [23]. They obtained a collagen nanofibrous scaffold with preserved
secondary structure and a fiber diameter range of 500–820 nm.
In this work, we demonstrate a simpler and more efficient way of producing COL/HA
nanofibers with a diameter of approximately 342 ± 67 nm using acetic acid and water as a “green”
electrospinning solvent. This formulation yields a nanofibrous structure, that maintains collagen’s
chemical structure, and that supports pre-osteoblast adhesion. This work highlights the potential
of acetic acid as a “green” solvent for the fabrication of a collagen composite scaffold with possible
biomedical applications.
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5.3 Methodology
5.3.1 Materials
Acetic acid (Acros Organics) was prepared at 90% v/v diluted in ultra-pure water at 18 MΩ
(NANOPURE unit, Thermo scientific, Marietta, OH.). The electrospinning solution consisted of
10% w/v of hydroxyapatite nanopowder with a particle size of “<200 nm” (Sigma Aldrich) and 20%
w/v of lyophilized type I collagen from cow tendons (generously donated by Integra LifeSciences
Holdings Corporation, Añasco, PR) dissolved in 90% v/v acetic acid.
5.3.2 Solution Preparation
A solution containing 10% (w/v) hydroxyapatite nanopowder in 90% (v/v) acetic acid was
first heated to 90 °C for 5 min with constant agitation at 125 rpm. The collagen was then added
slowly in small pieces to the heated solution and allowed to stand under constant agitation for 90
min for a final collagen concentration of 20% (w/v).
5.3.3 Electrospinning Collagen/Hydroxyapatite
The prepared electrospinning solution was loaded into a 3 mL luerlock syringe (BD TM,
VWR International) with a blunt end nozzle, controlled by a syringe pump (Model No. ne-300,
Farmingdale, NY, USA). The solution was pumped through a capillary blunt steel 23-gauge
needle (CML Supply). The needle was connected to the positive output of a high-voltage power
supply (Gamma High, Ormond Beach, FL). To collect the nanofibers, a rotational drum was
wrapped with aluminum foil and located at a fixed distance of 10 cm from the needle. The flow
rate of the solution, humidity, applied voltage, and spinning time were fixed at 3 mL/h, 55%, 45
kV, and 3 h, respectively, at a temperature of 20°C. The resulting membrane was crosslinked for
24 h using glutaraldehyde vapor from a 25% (v/v) glutaraldehyde solution as described in our
earlier work [15].
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5.3.4

Scanning

Electron

Microscopy

(SEM)

and

Energy-dispersive

X-ray

spectroscopy (EDAX)
A JEOL JSM-6390 Scanning Electron Microscope (SEM) operated at 10 keV was used to
evaluate nanofiber morphology and pre-osteoblast adhesion. The nanofibers were coated with
gold using a Denton Vacuum Desk IV sputter coater to improve conductivity. The instrument was
placed in energy-dispersive X-ray spectroscopy (EDAX) mode to analyze the chemistry and the
distribution of HA in the collagen nanofiber.
5.3.5 Fourier Transform Infrared (FT-IR) Spectroscopy and Particle Size Analyzer
FT-IR was used to confirm the presence of the functional groups of type I collagen and
HA. The infrared spectra of the samples were collected using an ALPHA Platinum Bruker with a
Diamond ATR holder with a wavenumber range of 500 to 1800 cm -1 using 300 scans at 4 cm-1
resolution. The diameter of the as-received HA particles was evaluated using a Particle Size
Analyzer (NanoBrook 90Plus, Brookhaven Instruments).
5.3.6 In-vitro Studies
An in-vitro study was conducted to observe cellular adhesion over the COL/HA crosslinked
nanofibrous scaffold using rat pre-osteoblasts MC3T3-E1 (ATCC, Manassas, VA). The MC3T3
subline of cells was used in this work, because it has been categorized as a model system in the
biology of bone tissue, and because of its potential to differentiate towards the osteogenic lineage
[24]. COL/HA scaffolds, crosslinked with 25% glutaraldehyde vapor, were cut with a punch hole
to fit wells of a 96-well plate. The membranes were washed with PBS overnight prior sterilization
using UV light. MC3T3-E1 cells were cultured in growth medium MEM Alpha (1X) with 10%
Gibco® calf serum and later seeded on the sterilized samples at 5000 cells/well and incubated for
24 hours at 37 ºC and 5% CO2. Once the incubation period was completed, the cells were fixed
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depositing 200 µl/well of formaldehyde at a concentration of 3.7% and subjected to
immunofluorescent labeling by staining the nucleus using the nuclear stain Hoechst. The
fluorescent images were captured using an Olympus IX71 confocal microscope (Olympus
America; PA, USA). For SEM evaluation, the samples were fixed with 3.7% formaldehyde,
dehydrated using ethanol solutions of sequentially increasing concentration (30%, 50%, 70%, and
100%), and further dried in a desiccator overnight. The samples were observed in the SEM as
mentioned above.
5.4 Results and Interpretation
5.4.1 Nanofiber Morphology
The SEM images presented in Figure 5-1 reveals the as-spun collagen nanofibrous mat
without HA (Figure 5-1A and 5-1B) and that we can successfully electrospun the COL/HA
solution to yield a nanofibrous composite mat (Figure 5-1C and 5-1D). On comparing the images,
it is evident that the surface of the COL/HA nanofiber mat is drastically altered by inclusion of
hydroxyapatite (Figure 5-1C). An increase in roughness of the previously smooth collagen fibers.
At higher magnifications, we can observe the distribution of the HA nanoparticles within the
nanofibrous scaffold (Figure 5-1D), in which larger particles are embedded within the fibers, while
smaller particles decorate the surface of the fiber. In Figure 5-1D, the different diameters of the
hydroxyapatite particles (acquired from Sigma Aldrich, manufacturer reports sizes less than 200
nm) can be appreciated. We evaluated the diameter of the HA as received using a particle size
analyzer, and we observed two distinctive populations with respect to particle diameter (Figure
5-1F). We observe a population with an average diameter of about 149 nm, and a smaller
population with an average diameter of about 448 nm. This distribution is in agreement with the
size of the HA particles in the COL/HA fibers (Figure 5-1D) and in accord with the particles
dispersed in an SEM stub and imaged (Figure 5-1E). Using ImageJ®, we compared changes in
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fiber diameter as a result of the addition of HA. We observed that, under the operating conditions
described in the methodology, as-spun collagen fibers without HA yields an average diameter of
142 ± 73 nm, while the addition of HA causes an increase in the average diameter to 342 ± 67
nm. However, the average diameter of the collagen nanofibers may be modulated by varying the
electrospinning operating conditions. We were able to modulate the ﬁber diameter and alignment
by adjusting the injection ﬂow or the voltage [15].
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Figure 5-1. Morphology of nanofibers with 3mL of injection flow and 47kV of power supply.
A) Collagen nanofibers (X5500 magnification) B) Collagen nanofibers (X11000 magnification) C)
Collagen/hydroxyapatite nanofibers (X5500 magnification) D) Collagen/hydroxyapatite
nanofibers (X11000 magnification) E) Morphology of hydroxyapatite dispersed on a SEM stub,
inset represents higher magnification (X16000 magnification), arrows indicate HA particles of
smaller and larger diameter F) Size distribution of the hydroxyapatite nanoparticles as determined
by DLS. Reprinted from MRS Communications, 6, Castilla-Casadiego D. A., Maldonado M.,
Sundaram P., and Almodovar J., “Green” electrospinning of a collagen/hydroxyapatite composite
nanofibrous scaffold, 402-407, Copyright 2016, with permission from Cambridge.
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5.4.2 Nanofibers Composition
The FTIR studies confirmed that the characteristic bands of type I collagen and HA were
clearly present, after the nanofiber fabrication process. In Figure 5-2A, the characteristic
absorption peaks of collagen can be observed including the amide I (1,700 – 1600 cm−1), amide
II (1,600 – 1,500 cm−1), and amide III (1,300 – 1,180 cm−1) for both pure and electrospun collagen
[15][25]. The HA particles exhibit absorptions bands corresponding to the phosphate PO4-3 (900
– 1100 cm−1 and 500 – 650 cm−1) [26] and carbonate (CO3-2), (877 cm−1 and 1400 – 1500 cm−1
[18][26]) groups. These characteristic peaks of HA were present in the COL/HA nanofibers
spectra, thus confirming the inclusion of the HA particles within the collagen nanofibrous scaffold.
In order to use the nanofibrous scaffold for cell culture, it must be crosslinked to a small degree
to avoid instantaneous dissolution. We have previously demonstrated a methodology for
crosslinking collagen nanofibers by exposure to glutaraldehyde vapor from a 25% w/v solution
[15]. In this work, we crosslinked the COL/HA composite nanofibers by exposing the sample to
glutaraldehyde vapor from a 25% w/v solution. FTIR confirms (Figure 5-2A) that the crosslinking
procedure did not affect the chemical structure of the native collagen or the HA. SEM reveals that
the fibrillar structure of the COL/HA fibers is maintained after crosslinking (Figure 5-3A).
EDAX was used to observe the distribution of HA in the collagen nanofiber. The results
reveal that calcium and phosphorus elements were present on the nanofiber surface. Spectra in
Figure 5-2B reveal that the peaks at 2 keV refer to P and the peak at 3.7 keV to Ca [18][27].
Elemental analysis yields a Ca:P ratio of 1.74 which is close to that expected for HA [28].
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Figure 5-2. Chemical Composition. A) Infrared spectra of hydroxyapatite nanoparticles, collagen
nanofibers, COL/HA nanofibers with and without crosslinking. B) EDAX spectrum of COL/HA
nanofibers. Reprinted from MRS Communications, 6, Castilla-Casadiego D. A., Maldonado M.,
Sundaram P., and Almodovar J., “Green” electrospinning of a collagen/hydroxyapatite composite
nanofibrous scaffold, 402-407, Copyright 2016, with permission from Cambridge.

5.4.3 In-vitro Cellular Evaluation
To demonstrate that the fabricated COL/HA scaffold supports cell adhesion, MC3T3-E1
cells were cultured on the scaffold. For these experiments, 5000 cells were seeded in wells
containing the crosslinked COL/HA scaffold. In Figure 5-3B, the SEM image demonstrates that
cells adhere well to the COL/HA scaffold after 24 hours of culture. Figure 5-3C shows a
fluorescent image of MC3T3-E1 cell nuclei stained with Hoescht. Counting the cells adhered per
area, we estimate that 50% of the initial amount seeded successfully adhered on the COL/ HA
scaffold. These results are in agreement with our previous results that demonstrate that
electrospun collagen scaffolds support fibroblast cell culture [15].
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Figure 5-3. (a) SEM micrograph of COL/HA nanofibers after glutaraldehyde crosslinking. (b) SEM
micrograph of MC3T3-E1 pre-osteoblast cultured on a COL/HA nanofibrous scaffold. (c)
Fluorescent image of MC3T3-E1, cultured on a COL/HA, cell nucleus staining (scale 200 µm).
Reprinted from MRS Communications, 6, Castilla-Casadiego D. A., Maldonado M., Sundaram P.,
and Almodovar J., “Green” electrospinning of a collagen/hydroxyapatite composite nanofibrous
scaffold, 402-407, Copyright 2016, with permission from Cambridge.

The inclusion of HA on collagen scaffolds is ideal given that HA promotes osteoblastic
matrix formation as well as pre-osteoblast and mesenchymal stem cell differentiation [29][30].
Incorporating HA into electrospun collagen nanofibers using a “green” solvent may lead to
solutions in bone regeneration as an ECM bone mimetic structure containing both an organic and
a mineral phase with similar chemistry, morphology, and mechanical cues as that of native ECM.
5.5 Conclusions
Our results demonstrate a new and simple methodology to prepare a composite COL/HA
nanofibrous scaffold using an acetic acid/water solution as a “green” solvent. SEM revealed the
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stability of the developed nanofibers, with an average diameter of 342 ± 67 nm. We were able to
demonstrate that these nanofibers preserve the chemical composition in the organic phase as
well as in the mineral phase. HA particles either decorated the surface of the fibers, or appear to
be embedded within the fibers. This phenomenon was observed to be dependent on the diameter
of the particle. In-vitro studies with pre-osteoblasts showed the ability of the cells to adhere to the
nanofibrous scaffold, which indicates that this non-toxic ECM mimetic structure of bone tissue
could be useful in tissue regeneration.
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CHAPTER 6.

Design, Characterization, and Modeling of a Chitosan Microneedle

Patch for Transdermal Delivery of Meloxicam as a Pain Management Strategy for
Use in Cattle

6.1 Abstract
This work describes the formulation and evaluation of a chitosan microneedle patch for the
transdermal delivery of meloxicam to manage pain in cattle. Microneedle patches composed of
chitosan and chitosan/meloxicam were evaluated regarding their chemical composition,
uniformity of physical characteristics, capacity to penetrate the skin, and response to thermal and
thermo-mechanical changes. Microneedle patches were prepared by varying the percentage of
acetic acid used during solution preparation, including 90% (v/v), 50% (v/v), and 10% (v/v). In
addition, drug release was assessed by modeling different percentages of penetration into the
skin and the number of microneedles on the microneedle patch. Scanning electron microscopy
confirmed the presence of microneedles uniformly organized on the patch surface for each
percentage of acetic acid used. Fourier transform infrared spectroscopy revealed that 10% (v/v)
of acetic acid in the solution was a suitable condition to preserve the characteristic bands of
chitosan (amide I and amide II) and meloxicam (amine N-H stretch and C=O stretch) as compared
to 90% (v/v) and 50% (v/v) of acetic acid used during the solution preparation. The resultant
microneedle patches were successful in penetrating the skin in a cow’s cadaver ear. Results
demonstrated that the average depth penetration measured after complete dehydration of the
penetrated skin was approximately 78 ± 1 μm. Chitosan and chitosan/meloxicam microneedle
patches with higher acetic acid percentages reflected greater resistance to compressive force as
temperature increased. Time-dependent simulation of the transport of diluted species by
COMSOL revealed that the transdermal drug delivery increases in function to the increment of
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the number of microneedles on the surface patch and percentage of penetration per microneedle.
One patch released a drug concentration of 3.57 × 10 -5 mol/m3 in the skin per week, which
represents the 26.2% of what is needed for pain management in cattle, established as 1.43 × 104

mol/m3. These results demonstrate that chitosan/meloxicam microneedles patches may be

suitable to manage pain in cattle after routine procedures.
6.2 Introduction
The term “animal welfare” refers to the relationships that people have with animals, specifically
related to the duty of ensuring that the animals under human care are treated compassionately
and responsibly [1]. Nowadays, this term is being used increasingly by a significant percentage
of society, including companies, consumers, transporters, veterinarians, scientists, and politicians
[2]. Countries including Canada, United States, Australia, and Belgium have amply demonstrated
interest in farm animal welfare, reporting concerns during routine animal management practices
such as castration, dehorning, and tail docking in cattle [2]. In the United States, dairy producers
have recognized that these practices are painful, but analgesia is rarely provided [2][3][4]. One
survey of cattle veterinarians showed that only 52.9% of surveyed veterinarians provided
analgesia during the castration of cattle older than six months [5]. As consumer awareness of
animal welfare increases, the need for veterinarians and cattle producers to address animal pain
mitigation also grows [2]. Pain management for livestock has become an important issue for
organizations like the American Veterinary Medical Association (AVMA), which is now
encouraging the use of pain relief during routine management practices in cattle [6]. Nevertheless,
few pain medications exist commercially that are Food and Drug Administration (FDA)-approved
for use in cattle.

The one FDA-approved pain management medication for livestock animals is flunixin
meglumine, which is a non-steroidal, anti-inflammatory drug (NSAID). A significant issue with
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flunixin meglumine is the degradation half-life, which is only 6.2 hours, and its administration by
injection or topical application every 12 to 24 hours to maintain analgesia [7]. However, many
livestock animals are not handled daily, and the need for frequent handling often results in added
stress for the animals and reduce the number of producers willing to use pain relievers. With postsurgical pain sensation occurring over an extended period of time, pain control therapy is best
applied over an extended period of time. However, no veterinary products with extended
analgesic activity currently exist for livestock in the United States [8]. Meloxicam is a promising
NSAID alternative, with a relatively long half-life of 28 hours. Currently, meloxicam is FDAapproved and routinely prescribed for pain mitigation in other veterinary species (i.e., dogs and
cats) [9]. Meloxicam is approved as an analgesic for cattle in the European Union and Canada,
where it is used for the alleviation of pain [10]. Administration of meloxicam results in systemic
analgesia and reduced inflammation. Studies demonstrate that the maximum blood serum
concentration of oral meloxicam dosed at 1 mg/kg ranged from 12 to 24 hours, which is a
significant increase over flunixin meglumine [11][12]. Unfortunately, meloxicam delivery to
animals is given orally through suspension or tablet form, which is not amenable for long-term
livestock analgesia [8].

This work proposes that a better approach for livestock drug delivery is through transdermal
application with polymeric microneedle patches. A microneedle patch is a platform composed of
needles uniformly organized and designed to painlessly penetrate the skin at a controlled depth,
avoiding stimulation of nerve endings [13]. These patches will be loaded with meloxicam cargo
that will be released in the skin and delivered to the site of action by capillaries or lymphatic
networks [13].

Microneedle patches have been constructed from different types of materials (e.g., silicon,
metals, ceramics) [14]; however, polymeric microneedle patches have been demonstrated to
provide better chemistry and mechanical properties [14]. In particular, the use of low-cost
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polymers such as chitosan [15] or starch [16] provide a promising material platform for drug
delivery and time-release mechanisms (i.e., through polymer degradation, polymer morphology,
or polymer chemistry). Chitosan, which is a derivative of chitin, is a polymer that has provoked
the interest of scientists around the world for its potential for biomedical applications. Because of
its characteristics, like biocompatibility, nontoxicity, polycationic properties, biodegradable ability,
and antibacterial properties, chitosan has demonstrated its ability to significantly improve cell
activities such as adhesion, proliferation, differentiation, and reduce the risk of infection in
fabricating or coating implants [17]. Studies have demonstrated that drugs embedded in chitosan
platforms are released through swelling and degradation of the chitosan matrix, which can be
seen as a sustained-release effect [18][15]. Since chitosan is a natural biodegradable biopolymer,
it goes through the process of enzymatic transformation to basic, non-toxic components. In vivo,
lysozyme degrades chitosan, producing non-toxic oligosaccharides, which can be then excreted
or incorporated to glycosoaminoglycans and glycoproteins [19]. However, in-vitro, chitosan can
be degraded via oxidation, chemical, or enzymatic hydrolysis reactions [20]. The process of
degradation usually begins with the random splitting of β-1,4-glycosidic bonds (depolymerization)
followed by N-acetyl linkage (deacetylation). The degradation of chitosan dependent on its
molecular weight, deacetylation degree, polydispersity, purity level, and moisture content [21].
Other in-vitro and in-vivo studies have reported that the kidney can clear the chitosan only if this
has a suitable molecular weight (3-50 kDa). Chitosan of excessive molecular weight (310–600
kDa) can be degraded by proteases into fragments proper for renal clearance [15]. For this
reason, chitosan has been amply used for producing solutions, hydrogels, fibers, powder, films,
fabrics, nano/microparticles, and sponges [17]. Similarly, chitosan-based [15][22] microneedle
patches have been successfully proposed as a drug delivery method for humans [14], yet little
work has been proposed in the development of micro-patches for veterinary applications.

217

This study engineered and tested the physical, chemical, thermal, and mechanical thermal
properties, and the microneedle insertion abilities in cow’s ear cadaver skin of a chitosan-based
polymeric microneedle patch for the transdermal delivery of meloxicam as a pain management
approach for use in cattle. The microneedle patch consisted of 225 microneedles with 600 µm of
height and 300 µm of base uniformly organized on an area of 8 mm x 8 mm, as shown in Figure
6-1 A-D. Additionally, drug release was evaluated by modeling different percentages of
penetration into the skin and the number of microneedles on the microneedle patch. As shown in
Figure 6-1 E, the penetration of the microneedles is through the epidermis and dermis where the
microneedle degradation and, consequently, the drug release begins. This approach will help
expand the use of the FDA-approved meloxicam in the pharmaceutical field as a pain
management medication for livestock animals.
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Figure 6-1. Schematic view and transdermal drug delivery of a microneedle patch. A) Top view
of a microneedle patch and its dimensions. B) Slanted microneedle patch view of with 225
microneedles. C) Side view of microneedle and dimension of one microneedle. D) Zoom of
microneedle with meloxicam incorporated. E) Schematic illustrations of transdermal delivery of
meloxicam using chitosan/meloxicam microneedle patches. Reprinted from Materials Science
and Engineering: C, 118, Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino D.,
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Figure 6-1. (Cont.) Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell J.,
Greenlee L., Almodovar J. Design, Characterization, and Modeling of a Chitosan Microneedle
Patch for Transdermal Delivery of Meloxicam as a Pain Management Strategy for Use in Cattle,
111544, Copyright 2020, with permission from Elsevier.

6.3 Materials and Methods
6.3.1 Materials
Chitosan (85% deacetylated, molecular weight: 1526.464 g/mol), purchased from Alfa
Aesar by Thermo Fisher Scientific (cat. no. J64143), and meloxicam (Molecular weight: 351.40
g/mol), purchased from Millipore Sigma (cat. no. PHR1799), were used to prepare
chitosan/meloxicam microneedle patches. Polydimethylsiloxane (PDMS; Sylgard 184) molds
were purchased from Micropoint Technologies Pte, Ltd., Singapore (cat. no. ST-05). The
dimensions of the mold, as shown in Figure 6-1 A-D, were as follows: size 8 mm × 8 mm, needle
height 600 μm, needle base 300 μm, and array size 15 × 15 (225 microneedles/patch). Acetic
acid (99.8%) (cat. no. 109088) from Sigma Aldrich and ultrapure water at 18 MΩ·cm obtained
from an ultrapure water system directly from tap producing Milli-Q® water (MilliporeSigma™
Direct-Q™ 3 Tap), were used during the solution preparation to dissolve chitosan polymer.
6.3.2 Solution Preparation
Chitosan solution was prepared by dissolving chitosan powder in 90% (v/v), 50% (v/v),
and 10% (v/v) of acetic acid in water at a final concentration of 10% w/v. One (1) gram of chitosan
was added to 10 mL of acetic acid at the different concentrations evaluated. For decreasing the
dissolution time, the solution was placed in a heating plate set at 70 °C for 3 h. Once the chitosan
solution was prepared, the chitosan/meloxicam solution consisted of adding and mixing 50 mg of
meloxicam in one milliliter of chitosan solution, which was used to build the first layer of the patch.
Another alternative for the solution preparation consisted of dissolving meloxicam first in dimethyl
sulfoxide (DMSO) purchased from Millipore Sigma (cat. no. D2650), preserving a concentration
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of 50 mg/mL. Then the diluted meloxicam was added to the chitosan solution prepared at the
different percentages of acetic acid established (90% (v/v), 50% (v/v), and 10% (v/v)) maintaining
the final concentration of chitosan at 10% w/v. The initial experimental design for both
formulations included 3%, 7%, 10%, 30%, 50%, 70%, and 90% (v/v) of acetic acid. However,
percentages under 10% (v/v) of acetic acid resulted in a highly viscous solution, which was not
useful to prepare the microneedle patch. As solutions prepared at 10%, 30%, 50%, 70%, and
90% (v/v) of acetic acid were successful in fabricating the microneedle patches, three levels were
established including, 10 % (v/v) of acetic acid as low, 50% (v/v) as medium, and 90% (v/v) as
high level for further characterization.
6.3.3 Chitosan/meloxicam Microneedle Patch Fabrication
The microneedle patch was prepared by placing the chitosan/meloxicam solution on a
PDMS mold. The process of fabricating the chitosan/meloxicam microneedle patch, as illustrated
in Figure 6-2, consisted of adding 500 mg of the casting solution onto the mold to create a
monolayer (See Figure 6-2 – step 1). After that, the mold was put into a 50 mL centrifuge tube
with a flat bottom (See Figure 6-2 – steps 2 and 3), and was centrifuged at 3000 RPM for 30 min
using a Hettich ROTOFIX 32 A Cell Culture Centrifuge from VWR (cat. No. 10813-152). Steps 1
and 2 were repeated four times for a total of 120 min of centrifugation (See Figure 6-2 – step 4).
Due to the microneedle only will be penetrating the skin, a second layer of the chitosan solution
without meloxicam was added. The second layer is on the surface of the skin thus not penetrating
the skin to allow drug release. The second layer was prepared by adding five milliliters of chitosan
solution (0.1 g/mL in acetic acid at 10% (v/v), 50% (v/v), or 90% (v/v)) into the 50 mL tube
containing the mold loaded with the chitosan/meloxicam solution (See Figure 6-2 – step 5) and
centrifuged at 3000 RPM for 60 min. Lastly, the mold in the 50 mL tube was placed in an oven to
dry without the cap at 28 °C for three days (See Figure 6-2 – step 6). The microneedle patch was
gently removed from the tube with tweezers (See Figure 6-2 – step 7).
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Figure 6-2. Schematic illustrations of the chitosan/meloxicam microneedle fabrication process.
Reprinted from Materials Science and Engineering: C, 118, Castilla-Casadiego D. A., Carlton H.,
Gonzalez-Nino D., Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee
L., Almodovar J. Design, Characterization, and Modeling of a Chitosan Microneedle Patch for
Transdermal Delivery of Meloxicam as a Pain Management Strategy for Use in Cattle, 111544,
Copyright 2020, with permission from Elsevier.
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6.3.4 Morphological Analysis
To assess the shape, size, and consistency of chitosan and chitosan/meloxicam
microneedle patches fabricated at the different percentages of acetic acids evaluated, a TESCAN
VEGA3 scanning electron microscope (SEM) operated at 5 keV was used. It was not necessary
to coat the microneedle patch with gold to improve conductivity.
6.3.5

Analysis of the Chemical Composition
To confirm the presence of the functional groups of pure chitosan, pure meloxicam, and

the microneedle patches consisting of pure chitosan and chitosan/meloxicam, a Fourier transform
infrared spectroscopy (FTIR) was used. The infrared spectra of the samples were collected using
a PerkinElmer Frontier FTIR with a Diamond ATR holder within a wavenumber range of 600–
1800 cm−1 using 4 scans at 4 cm−1 resolution.
6.3.6 Analysis of the Thermal Properties
Thermal measurements of chitosan powder, meloxicam powder, and microneedle patches
of chitosan and chitosan/meloxicam using 90% (v/v), 50% (v/v), and 10% (v/v) of acetic acid
during the solution preparation were assessed to provide information regarding the chemical
composition and water content of the patches. Thermogravimetric analysis (TGA) was carried out
on a 5500 TA Instrument, using an argon atmosphere at a flow rate of 20 mL/min, from room
temperature to 1000 °C operating at a ramp temperature of 20 °C/min. The use of differential
scanning calorimetry allowed for the chitosan samples to be compared in terms of their thermal
properties. A TA Differential Scanning Calorimeter (DSC)-25 was used to test all chitosan
samples in this study. Prior to measurement, the weight of each sample was recorded and entered
into the DSC software to ensure accurate, normalized heat flow measurements. A hand press
sealed each sample hermetically inside an aluminum sample container. The samples were placed
on the testing platform within the DSC. The DSC gradually increased the temperature of the
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sample from 0 °C to 200 °C at a rate of 3 °C/min; this temperature range was selected based on
TGA measurements of the measured samples as well as from a review of literature pertaining to
the thermal properties of chitosan [23]. Following measurement, the heating curves were
examined using TA analysis software.
6.3.7

Analysis of the Mechanical Properties
Further investigation with a TA Q400 Thermomechanical Analyzer (TMA) helped to

elucidate the thermo-mechanical properties of the chitosan and chitosan/meloxicam microneedle
patches. The TMA can be used for several different tests to determine how different mechanical
properties of the patches change with respect to temperature. The versatility of the TMA allowed
for each sample to undergo two types of testing: penetration and dynamic temperature ramp.
Penetration testing
The premise of penetration testing was to examine the structural behavior of the patches
under a constant mechanical load. A typical test consisted of placing a chitosan or
chitosan/meloxicam microneedle patch on the sample platform with the microneedle tip side
facing upward; the penetration probe was then gently lowered until it rested on the tip of a single
microneedle, as shown in Figure 6-6D (i). Immediately following probe placement, a constant
load of 0.1 N was applied to the probe, and the local temperature of the sample environment was
increased from 25 °C to 200 °C at a rate of 5 °C/min. The selection of 0.1 N was highly
experimental in nature, and not necessarily found from a particular reference. The weight needed
to be heavy enough to provide a constant normal load on a microneedle (and not deform it at
room temperature), but not heavy enough to crush the microneedle as soon as the weight is
applied. The weight of 0.1 N provided a good middle-ground. Using a linear variable differential
transformer (LVDT), the relative change in the probe’s position was measured, which correlated
to changes in the spike’s geometry with respect to temperature.
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Dynamic temperature ramp
Unlike the penetration testing, dynamic temperature ramp testing applied a tensile load to
long strips of bulk chitosan, rather than testing the patches themselves, as shown in see Figure
6-6D (ii). After recording the dimensions of a chitosan strip, the ends were secured with stainless
steel clamps and subsequently placed into the TMA dynamic testing apparatus. In the TMA’s
enhanced mode, the motor applied a cyclic tensile load to the sample between 0 and 0.1 N at a
rate of 0.5 Hz; concurrently, the environmental temp gradually increased from 25 °C to 200 °C at
a rate of 5 °C/min. By comparing the sample stress versus the strain, measured by the LVDT
during cyclic testing, the sample’s viscoelastic properties were extracted through the software;
specifically, the loss modulus and storage modulus, which when leveraged together, can be used
to determine tan(delta) with respect to temperature. The parameter tan(delta) indicates material
damping or essentially the material’s level of viscoelasticity.
6.3.8

In-vitro Imaging of Microneedle Insertion in Cow’s Ear Cadaver Skin
To assess the skin insertion capability of chitosan/meloxicam microneedle patches, ears

stored at -80 °C (to maintain preservation) were defrosted until reaching room temperature. Then,
the ear was trimmed and shaved until the hair was removed completely from the skin surface.
Next, a superficial incision of approximately 9 mm x 8 mm was done on the animal leather to
supply direct penetration of the microneedle patch on the skin. Finally, the chitosan/meloxicam
microneedle patches prepared at 10% (v/v) of acetic acid were manually inserted into cow’s ear
cadaver skin by pressing against their backing layer for 3 min. Subsequently, the skin was dried
at room temperature for 24 hours. The ear was from a crossbred Angus steer (castrated make)
that was approximately 18 months of age. The skin was imaged under a laser microscope 3D &
profile measurement (VHX-7000 Series Digital Microscope) from Keyence and a TESCAN
VEGA3 scanning electron microscope to determine the insertion depth. It was necessary to coat
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the microneedle patch with gold using a DII 29010SCTR Smart Coater to improve conductivity for
1 min.

6.3.9 Modeling of Drug Release into the Skin

COMSOL Multiphysics 5.4 software was used to simulate transdermal drug delivery from
the microneedle patch system as a 3D model. The model consisted of microneedles penetrating
the three layers that make up the skin: the epidermis, dermis, and fat (Figure 6-1E). The
microneedles were represented as a cone with a base length of 300 µm, a height of 600 µm, and
a spacing of 250 µm as presented in Figure 6-1 A-D. These are the dimensions of the PDMS
mold used to create the microneedle patches. The skin consisted of three parallelepipeds with
80,000 µm of length and width. The height for each parallelepiped was established as reported
for real layers of cow skin. The dimensions for the epidermis, dermis, and fat layer were set at
45.37 µm, 3,580 µm, and 2,000 µm, respectively, as reported in the literature [24]. The skin and
fat materials were selected from the materials section provided for the COMSOL software and
specified to the corresponding layer to be modeled.

Governing equations
The physics chosen for this model was the Transport of Diluted Species. The system was
modulated under a time-dependent model. Laminar flow was placed on the fat layer to simulate
capillary blood flow. For modeling the diffusion and convection of the material, the following
equations were used.
Convection–diffusion equation:
𝑑𝑐𝑖
+ ∇ ⋅ 𝐽𝑖 + 𝑢 ⋅ ∇𝑐𝑖 = 𝑅𝑖
𝑑𝑡
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Fick's first law:
𝐽𝑖 = − 𝐷𝑖 ∇𝑐𝑖

Where 𝑐𝑖 is the target dissolved species (meloxicam) [mol/m 3], t is time [s], the mass
source that describes sources or sinks of the quantity 𝑐𝑖 is 𝑅𝑖 [mol/(m3.s)], 𝐷𝑖 is the
diffusion coefficient [m2/s], 𝑢 is the velocity field [m/s], 𝐽𝑖 is the total flux [m2/s] and ∇
represents the gradient operator.
For laminar flow, the Navier-Stokes equations govern the motion of fluids and can be seen
as Newton's second law of motion for fluids.
Navier–Stokes momentum equation (convective form)

𝜌

𝜕𝑢
+ 𝜌(𝑢 ⋅ ∇)𝑢 = ∇ ⋅ [−pI + K] + F
𝜕𝑡

𝜌∇ ⋅ (𝑢) = 0
Stokes's stress constitutive equation (expression used for incompressible viscous fluids)
K = µ(∇𝑢 + (∇𝑢)𝑇 )

Here, 𝜌 is the fluid density [kg/m3], µ is the fluid dynamic viscosity [Pa.s], 𝑢 is the velocity
field [m/s], 𝑝 is the fluid pressure [Pa], I is the identity matrix, T is stress vector, and F is
the volume force [N/m3].
Boundary conditions
The boundary conditions for the 3D mass transport model were assumed as follows:
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𝜕𝑐
⃒
𝜕𝑧 𝑧=0

(skin boundary, needle wall, t) = 0

c(z,t = 0) tissue = 0

;

c(z,t = 0) needle = 1.43 × 10 -4 mol/m3

Assumptions
•

The initial concentration of meloxicam per each microneedle was assumed as 1.43 × 10 4

mol/m3 based on the necessary amount of drug per kilogram of the cattle (1 mg/kg).

•

Diffusion coefficient as 1.5 × 10 -9 m2/s of meloxicam gel through rat skin [25].

•

A concentration of 0 mol/m3 was established on the skin at t = 0.

•

100% of the available microneedle surface area is touching the skin once the needles are
in place.

•

The diffusion of the drug is modeled into the dermis layer.

Experiments
The effect of the penetration percent of one microneedle and number of microneedles into
the skin was evaluated on transdermal drug delivery. For the penetration percent study, the
following values were evaluated: 25%, 50%, 75%, and 100%. This experiment consisted of
modeling one microneedle into the small piece of skin. The skin consisted of three parallelepipeds
with 8,000 µm of length and width. The thickness of each layer was established, as mentioned. A
second experiment consisted of evaluating an empirical equation to predict the tendency of
transdermal drug delivery. For this experiment, a maximum of 30 microneedles were evaluated
on the patch. The skin consisted of three parallelepipeds with 80,000 µm of length and width. The
area of the skin was increased 10 times compared to the penetration study to obtain a better
visualization of the concentration profile generated by the increment of number of microneedles.
The height for each parallelepiped was established as reported for real layers of cow skin [24].
For both experiments, the time-dependent model was set until 10,000 min or one week. To
monitor the transdermal drug delivery versus number of microneedles, a study point was set at x
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= 40,000 µm, y = 70,000 µm, and z = 1,000 µm. Because the penetration percent study was
modeling one microneedle, the point was located at x = 4,900 µm, y = 2,500 µm, and z = 3,000
µm.
6.4 Results and Interpretation
6.4.1 Physical Characteristics of Microneedle Patch Surface
SEM was used to characterize the morphology, topography, and distribution of
microneedles of chitosan and chitosan/meloxicam patches at different percentages of acetic acid
used during the solution preparation.

Figure 6-3 demonstrates that chitosan and

chitosan/meloxicam microneedle patches have a consistent distribution and dimension of
microneedles, and patches are successfully fabricated using any percentage of acetic acid
assessed. Figures 6-3A and 6-3A’ show the morphology of chitosan microneedles constructed
from a 90% v/v acetic acid solution. These figures reveal that chitosan microneedles have a
smooth and homogeneous surface due to the complete dissolution of chitosan in acetic acid.
Figure 6-3A’ confirms that the height and base length of the microneedle are approximately 600
μm and 300 μm, respectively, matching the dimensions of the mold used (section 6.3.3). Figures
6-3 B-D and 6-3 B’-D’ show that chitosan/meloxicam microneedle patches have a rough surface
compared with chitosan microneedle patches (Figures 6-3A and 6-3A’). This characteristic
topography is related to the fact that the drug is not soluble in acetic acid. Several studies have
demonstrated that meloxicam only dissolves completely in a few solvents, such as dimethyl
sulfoxide (DMSO) [26]. To test whether the solubility of meloxicam caused an increase in surface
roughness, a solution of meloxicam dissolved in DMSO at a concentration of 50 mg/mL (the
meloxicam dissolved completely) was prepared and added to the chitosan solution. Microneedle
patches

were

successfully

fabricated,

but

the

rough

surface

still

observable

on

chitosan/meloxicam microneedle patches using any percentage of acetic acid evaluated and
dissolving the meloxicam in DMSO (See Figure 6-S1 in supporting information (Appendix A.3)).
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When comparing the topography of chitosan/meloxicam microneedle patches prepared at
different percentages of acetic acid (Figures 6-3 B-D and 6-3 B’-D’), patches fabricated using
90% (v/v) acetic acid (Figures 6-3 A-A’) present a notably less rough surface than patches at
50% (v/v) and 10% (v/v) of acetic acid (Figures 6-3 C-D and 6-3 C’-D’). This observation can be
associated with the dissolution capacity that solvents with high concentration have compared with
a low concentration of the same solvent. The same result was observed in patches fabricated
with meloxicam dissolved in DMSO (See Figure 6-S1C’ in supporting information (Appendix
A.3)). Although patches fabricated at 90% (v/v) of acetic acid and the addition of DMSO show a
slight improvement in the topography and appearance of chitosan/meloxicam microneedle, high
percentages of acetic acid and the inclusion of DMSO during the solution preparation drastically
alter the chemical composition of the microneedle patch as demonstrated in the section 6.4.2,
chemical composition of the microneedle patches. Give that using 10% (v/v) of acetic acid during
the solution preparation successfully microneedles were fabricated maintaining the physical
characteristics of the mold used, we suggested to use this percentage to be used for the
fabrication of patch for in-vivo studies or scale-up this technology to industrial scale. This
formulation will avoid the use of a high amount of acetic acid during the solution preparation and
the exposition of the animal to traces of acetic acid that can be released, as mentioned in section
6.4.2.
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Figure 6-3. SEM characterization demonstrated the presence of microneedles uniformly
organized on the patch surface per each percentage of acetic acid used during the solution
preparation. Distribution of microneedle on patch. A) Chitosan microneedle at 90% (v/v) acetic
acid. B) Chitosan/meloxicam microneedle at 90% (v/v) acetic acid. C) Chitosan/meloxicam
microneedle at 50% acetic acid. D) Chitosan/meloxicam microneedle at 10% (v/v) acetic acid.
The topography of one microneedle. A’) Chitosan microneedle at 90% (v/v) acetic acid. B’)
Chitosan/meloxicam microneedle at 90% (v/v) acetic acid. C’) Chitosan/meloxicam microneedle
at 50% (v/v) acetic acid. D’) Chitosan/meloxicam microneedle at 10% (v/v) acetic acid. Reprinted
from Materials Science and Engineering: C, 118, Castilla-Casadiego D. A., Carlton H., GonzalezNino D., Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee L.,
Almodovar J. Design, Characterization, and Modeling of a Chitosan Microneedle Patch for
Transdermal Delivery of Meloxicam as a Pain Management Strategy for Use in Cattle, 111544,
Copyright 2020, with permission from Elsevier.

6.4.2 Chemical Composition of the Microneedle Patches
FTIR was used to assess the chemical composition of chitosan and chitosan/meloxicam
microneedle patches. Figure 6-4 shows the FTIR spectrums of the microneedle patches, pure
chitosan, and pure meloxicam. Results demonstrated that chitosan and chitosan/meloxicam
microneedle patches preserve the chemical composition of the chitosan polymer and meloxicam
drug.
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Analyzing the FTIR spectra of pure chitosan in Figure 6-4D and comparing with its
molecular structure in Figure 6-S2A in supporting information (Appendix A.3), it is possible to
observe that the characteristic absorption peaks of chitosan are shown at 3435 cm-1 (-OH bond),
2922 cm-1 (C–H stretch), 1656 cm-1 (NH2 deformation, amide I), 1603 cm-1 (N–H, N-acetylated
residues, amide II), 1160 cm-1 (bridge –O– stretch), 1085 cm-1 (C–O stretch, secondary hydroxyl
group), and 1030 cm-1 (C–O stretch, primary hydroxyl group), as reported in the literature
[27][28][29]. Figures 6-4A, 6-4B, and 6-4C show the spectrum of chitosan microneedle patches
at different percentages of acetic acid used during the solution preparation 90% (v/v), 50% (v/v),
and 10% (v/v), respectively.
Comparing the FTIR spectrum for chitosan microneedle patches shown in Figure 6-4A,
6-4B, and 6-4C with the pure chitosan spectrum in Figure 6-4D, it is possible to observe that
chitosan microneedle patch spectrums exhibit the same characteristic bands of chitosan, amide
I, amide II, and C-O-C stretch. Although the characteristic bands of chitosan are observed in these
spectrums, high percentages of acetic acid alter the chemical composition of chitosan
microneedles (Figure 6-4A). In Figure 6-4A, chitosan microneedles at 90% (v/v) acetic acid
display peaks attributed to traces of acetic acid at 1721 cm -1 (C=O stretch) and 1420 cm-1 (-OH
bond) (See acetic acid molecular structure in Figure 6-S2C in supporting information (Appendix
A.3), which may produce anomalies such as blistering or burns on the implanted area [30].
Chitosan microneedle patches at 10% (v/v) and 50% (v/v) acetic acid reveal a similar spectrum
with the exception of the appearance of a small peak at 1721 cm -1 corresponding to the C=O
stretch from acetic acid (Figure 6-4B and 6-4C). Notably, increasing the amount of acetic acid
used in the preparation of the chitosan microneedle patches yields FTIR spectrums containing
stronger peaks associated to acetic acid as observed in Figure 6-4A when using 90% (v/v) acetic
acid. This is an indication that the acetic acid is not completely removed during the drying process.
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Therefore, to prepare the chitosan solution, low percentage of acetic acid helps to reduce traces
on the final patch.
A meloxicam FTIR spectrum is presented in Figure 6-4E. Figure 6-4E shows that the
characteristic absorption peaks of meloxicam are located at 3310 cm -1 (amine N-H stretch), 3201
cm-1 (O-H stretch), 2850 cm-1 (aliphatic C-H stretch), 2905 cm-1 (aromatic C-H stretch), 1560 cm1

(C=O stretch), 1340 cm-1 (aromatic C=C stretch), and 1190 cm -1 (aromatic C=C stretch), as

reported in the literature [25] and presented in its molecular structure in Figure 6-S2B in
supporting information (Appendix A.3), which shows the series of aromatic groups that make up
its molecular structure. Figures 6-4A’, 6-4B’, and 6-4C’ show the spectra of chitosan/meloxicam
microneedle patches at different percentages of acetic acid used during the solution preparation
90% (v/v), 50% (v/v), and 10% (v/v), respectively. Comparing the spectrums for
chitosan/meloxicam microneedle patches with pure chitosan (Figure 6-4D) and pure meloxicam
(Figure 6-4E), the FTIR spectrums for chitosan/meloxicam microneedle patches demonstrate that
the characteristic absorption peaks of pure chitosan and meloxicam are present, as described
above. Analyzing the chitosan/meloxicam microneedle spectrums (Figures 6-4A’, 6-4B’, and 64C’), it is possible to observe that most of the characteristic bands of chitosan/meloxicam
microneedle are located between 800 cm -1 and 1600 cm-1, similar to pure chitosan and meloxicam
(Figure 6-4D and 6-4E). Chitosan/meloxicam microneedle patch spectrums show the
characteristic peaks of chitosan at 1160 cm -1 (bridge –O– stretch), 1085 cm-1 (C–O stretch,
secondary hydroxyl group), and 1030 cm -1 (C–O stretch, primary hydroxyl group). Likewise, the
chitosan/meloxicam microneedle spectra also present the characteristic peaks of meloxicam.
Notably, one of the most relevant peaks of meloxicam at 3310 cm -1 (amine N-H stretch) is present
on the chitosan/meloxicam microneedle spectra (See label on Figure 6-4E). In addition, it is
possible to observe two peaks around 1560 cm -1, which are attributed to C=O stretch (See label
on Figure 6-4E). These two sets of crucial peaks (amine N-H stretch and C=O stretch) from
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meloxicam are predominantly observed when the solution was prepared at 10% (v/v) of acetic
acid (Figure 6-4C’) compared with patches prepared at 50% (v/v) (Figure 6-4B’) and 90% (v/v)
(Figure 6-4A’) of acetic acid. Therefore, these results confirm the meloxicam is successfully
incorporated into the microneedle patches by using the methodology proposed in this study.
Figure 6-S3 in supporting information (Appendix A.3) shows the FTIR spectra of
chitosan/meloxicam microneedles at 10% (v/v) acetic acid prepared with and without DMSO used
to dissolve the meloxicam. These results demonstrated that the process of using DMSO to
dissolve the meloxicam completely before adding it to the chitosan solution is not ideal as it does
not keep the chemical composition of meloxicam. The important peaks of meloxicam at 3310 cm 1

(amine N-H stretch) and 1560 cm-1, which are attributed to C=O stretch, were drastically altered

by using DMSO in the solution preparation. Hence, the use of 10% (v/v) of acetic acid during the
solution preparation helps to reduce traces on the final patch to obtain chitosan/meloxicam
microneedle patches that preserve the chemical composition of chitosan polymer and the
meloxicam drug.
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Figure 6-4. FTIR characterization demonstrated that chitosan and chitosan/meloxicam
microneedle patches preserve the chemical composition of the polymer and drug. FTIR
spectrums A) Chitosan microneedles at 90% (v/v) acetic acid, B) Chitosan microneedles at 50%
(v/v) acetic acid, C) Chitosan microneedles at 10% (v/v) acetic acid, D) Pure chitosan, E) Pure
meloxicam, A’) Chitosan/meloxicam microneedles at 90% (v/v) acetic acid, B’)
Chitosan/meloxicam microneedles at 50% (v/v) acetic acid, C’) Chitosan/meloxicam
microneedles at 10% (v/v) acetic acid. Reprinted from Materials Science and Engineering: C, 118,
Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino D., Miranda-Muñoz K. A., Daneshpour R.,
Huitink D., Prinz G., Powell J., Greenlee L., Almodovar J. Design, Characterization, and Modeling
of a Chitosan Microneedle Patch for Transdermal Delivery of Meloxicam as a Pain Management
Strategy for Use in Cattle, 111544, Copyright 2020, with permission from Elsevier.
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6.4.3 Thermal Properties of the Microneedle Patches
TGA and DSC were used to assess the thermal properties of chitosan and
chitosan/meloxicam microneedle patches (Figure 6-5). According to the TGA graphs (Figures 65A and 6-5B), the breakdown of the bulk chitosan occurs in three separate regions. The first
region (< ~200 °C) corresponds to a loss of water within the chitosan structure. When observing
the TGA curve for bulk chitosan, it can be seen that the loss of water was minimal within this
range (most likely due to residual water introduced during synthesis), but samples with varying
acetic acid concentrations showcased larger water losses (Figures 6-5A). By comparison, the
microneedle patches without meloxicam observed a much larger loss of water within this region
(10-20 wt.%) than the patches with meloxicam (5-10 wt.%) (Figures 6-5B). The next region (200
°C < T < 400 °C) indicated both the deacetylation and breakdown of the chitosan structure
[31][32]; similar degradation occurs for the meloxicam as well. All the samples tested showed
degradation within this range, characterized by a significant drop in weight ranging from 10-30
wt.%. The last region (> 400 °C) illustrates a breakdown of the remaining carbon left in the sample
test chamber. These findings demonstrate that the chitosan/meloxicam samples not only had a
lower water loss in the low-temperature regions, but they also resulted in reduced degradation
and organic weight loss within the second region.
DSC curves do not display a noticeable glass transition point for any of the tested chitosan
samples; however, the results do coincide well with the TGA observations for temperatures less
than 200 °C. As discussed in the previous section, the chitosan patches within this region
experience a loss of water through vaporization, which is an endothermic process. The DSC
captures this endothermic process quite well in Figures 6-5C, 6-5D, and 6-5E. For all the
samples, there exists a broad negative peak ranging from 50-200 °C which corresponds to water
vaporization [33][34]. However, for all tested sets of chitosan patches, the addition of meloxicam
significantly reduces the area encompassed by the endothermic peak, which corresponds to
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reduced latent heat absorption. This reduction in area correlates well with TGA results in the lowtemperature regime, which showed reduced water loss for the chitosan samples with meloxicam.
The DSC measurement of meloxicam in Figure 6-5F reported that there is a slight gradual
decrease in heat flow, but there were minimal indications of any phase changes occurring
between 0 and 200 C, as described in the literature [25].
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Figure 6-5. Thermal properties of the microneedle patches. Thermogravimetric analysis A)
Chitosan microneedle patches prepared at 90% (v/v), 50% (v/v), and 10% (v/v) acetic acid and
pure chitosan. B) Chitosan/meloxicam microneedle patches prepared at 90% (v/v), 50% (v/v),
and 10% (v/v) acetic acid and pure meloxicam. Differential scanning calorimetry studies C)
Chitosan and chitosan/meloxicam microneedle patches prepared at 10% (v/v) acetic acid. D)
Chitosan and chitosan/meloxicam microneedle patches prepared at 50% (v/v) acetic acid. E)
Chitosan and chitosan/meloxicam microneedle patches prepared at 90% (v/v) acetic acid. F) Pure
meloxicam. Reprinted from Materials Science and Engineering: C, 118, Castilla-Casadiego D. A.,
Carlton H., Gonzalez-Nino D., Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell
J., Greenlee L., Almodovar J. Design, Characterization, and Modeling of a Chitosan Microneedle
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Figure 6-5. (Cont.) Patch for Transdermal Delivery of Meloxicam as a Pain Management Strategy
for Use in Cattle, 111544, Copyright 2020, with permission from Elsevier.

6.4.4 Mechanical Properties of the Microneedle Patches
In addition to thermal testing, the chitosan samples also underwent mechanical analysis.
A TMA penetration probe, illustrated in Figure 6-6D (i), tested the compression strength of single
microneedles by applying a constant compressive force and gradually raising the temperature.
For the chitosan patches with and without meloxicam, the microneedles with higher acetic acid
percentages observed a greater resistance to compressive force as temperature increased (i.e.,
the dimensional change was less for the 50% (v/v) acetic acid samples than the 10% (v/v) acetic
acid samples) (See Figure 6-6 A-B). This implies that chitosan patches with higher acetic acid
percentages would be more resistant to microneedle deformation during drug delivery. Adding
meloxicam further reduced their total dimensional change, which means that adding meloxicam
greatly increased the stiffness of the microneedles throughout the temperature range (See Figure
6-6 A-B). This is related to the fact that the drug is not soluble in acetic acid; therefore, the
significant increment in stiffness is contributed by the addition of the meloxicam powder during
the microneedle patch preparation. An interesting observation came when analyzing the 50%
(v/v) acetic acid sample with meloxicam; there is a rapid drop in dimensional change by over 200
μm around 100 °C. Similar decreases are observed in other samples at that temperature, which
correlate with water loss in the chitosan structure; however, this dramatic change implies the
microneedle collapsed suddenly under the weight of the probe, rather than a gradual
compression. One possible explanation could be that the chitosan underwent a more brittle failure
when water was removed from the chitosan patch at heightened temperatures.
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Dynamic testing of chitosan samples, illustrated in Figure 6-6D (ii), indicated how their
viscoelastic properties changed with respect to temperature, particularly the value tan(delta),
which is the ratio of the loss modulus to storage modulus of the material. In short, the value
represents the damping ability of the chitosan or the degree of viscoelasticity. Both the 10% (v/v)
and 50% (v/v) acetic acid dynamic tests (See Figure 6-6C) appeared very similar to one another
across the temperature range. Both have an initial value of ~0.5, and as the temperature is
increased, the material shifts towards more elastic behavior, which occurred when water
vaporization was observed in the DSC testing. The value eventually returns to exhibit more
viscous or dissipative behavior at higher temperatures. The lack of a positive peak in tan(delta)
indicates that a glass transition point likely does not occur within this temperature range, which is
corroborated by both TGA and DSC results.

Figure 6-6. Mechanical properties of the microneedle patches. TMA penetration probe. A)
Chitosan and chitosan/meloxicam microneedle patches prepared at 50% (v/v) acetic acid. B)
Chitosan and chitosan/meloxicam microneedle patches prepared at 10% (v/v) acetic acid. TMA
tensile probe.
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Figure 6-6. (Cont.) C) Dynamic temperature ramp testing applied a tensile load to long strips of
chitosan prepared at 10% (v/v) and 50% (v/v) acetic acid. D) Diagram schematic of i) TMA
penetration probe and ii) TMA tensile set-up. Reprinted from Materials Science and Engineering:
C, 118, Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino D., Miranda-Muñoz K. A.,
Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee L., Almodovar J. Design,
Characterization, and Modeling of a Chitosan Microneedle Patch for Transdermal Delivery of
Meloxicam as a Pain Management Strategy for Use in Cattle, 111544, Copyright 2020, with
permission from Elsevier.

6.4.5 In-vitro Imaging of Microneedle Insertion in Cow’s Ear Cadaver Skin
To evaluate the insertion capability of microneedles, the microneedle patch was inserted in the
skin of a cadaver cow’s ear. Figure 6-7A shows a macroscopic picture of the microneedle patch
used. This patch has 225 microneedles uniformly organized on an area of 8 mm × 8 mm with a
distribution of 15 × 15 microneedles, as was described above in section 6.3.3. Our device has
extra material around the microneedle patch surface that may be used to place an adhesive tape
to improve adhesion on the cattle skin (Figure 6-7A). Our goal is to treat the animal during the
healing process; therefore, if the process takes one or two weeks and the patch is not retained
on the cattle skin for that time, the microneedle patch can be modified on the ring around the
patch with an adhesive part. Figure 6-S4A available in supporting information (Appendix A.3).
shows the section of skin where the microneedle patch was inserted. A zoom of the microneedle
penetration on the skin is presented in Figure 6-S4B available in supporting information
(Appendix A.3). Figure 6-7B, 6-7C, and 6-7D demonstrate that the penetration into the skin was
effective. Using a SEM, Figure 6-7B and -6-7C revealed that the penetration on the skin is
uniform, and that the distribution of the microneedles is maintained. A bright-field microscope
image of the section of the penetrated skin shown in Figure 6-S4C in the supporting information
(Appendix A.3) confirms this observation. Figure 6-7C shows the penetration of one single
microneedle, demonstrating that the hole has approximately an area of 150 μm x 150 μm on the
dry skin. Using a 3D laser microscope, it was possible to measure the penetration after the skin
was dried at room temperature for 24 h (Figure 6-7D). The results show an average depth
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penetration of approximately 78 ± 1 μm after the skin was dried. Thus, these results confirm that
our microneedle patch has the capability of penetrating the epidermis and dermis layer of the skin,
which is essential for the transdermal drug delivery.

Figure 6-7. Insertion study demonstrated that microneedle patches were able to penetrate the
skin of a cow’s ear. A) Macroscopy picture of a microneedle patch prepared at 10% (v/v) of acetic
acid, B) SEM picture of penetrated skin, C) Skin section showing the penetration of one
microneedle, D) Depth penetration profile in the skin. Reprinted from Materials Science and
Engineering: C, 118, Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino D., Miranda-Muñoz K.
A., Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee L., Almodovar J. Design,
Characterization, and Modeling of a Chitosan Microneedle Patch for Transdermal Delivery of
Meloxicam as a Pain Management Strategy for Use in Cattle, 111544, Copyright 2020, with
permission from Elsevier.
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6.4.6 Modeling Transdermal Drug Delivery
COMSOL Multiphysics 5.4 software was used to simulate the effect of percent of
penetration depth of one microneedle and the number of microneedles penetrating the skin on
transdermal drug delivery. The modeled system included the three layers that make up the skin,
the epidermis, dermis, and fat. The system was modeled in COMSOL under a physic of transport
of diluted species and time-dependent study in a space dimension 3D. Figure 6-8A shows the 3D profiles of transdermal drug delivery for a penetration of 25%, 50%, 75%, and 100%. Results
in Figure 6-8 A-B demonstrate that if the percentage of insertion increases, the transdermal drug
delivery increases too into the skin. Figure 6-8A (i) shows that a 25% penetration resulted in a
low transdermal drug delivery compared with 100% insertion (Figure 6-8A (iv)). When the
insertion of the microneedle increases into the skin, the area of the microneedle with drug
increases. If the area of the microneedle that is penetrating the skin increases, it will allow more
drug release into the skin. This effect will allow a high amount of the drug to be released.
Therefore, to guarantee a high transdermal drug delivery in a short time, the microneedle should
penetrate 100% into the skin. Figure 6-8B presents the transdermal drug delivery for one week.
Results reveal that the 100% penetration requires 4,520 min to obtain a concentration of 1.43 ×
10-4 mol/m3 at the study the point located at the end of the dermis layer (x = 4,900 µm, y = 2,500
µm, and z = 3,000 µm), while 75% and 50% penetration require 5,480 min and 8,570 min,
respectively. Therefore, the microneedle penetration is a crucial factor to obtain high drug
concentration in a short time. For 25% penetration, it was only possible to obtain a drug
concentration of 1.34 × 10-4 mol/m3 at 10,000 min or one week, which represents 93.7% of initial
drug concentration stablished on the patch of 1.43 × 10-4 mol/m3 and that represents what is
needed for pain management in cattle. As mentioned, our results about the in-vitro imaging of
microneedle insertion in cow’s ear cadaver skin revealed that the skin after the drying process
reported only 13% penetration. The drug concentration to be released for the real patch should
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be approximately 1.34 × 10-4 mol/m3 in around two weeks compared with the yield of the modeled
patch for 25% penetration in one week. Hence, full microneedle penetration in the skin reduces
the time needed to release the required drug on the target point.

Several researchers have demonstrated that the distributions of the microneedles (square,
hexagonal, triangular, and rectangular) [35], geometry or microneedle dimensions (e.g.,
microneedle radius, spacing, height, etc.) [36][37][38], and the number of microneedles
significantly contribute to efficient transdermal drug delivery. The effect of the number of
microneedles on transdermal drug delivery evaluated in this study is presented in Figure 6-8 CE. Results demonstrate that by increasing the number of microneedles, it is possible to obtain
high transdermal drug concentration into the skin. One microneedle penetrating the skin
generates a low drug concentration of 2.02 × 10 -6 mol/m3 (See Figure 6-8C (i)), while thirty
microneedles produce a high drug concentration of 1.07 × 10 -5 mol/m3 (See Figure 6-8C (ii)).
Therefore, many microneedles increase the drug distribution in a major area into the skin. Other
researchers, such as Parket [39], Stoeber [40], and collaborators, in separated studies, also
demonstrated that the number of microneedles is an essential parameter in designing an efficient
microneedle array. The authors both found that skin permeability increases by increasing the
number of microneedles.

An empirical equation, which helps to predict the drug release for the full patch, was
developed by evaluating transdermal drug delivery from 1 to 30 microneedles. Figure 6-8D shows
the graph and empirical equation that describes the tendency of the transdermal drug delivery
into the skin. The transdermal drug delivery tendency was described for Y = 2 × 10 -6 X0.5324
(mol/m3) where Y is drug concentration and X is number of microneedles penetrating the skin.
Calculations using the empirical equation predict that one patch, which contains 225
microneedles, is enough to achieve a drug concentration of 3.57 × 10 -5 mol/m3 in the skin per
week (See Figure 6-8E). Drug concentration value that represents the 26.2% of what is needed
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for pain management in cattle, stablished as 1.43 × 10 -4 mol/m3. In Figure 6-8E, results reveal
that the transdermal drug delivery of two, three, and four patches are 1.45-fold, 1.79-fold, and
2.09-fold greater than one patch, respectively. These results indicate that one patch will not be
enough to supply the required drug concentration of 1.43 × 10 -4 mol/m3, and approximately eight
patches will be needed. As a solution to improve the incapability of using eight patches, in future
plans can be included the study of increasing the amount of drug to be contained per patch and
achieved the reduction of using several patches per cattle. In summary, these findings
demonstrate that both the percentage of penetration of the microneedles and the number of
microneedles are essential parameters in transdermal meloxicam delivery. Although the model
simulated in this study presents several limitations such as the non-inclusion of mechanical
properties of the patch, the weight, age, sex, kind of cattle, movement of the patch, and
environmental condition of the area where the cattle are located, the simulation offers important
information about the transdermal drug release that the microneedle patch could provide. Also,
the simulation confirms our hypothesis related to the number of patches needed to deliver the
dose essential for treating animals with high body mass such as cow. In particular, our patch with
225 microneedles is not capable to supply the rate of drug required. Similarly, the model projects
an idea about patch functionality time, results elucidate that the microneedle patch platform helps
to extend half-life meloxicam for around one week in comparison to 28 hours when meloxicam is
given orally or by injection. Thus, our microneedle patch extends the use of the meloxicam as
pain management medication for livestock animals and present a favorable alternative to
eliminate the laborious and continuous oral administration during the pain release time.
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Figure 6-8. COMSOL simulation demonstrated that the transdermal drug delivery increases in
function to the increment of the number of microneedles on the surface patch and percentage of
penetration per microneedle. Effect of penetration % of one microneedle into the skin. A) Insertion
of one microneedle into the skin. i) 25% insertion, ii) 50% insertion, iii) 75% insertion, and iv) 100%
insertion. B) Transdermal drug delivery versus % of penetration of one microneedle into the skin.
Effect of the number of microneedles. C) Concentration profile of microneedles into the skin. i)
one microneedle, ii) thirty microneedles. D) The tendency of transdermal drug delivery versus the
number of microneedles into the skin, empirical equation. E) Transdermal drug delivery versus
the number of microneedle patches penetrating the skin.
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Figure 6-8. (Cont.) Reprinted from Materials Science and Engineering: C, 118, CastillaCasadiego D. A., Carlton H., Gonzalez-Nino D., Miranda-Muñoz K. A., Daneshpour R., Huitink
D., Prinz G., Powell J., Greenlee L., Almodovar J. Design, Characterization, and Modeling of a
Chitosan Microneedle Patch for Transdermal Delivery of Meloxicam as a Pain Management
Strategy for Use in Cattle, 111544, Copyright 2020, with permission from Elsevier.
6.5 Conclusions

A microneedle patch of chitosan was a successfully created for the delivery of meloxicam.
Chitosan/meloxicam patches presented an organized distribution and homogeneous dimension
of microneedles. Results revealed that the chemical composition of chitosan and meloxicam were
successfully preserved when using acetic acid as the solvent at 10% (v/v). A penetration study
showed a sustained insertion of microneedles in cow’s ear cadaver skin. The percentage of acetic
acid used during the solution preparation was a crucial factor in controlling the thermo-mechanical
properties of the patches. Chitosan and chitosan/meloxicam microneedle patches with higher
acetic acid percentages showed a greater resistance to compressive force as temperature
increased. Modeling of the microneedle patches revealed that an increment of the number of
microneedles on the surface patch and percentage of penetration per microneedle in the skin play
an important role in the transdermal delivery of meloxicam. These results suggest that
chitosan/meloxicam microneedles patches may be suitable to manage pain in cattle after routine
procedures. Future plans include the study of increasing the amount of drug to be contained per
patch and achieved the reduction of using several patches per cattle given that the modeling
transdermal drug delivery study predicted that the patch with 225 microneedles is not capable to
supply the rate of drug required.
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CHAPTER 7.

Conclusions and Future Work

7.1 Conclusions
This dissertation demonstrates the potential of polymers such as collagen, heparin, and
chitosan for the development of biomaterials for cell manufacturing, tissue regeneration, and drug
delivery. In addition, the use of polymers has demonstrated to be useful to modify other surfaces
either silicon, glass, or even type of plastics such as TCP.
Polymeric multilayers prepared by the Layer-by-Layer technique are capable of altering
either the chemical composition, physical, thermal, or mechanical properties of surfaces. This
allows to generate multilayers at nano scale that in this dissertation were fully characterized by
Infrared Variable Angle Spectroscopic Ellipsometry (IRVASE). This technique was useful to (1)
analyze the formation and growth of the multilayers, (2) study their chemical composition, (3)
study their thickness, (4) study their roughness, and (5) study their thermal stability. Results
showed that HEP/COL multilayers prepared using a washing solution of pH 5, reported values of
40.3 nm for three bilayers, a film roughness of 33.58 nm for three bilayers of HEP/COL, a Young’s
modulus of 9000 kPa for 12 bilayers compared with 24000 kPa for three bilayers, and thermal
results showed temperatures above 37 °C drastically alter the chemistry and the thickness of the
HEP/COL multilayers indicating a possible degradation of the polymers. Regarding the cell
manufacturing applications, polymeric multilayers of HEP/COL with IFN-γ supplementation in the
culture medium were able to promote the improvement of cellular behaviors of h-MSCs compared
to standard TCP. Our results on the percent of EdU-positive cells for h-MSCs seeded over the
surfaces supplemented with IFN-γ reported an approximate value of 33%, 23%, and 22% for
HEP-terminated films, COL-terminated films, and TCP, respectively. HEP/COL coatings allow the
preactivation of h-MSCs using IFN-γ to enhance their immunomodulatory properties and
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therapeutic potential while eliminating IFN-γ’s antiproliferative effect. A P-value < 0.001 was
obtained when comparing HEP/COL multilayers with the presence of IFN-γ and the other
conditions evaluated. Our results suggest that this technology could be implemented in h-MSC
manufacturing by creating surfaces that allow their preactivation without limiting their growth.
Collagen and collagen/hydroxyapatite nanofibers prepared by the electrospinning
technique are promising platforms to mimic the ECM environment with controlled diameter,
mechanical properties, morphology, and orientation of nanofibers. These nanofibrous collagen
scaffolds demonstrated to support mammalian cell culture, indicating potential promise in the field
of tissue engineering. SEM results revealed the stability of the developed collagen/hydroxyapatite
nanofibers, with an average diameter of 342 ± 67 nm and 175 – 400 nm for collagen nanofibers
by adjusting the injection flow or the voltage. Mechanical properties can be modulated in the range
of native tissues of 2.7 to 4.1 MPa by the selection of the crosslinking method. In addition, results
showed how “green” electrospinning using an acetic acid/water solution as a “green” solvent could
be used to generate nanocomposite scaffolds with potential biomedical applications.
Microneedle patch of chitosan was successfully created for the delivery of meloxicam by
the modeling technique. SEM confirmed the presence of microneedles uniformly organized on
the patch surface. The resultant microneedle patches were successful in penetrating the skin in
a cow’s cadaver ear, reporting an average depth penetration of 78 ± 1 μm measured after
complete dehydration of the penetrated skin. Modeling of the microneedle patches revealed that
one patch is not enough to supply the required drug concentration of 1.43 × 10 -4 mol/m3 to treat
the animal, and approximately eight patches will be needed to manage pain in cattle after routine
procedures.
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This work demonstrates that using polysaccharide-based nanomaterials can be fabricated
multifunctional surfaces to promote cell manufacturing, tissue regeneration, and control drug
delivery applications.
7.2 Future Work
Future studies for the cell manufacturing topic will focus on elucidating the mechanisms
by which HEP-terminated films enhance IFN-γ activity. Moreover, we will perform experiments to
evaluate the translational potential of this technology toward manufacturing by coating bioreactors
and evaluating xeno-free media. For the tissue regeneration topic, future work includes decorating
these collagen nanofibers with biochemical cues to induce in-vivo tissue formation in rabbits. Also,
cellular differentiation studies will develop by seeding h-MSCs on the nanofibrous scaffolds.
Finally, for the drug delivery topic, future plans include the study of increasing the amount of drug
to be contained per patch and achieved the reduction of using several patches per cattle given
that the modeling transdermal drug delivery study predicted that the patch with 225 microneedles
is not capable of supplying the rate of drug required. In addition, in-vivo experiments in cattle will
be developed to assess transdermal drug delivery and pain relief during routine management
practices.
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Appendix
A.1 Supporting Information for Chapter 2
Figure 2-S1 of this supplementary information represents as an example, the data and
precision of a fit generated by the WVASE-IR, for the formation of 12 bilayers. An identical
behavior was observed by the other experiments, validating the reliability of the obtained results.
Figure 2-S2 presents the molecular structure of: A) PEI, B) PSS, C) HEP and D) macroscopic
structure of Collagen. Figures 2-S3 and 2-S6 present IRVASE spectra of 12 polymeric bilayers
of PEI/PSS and HEP/COL in the range of 1700 cm-1– 800 cm-1., respectively. Figure 2-S4
presents the physical characteristics for PEI/PSS system by AFM and, the Figure 2-S5 presents
the mechanical properties of the multilayers for PEI/PSS and HEP/COL by AFM.
Tables S1, S2, S3 and S4 present the data obtained using the WVASE-IR software; the
offset, n/k, and MSE, which indicate the precision and reliability of the obtained characterization.
The offset shows the amount by which the measurement presented could be out of line; the
smaller the number, the better. It should also not vary between samples, since they have all been
prepared and contain the same polymers. The MSE, or Mean Squared Error, represents how
much the software needed to work to acquire the data, meaning that also, the smaller the number
the better to validate the reliability of the results. Optical constants n and k are characteristic to
the polymers that are used and should not greatly vary between samples of the same number of
bilayers.
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Figure 2-S1. 12 bilayers of PEI/PSS at a pH of 5 and room temperature showing the Model Fit
provided by the WVASE_IR software at 65 and 75. Reprinted from Colloids and Surfaces A:
Physicochemical and Engineering Aspects, 553, Castilla‐Casadiego D. A., Pinzon-Herrera L. C.,
Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and Almodovar J., Simultaneous
characterization of physical, chemical, and thermal properties of synthetic and natural polymeric
multilayers using infrared spectroscopic ellipsometry, 155-168, Copyright 2018, with permission
from Elsevier.
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Table 2-S1. Data of the WVASE-IR software for the experimental data in Figure 2. Reprinted
from Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553, Castilla‐
Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and
Almodovar J., Simultaneous characterization of physical, chemical, and thermal properties of
synthetic and natural polymeric multilayers using infrared spectroscopic ellipsometry, 155-168,
Copyright 2018, with permission from Elsevier.

Table 2-S2. Data of the WVASE-IR software for the experimental data in Figure 3. Reprinted from
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553, Castilla‐Casadiego D.
A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and Almodovar
J., Simultaneous characterization of physical, chemical, and thermal properties of synthetic and
natural polymeric multilayers using infrared spectroscopic ellipsometry, 155-168, Copyright 2018,
with permission from Elsevier.
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Table 2-S3. Data of the WVASE-IR software for the experimental data in Figure 5. Reprinted from
Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553, Castilla‐Casadiego D.
A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and Almodovar
J., Simultaneous characterization of physical, chemical, and thermal properties of synthetic and
natural polymeric multilayers using infrared spectroscopic ellipsometry, 155-168, Copyright 2018,
with permission from Elsevier.
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Table 2-S4. Data of the WVASE-IR software for the experimental data in Figure 2-6. Reprinted
from Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553, Castilla‐
Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and
Almodovar J., Simultaneous characterization of physical, chemical, and thermal properties of
synthetic and natural polymeric multilayers using infrared spectroscopic ellipsometry, 155-168,
Copyright 2018, with permission from Elsevier.
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Figure 2-S2. Molecular structure: A) PEI, B) PSS, C) HEP, and D) Macroscopic structure of
Collagen. Reprinted from Colloids and Surfaces A: Physicochemical and Engineering Aspects,
553, Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A.,
Suleiman D., and Almodovar J., Simultaneous characterization of physical, chemical, and thermal
properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.
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Figure 2-S3. IRVASE spectrum of 6 polymeric bilayers of PEI/PSS collected at a resolution of 16
cm-1, 200 scans, and in the range of 1700 cm -1– 800 cm-1. Reprinted from Colloids and Surfaces
A: Physicochemical and Engineering Aspects, 553, Castilla‐Casadiego D. A., Pinzon-Herrera L.
C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and Almodovar J., Simultaneous
characterization of physical, chemical, and thermal properties of synthetic and natural polymeric
multilayers using infrared spectroscopic ellipsometry, 155-168, Copyright 2018, with permission
from Elsevier.
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Figure 2-S4. Physical characteristics for PEI/PSS system by AFM. A) Thickness vs. number of
bilayers and B) Roughness vs. number of bilayers. The error bars indicate the standard deviation
of the samples as is described in the materials and methods section. The p-values < 0.01 are
represented by #, @, &, ψ, ϴ and ϕ. The bars that have the same symbol are statistically different.
Reprinted from Colloids and Surfaces A: Physicochemical and Engineering Aspects, 553,
Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman
D., and Almodovar J., Simultaneous characterization of physical, chemical, and thermal
properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.

Figure 2-S5. Mechanical properties of the multilayers by AFM. A) Young’s Modulus of PEI/PSS
multilayers vs. number of bilayers B) Young’s Modulus of HEP/COL multilayers vs. number of
bilayers.
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Figure 2-S5. (Cont.) The error bars indicate the standard deviation of the samples as is described
in the materials and methods section. The p-values < 0.01 are represented by #, @, &, ψ and ϴ.
The p-values < 0.05 are represented by $, %, * and !. The bars that have the same symbol are
statistically different. Reprinted from Colloids and Surfaces A: Physicochemical and Engineering
Aspects, 553, Castilla‐Casadiego D. A., Pinzon-Herrera L. C., Perez-Perez M., Quiñones-Colón
B. A., Suleiman D., and Almodovar J., Simultaneous characterization of physical, chemical, and
thermal properties of synthetic and natural polymeric multilayers using infrared spectroscopic
ellipsometry, 155-168, Copyright 2018, with permission from Elsevier.

Figure 2-S6. IRVASE spectrum of 6 polymeric bilayers of HEP/COL collected at a resolution of
16 cm-1, 200 scans, and in the range of 1700 cm-1– 800 cm-1. Reprinted from Colloids and
Surfaces A: Physicochemical and Engineering Aspects, 553, Castilla‐Casadiego D. A., PinzonHerrera L. C., Perez-Perez M., Quiñones-Colón B. A., Suleiman D., and Almodovar J.,
Simultaneous characterization of physical, chemical, and thermal properties of synthetic and
natural polymeric multilayers using infrared spectroscopic ellipsometry, 155-168, Copyright 2018,
with permission from Elsevier.
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A.2 Supporting Information for Chapter 3
Analysis of IFN-γ levels in the fetal bovine serum. Results for EdU and Luminex assays
are shown below performed with cells from a different donor and vendor following the same
procedure stated in the manuscript. Low power images of immunostaining of adhesive proteins
of h-MSCs are shown for each group after incubation for 3 days by fluorescent detection at 20X.
h-MSCs were acquire from RoosterBio. h-MSCs from Lot 00174 were used, which correspond to
a 25-year-old male donor. The certificate of analysis provided by RoosterBio shows that the cells
were positive for CD166, CD105, CD90, and CD73; and they were negative for CD14, CD34, and
CD45 surface markers, thus confirming they are h-MSCs. Moreover, the cells efficiently
differentiated into adipocytes and osteocytes as characterized by Oil Red lipid stain and Alizarin
red calcium stain. h-MSCs were cultured on HEP/COL films terminated either in COL or HEP with
and without 50 ng/mL of IFN-γ for 3 days.

Figure 3-S1. Analysis of IFN-γ levels in undiluted fetal bovine serum. Data is presented as mean
± standard deviation of n=4 samples.
263

Figure 3-S1. (Cont.) Reprinted from ACS Biomaterials Science & Engineering, 5, CastillaCasadiego D. A., García J. R., García A. J., Almodovar J., Heparin/Collagen Coatings Improve
Human Mesenchymal Stromal Cell Response to Interferon Gamma, 2793-2803, Copyright 2019,
with permission from ACS.

Figure 3-S2. h-MSC proliferation response measured by the EdU assay on TCP, 12 layers of
HEP/COL(layers ending in COL), and 13 layers of HEP/COL (layers ending in HEP) using
medium supplemented with and without IFN-γ using cells from RoosterBio (male 25 yrs old). A)
Representative EdU assay images for each condition, the blue color represents the nucleus
(DAPI) and the green the EdU label. B) h-MSCs proliferation response. Data are presented as
the mean ± standard deviation of n=4 samples. The p < 0.05 are represented by *. Reprinted from
ACS Biomaterials Science & Engineering, 5, Castilla-Casadiego D. A., García J. R., García A. J.,
Almodovar J., Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell Response
to Interferon Gamma, 2793-2803, Copyright 2019, with permission from ACS.
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Figure 3-S3. Cytokine levels as assessed by Luminex assay using cells from RoosterBio (male
25 yrs old). Comparative protein expression of h-MSCs seeded on TCP, 12 layers of HEP/COL
(layers ending in COL), and 13 layers of HEP/COL (layers ending in HEP) using medium
supplemented with and without IFN-γ. A) IL-6. B) VEGF-A. C) FGF-2. D) M-CSF. Data are
presented as the mean ± standard deviation of n=4 samples. The p-values < 0.05 are represented
by * and p-values < 0.001 by ***. Reprinted from ACS Biomaterials Science & Engineering, 5,
Castilla-Casadiego D. A., García J. R., García A. J., Almodovar J., Heparin/Collagen Coatings
Improve Human Mesenchymal Stromal Cell Response to Interferon Gamma, 2793-2803,
Copyright 2019, with permission from ACS.
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Figure 3-S4. Analysis of h-MSCs adhesion in each group after incubation for 3 days by
fluorescent detection at 20X. A) Fluorescent images of triple staining with phalloidin for actin
filaments (red), DAPI for nuclei (blue) and antibodies (p-FAK, eta-1, and Beta-3) (green) showed
focal adhesion formation for h-MSCs seeded over the surface of TCP without IFN-γ supplemented
in the culture medium. B) Fluorescent images of triple staining for h-MSCs seeded over the
surface of TCP with IFN-γ supplement. C) Fluorescent images of triple staining for h-MSCs
seeded over the surface of 12 layers of HEP/COL without IFN-γ supplement. D) Fluorescent
images of triple staining for h-MSCs seeded over the surface of 12 layers of HEP/COL with IFNγ supplement. E) Fluorescent images of triple staining for h-MSCs seeded over 13 layers of
HEP/COL without IFN-γ supplement. F) Fluorescent images of triple staining for h-MSCs seeded
over 13 layers of HEP/COL with IFN-γ supplement. Reprinted from ACS Biomaterials
Science & Engineering, 5, Castilla-Casadiego D. A., García J. R., García A. J., Almodovar J.,
Heparin/Collagen Coatings Improve Human Mesenchymal Stromal Cell Response to Interferon
Gamma, 2793-2803, Copyright 2019, with permission from ACS.
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A.3 Supporting Information for Chapter 6

Figure 6-S1. SEM reported that chitosan/meloxicam microneedles prepared by dissolving the
meloxicam in DMSO at a concentration of 50 mg/ml (the meloxicam dissolved completely) before
adding to the chitosan solution. Distribution of microneedle on patch.
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Figure 6-S1. (Cont.) A) Chitosan/meloxicam microneedle at 10% (v/v) acetic acid. B)
Chitosan/meloxicam microneedle at 50% (v/v) acetic acid. C) Chitosan/meloxicam microneedle
at 90% (v/v) acetic acid. The topography of one microneedle. A’) Chitosan/meloxicam
microneedle at 10% (v/v) acetic acid. B’) Chitosan/meloxicam microneedle at 50% (v/v) acetic
acid. C’) Chitosan/meloxicam microneedle at 90% (v/v) acetic acid. Reprinted from Materials
Science and Engineering: C, 118, Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino D.,
Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee L., Almodovar J.
Design, Characterization, and Modeling of a Chitosan Microneedle Patch for Transdermal
Delivery of Meloxicam as a Pain Management Strategy for Use in Cattle, 111544, Copyright 2020,
with permission from Elsevier.

Figure 6-S2. Molecular structure: A) Chitosan, B) Meloxicam, C) Acetic acid. Reprinted from
Materials Science and Engineering: C, 118, Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino
D., Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee L., Almodovar
J. Design, Characterization, and Modeling of a Chitosan Microneedle Patch for Transdermal
Delivery of Meloxicam as a Pain Management Strategy for Use in Cattle, 111544, Copyright 2020,
with permission from Elsevier.
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Figure 6-S3. FTIR characterization demonstrated that the addition of DMSO alters the chemical
composition of chitosan/meloxicam microneedle patches (N-H and C=O functional group of
meloxicam affected). FTIR spectrum of chitosan/meloxicam microneedles at 10% (v/v) acetic acid
prepared with and without DMSO used to dissolve the meloxicam. Reprinted from Materials
Science and Engineering: C, 118, Castilla-Casadiego D. A., Carlton H., Gonzalez-Nino D.,
Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G., Powell J., Greenlee L., Almodovar J.
Design, Characterization, and Modeling of a Chitosan Microneedle Patch for Transdermal
Delivery of Meloxicam as a Pain Management Strategy for Use in Cattle, 111544, Copyright 2020,
with permission from Elsevier.
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Figure 6-S4. In-vitro microneedle insertion study demonstrated that microneedle patches were
able to penetrate cow’s ear cadaver skin. Microneedle insertion testing. A) Microneedle patch,
and cow’s ear cadaver skin. B) Zoom macroscopy picture of in-vitro microneedle insertion on
cow’s ear cadaver skin. C) Bright-field microscope picture of the monolayer section of the
penetrated skin. Reprinted from Materials Science and Engineering: C, 118, Castilla-Casadiego
D. A., Carlton H., Gonzalez-Nino D., Miranda-Muñoz K. A., Daneshpour R., Huitink D., Prinz G.,
Powell J., Greenlee L., Almodovar J. Design, Characterization, and Modeling of a Chitosan
Microneedle Patch for Transdermal Delivery of Meloxicam as a Pain Management Strategy for
Use in Cattle, 111544, Copyright 2020, with permission from Elsevier.
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